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ABSTRACT 
Jorge Alejandro Henao-Mejia 
 
Sam68, Stress Granules, and Translational Control of HIV-1 nef mRNA 
 
More than 20 million people have died of AIDS since the early eighties, while 
nearly 34 millions are currently infected with the HIV.  Anti-retroviral therapy 
(ART) directed at key viral enzymes has changed AIDS from uniformly fatal to a 
manageable chronic disease.  However, ART-associated drug resistance and 
toxicity have posed a great challenge for long-term management of the disease 
and have called for development of new therapeutics.  In this study, we focused 
on the viral factor Nef and the host factor Sam68.  Nef is a major pathogenic viral 
determinant for HIV-1, and no therapeutics have been targeted to this factor.  
Sam68 is indispensible for HIV-1 propagation.  We revealed that Sam68 variants 
were very potent in preventing Nef expression.  We found that these effects were 
associated with their ability to form a macromolecular structure called stress 
granules (SG).  In addition, we demonstrated that these variants bound to nef 
mRNA in a sequence-specific manner.  Furthermore, we showed that these 
variants co-localized with nef mRNA in SG.  Importantly, we validated these 
findings in the context of HIV-1 infection of its natural target cells and found 
significant loss of Nef function in these cells.  Taken together, these results 
demonstrate that SG induction and nef mRNA sequestration account for 
translational suppression of Nef expression and offer a new strategy for 
development of anti-HIV therapeutics.   
 vii
Sam68 is implicated in a variety of other important cellular processes.  Our 
findings that Sam68 variants were able to induce SG formation prompted us to 
investigate whether wild-type Sam68 was also recruited to SG.  We found that 
Sam68 was increasingly recruited into SG under oxidative stress, and that its 
specific domains were involved.  However, Sam68 knockdown had no effects on 
SG assembly, suggesting that Sam68 is not a constitutive component of SG 
assembly.  Lastly, we demonstrated that Sam68 complexed with TIA-1, an 
essential SG component.  Taken together, these results provide direct evidence 
for the first time that Sam68 is recruited into SG through complexing with TIA-1, 
and suggest that SG recruitment of Sam68 and ensuing changes in Sam68 
physiological functions are part of the host response to external stressful 
conditions. 
 
 
 
       
       Johnny J. He, Ph.D., Chair 
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INTRODUCTION 
 
1. HIV-1 AND THE  AIDS PANDEMIC 
1.1 The HIV-1 pandemic 
1.1.1 Global perspective 
The acquired immunodeficiency syndrome (AIDS) remains as one of the greatest 
public health hazards in the world today.  Since the beginning of the pandemic 27 
years ago, more than 20 million people have died, and approximately 34 million 
are currently infected with the human immunodeficiency virus type 1 (HIV-1) 
worldwide.  The global incidence of HIV-1 infections and AIDS cases are 
considered to have reached a plateau.  Nevertheless,  approximately 2.7 million 
new infections occurred, and 2 million people died of AIDS in 2007 [1].  The 
landscape of the epidemic has changed drastically since the early 1980s, with 
profound implications for the social and economical development of different 
regions.  Nowadays, 50% of people living with HIV-1 are women, the number of 
HIV-1-infected children younger than 15 has steadily increased since 2001, and 
45% of newly infected people are between the ages of 15 and 24 years [1].  
Moreover, despite the recent decrease in the overall number of yearly new 
infections, the total number of HIV-1-infected people continues to increase 
steadily due to the successful life extending HIV-1 treatments [1]. 
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1.1.2  Regional perspective 
The main concerns of the HIV-1 pandemic are focused in two regions: sub-
saharan Africa and southeast Asia.  Two thirds of the infected people worldwide 
live in sub-sahara Africa, where 1.9 million new infections and 75% of all AIDS 
deaths occurred in 2007 [1].  The epidemics vary considerably from country to 
country with HIV-1 adults prevalence ranging from 2% to above 15%, although 
the epidemic has stabilized in some countries in this region.  Heterosexual 
intercourse remains the main mode of HIV-1 transmission in this region [1].  It is 
estimated that nearly 5 million people are currently infected in Asia, with the 
highest level of prevalence in southeast Asia.  Countries such as Thailand show 
a decline in the HIV-1 prevalence, whereas in other countries such as Vietnam 
the epidemic is rapidly growing.  Injectable drug use remains the main risk factor 
driving the epidemic in several Asian countries [1].  Another region of concern is 
central Europe and east Asia, where the annual number of new HIV-1 infections 
has doubled since 2001 [1].  
 
1.1.3  The United States perspective 
There were a total of 1.2 million HIV-1 infected people in the United States in 
2007 [1].  The yearly number of new infections has remained stable for the past 
several years. Life expectancy has increased among HIV-1 infected individuals 
due to wide access to anti-retroviral therapy (ART), leading to an increase in the 
estimated number of people living with HIV-1 infection in the United States.  
However, the epidemiological trends in some ethnic populations are worrisome.  
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In 2005, blacks (including African Americans) accounted for nearly 50% of newly 
diagnosed AIDS and HIV-1 infections.  Moreover, the rate of AIDS diagnosis for 
blacks was ten times that of whites and nearly three times that of hispanics.  The 
main route of transmission for black men was sexual contact with other men, 
whereas for women it was heterosexual contact [2].      
 
1.2 Clinical, virological, and immunological aspects of HIV-1 infection 
The course of HIV-1 infection begins with an acute symptomatic illness, which 
lasts a few weeks.  This is generally followed by an asymptomatic phase of 
chronic infection, which lasts an average of 8-10 years.  Finally, AIDS develops, 
characterized by low CD4+ T cell counts, opportunistic infections and tumors 
(Fig. 1).  
 
1.2.1 The acute phase  
Clinical manifestations in acutely HIV-1-infected individuals are usually observed 
2-4 weeks after exposure; they are described as a flu-like syndrome.  Patients 
present a variety of signs and symptoms such as fever, lymphadenopathy, 
pharyngitis, mucocutaneous lesions, myalgia, arthralgia, headache, 
gastrointestinal symptoms, and weight loss [3].  The onset of clinical symptoms is 
associated with a peak high viremia [4], which is rapidly followed by a 100 to 
1000-fold viral load drop [5].  The earliest targets of HIV are mucosal memory 
CD4+ CCR5+ T cells [6], which are the majority of the CD4+ T cell pool, with the  
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Figure 1.  Natural history of HIV-1 infection.  Clinical, virological and 
immunological evolution of a typical HIV-1-infected individual, shown as changes 
in HIV-1 plasma viral load (red), peripheral blood CD4+ T cell counts (blue), and 
gastrointestinal tract mucosa CD4+ T cell numbers (green).  The X axis 
represents time after primary infection.  The Y axis represents CD4 T cell counts 
on peripheral blood or gastrointestinal mucosa and viral RNA copies in plasma. 
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gastrointestinal (GI) tract mucosa harboring nearly 80% of the total population.  
Peak viremia is accompanied by a rapid and transient decrease in peripheral 
blood (PB) CD4+ T cell numbers, and a largely irreversible depletion of GI 
mucosal CD4+CCR5+ memory T cells [7-9].  A partial rise in PB CD4+ T cells is 
coupled with viral load drop, resolution of flu-like symptoms, and establishment of 
a chronic infection. 
 
1.2.2 The chronic phase 
The acute and chronic phases of the infection are markedly different.  Clinically, 
the chronic phase is generally asymptomatic.  The viremia is significantly lower 
than the one observed at the peak in the acute stage, but from this point it will 
continue a steady and slow rise [4].  PB CD4+T cells will reach a plateau after 
the partial recovery at the end of the acute stage, but then they fall slowly over a 
average period of 10 years before the onset of AIDS [5].  Recovery of mucosal 
CD4+ T cell levels is minimal.  Moreover, this stage is characterized by a state of 
deleterious chronic immune hyper-activation, which is a better predictor of 
disease progression than viral RNA loads [10].  Continuous translocation of 
microbial products due to massive depletion in CD4+T cells in the gut, along with 
ensuing broad activation of the innate immune system seems to be the 
underlying mechanism behind this phenomenon [11]. 
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1.2.3 The AIDS stage 
The AIDS stage is a continuation of the immunological and virological features 
observed in the previous phase.  PB CD4+ T cells continue to decline below 200 
cells/μl, which is often associated with a sudden rise in the viral load of the 
patients [12].  Clinically, this stage is characterized by the onset of AIDS-related 
opportunistic infections or tumors such as: toxoplasmosis or Kaposi sarcoma, 
that eventually lead to the death of the infected individuals.  
 
1.3 HIV-1 and its genome 
HIV-1 has an approximate diameter of 120 nm and is composed of fifteen 
proteins and two molecules of viral genomic RNA.  The HIV-1 genome is ~9 kb 
and encodes nine open reading frames (ORF).  Three of these ORF encode the 
Gag, Pol and Env polyproteins which are subsequently processed into individual 
proteins.  Gag encodes four structural proteins MA (matrix), CA (capsid), NC 
(nucleocapsid) and p6 that make up the core of the virion; Env generates the 
glycoproteins gp120 and gp41, which are the two main components of the outer 
virion layer; there are three Pol proteins: PR (protease), RT (reverse 
transcriptase), and IN (integrase), they provide essential enzymatic functions and 
are also encapsulated within the virion.  The six additional ORFs encode the 
accessory viral proteins Tat, Rev, Nef, Vpr, Vpu, and Vif.  Vpr induces cell cycle 
arrest and regulates nuclear importation of preintegration complexes in 
nondividing cells [13];  Vpu is involved in viral budding, enhancing virion release 
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from the cell [14];  Vif neutralizes a potent host antiretroviral pathway mediated 
by APOBEC3 [15].  Nef, Vpr, and Vif are also found within the viral particle.  Tat, 
Rev and Nef provide essential regulatory functions that will be discussed in detail 
in the following sections.  In addition, a number of non-coding regions required 
for efficient replication are located near the ends of the HIV-1 genome.  These 
include R, a short sequence repeated at each end; U5, a unique sequence 
between R and PB near the 5’ end; PB, which provides the primer binding site for 
the synthesis of the minus strand of the cDNA; PP, a stretch of purine 
nucleotides that provide the primer for the plus strand of cDNA; and U3, a unique 
sequence between PP and R near the 3’ end.  During reverse transcription, U3, 
R and U5 are duplicated at the ends of the DNA to form a structure called the 
long terminal repeat (LTR), allowing the virus to generate the transcriptional 
control elements that lie outside the transcribed region [16].    
 
1.4 HIV-1 life cycle 
Infectious HIV-1 virions initially bind to the cellular receptor CD4 and chemokine 
co-receptors CCR5 or CXCR4 on the surface of susceptible cells via envelope 
(Env) glycoprotein gp120 [17, 18] (Fig. 2).  Following binding, gp41 undergoes a 
conformational change that promotes virus-cell membrane fusion [19], thereby 
allowing the viral nucleocapsid to enter the cytoplasm.  The viral core is then 
uncoated to expose a nucleoprotein complex, which contains the viral proteins 
MA, RT, IN, PR, Vpr, Vif, Nef, and RNA [16].  The linear single stranded RNA 
genome is then reverse transcribed to a dsDNA molecule by the RT enzyme [16].  
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Figure 2.  HIV-1 replication cycle and targets of therapeutic intervention.  1. 
Binding; 2. Membrane fusion; 3. Uncoating; 4. Reverse transcription; 5. 
Assembly of the pre-integration complex; 6. Nuclear importation of the pre-
integration complex and integration; 7. Rev-independent exportation of 
completely spliced mRNA and translation of Tat, Rev and Nef; 8. Rev-dependent 
exportation of intron containing mRNA; 9 and 10. Translation of structural 
proteins and viral enzymes; 11. Virion assembly; and 12. Budding and 
maturation.  FDA-approved agents against HIV-1 and their targets are indicated 
(Boxes). 
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The dsDNA enters the nucleus as a nucleic acid-protein complex (the pre-
integration complex) and is incorporated in the cell’s genome by the action of the 
IN enzyme [16].  The integrated genome, also known as provirus, serves as a 
template for virus replication.  Viral transcripts are expressed from the promoter 
located in the 5’ LTR, with Tat greatly enhancing the rate of transcription [20, 21].  
Completely spliced transcripts are exported to the cytoplasm by the cellular 
mRNA exportation machinery; translation of this RNA leads to the synthesis of 
the regulatory proteins Tat, Rev and Nef.  Singly spliced and genome-length 
unspliced RNA are transported to the cytoplasm through a Rev-regulated 
mechanism [22, 23].  The latter RNA species upon translation give rise to the 
Gag and Gag-Pol polyproteins which become localized to the cell membrane, 
while the singly spliced RNA translates to the Env followed by its localization to 
the endoplasmic reticulum (ER).  The polyproteins that form the viral core, 
namely the products of the Gag and Pol genes, initially assemble into immature 
nucleocapsids together with two copies of the full length viral RNA (viral 
genome), and immature virions begins to bud from the cell surface.  As these 
structures bud through the plasma membrane, they become encapsulated by a 
layer of membrane that harbors Env glycoproteins.  Coincident with budding a 
third viral enzyme known as protease (PR) cleaves the core proteins into their 
final forms, and the virion undergoes morphologic changes known as maturation 
[16]. 
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1.5 HIV-1 transcription and splicing 
HIV-1 mRNA is transcribed from integrated proviral DNA by RNA polymerase II, 
producing 5’ capped and 3’ polyadenylated primary RNA transcripts.  The HIV-1 
LTR region includes four functional domains: the transactivation region (TAR), 
the core promoter, the enhancer region, and the regulatory elements.  The core 
promoter resembles that of many eukaryotic genes; it contains a TATA box and 
three tandem Sp1 sites [24].  General transcription factors, Sp1 and a number of 
host proteins interact with this region and regulate transcription initiation.  The 
HIV-1 enhancer region consists of two tandem binding sites for the transcription 
factor NF-β and an AP2 binding site. Their recruitment significantly increases 
the basal transcriptional activity of the HIV-1 LTR promoter and is crucial for the 
initial rounds of transcription in the absence of Tat protein [25, 26].  The 
upstream regulatory region has positive and negative effects on the LTR 
transcriptional activation; it is proposed to be bound by multiple proteins including 
NFAT, Myb, C/EBP and AP-1, among others [27].  The presence or absence of 
these transcriptional regulatory factors in a specific cell is considered a limiting 
factor for efficient viral replication.  The role of Tat and TAR on transcriptional 
activation will be discussed in detail in the following sections. 
 
HIV-1 requires unspliced, singly spliced, and completely spliced mRNA to 
replicate efficiently.  The virus depends on cis-signals in its genome and on the 
host cell RNA splicing machinery to generate a myriad of spliced viral mRNA 
present in the infected cell [28].  The HIV-1 genome contains five 5’-splice sites, 
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and nine 3’-splice sites.  The sequences and locations of all but one of the 5’-
splice sites and four 3’-splice sites are conserved in all strains of HIV-1 [28], 
highlighting the importance of splicing for the persistence of the virus.  The 
alternative use of 5’-and 3’-splicing sites results in the generation of 
approximately 30 spliced mRNA species of 4 kb (singly spliced) and 2 kb 
(completely spliced) in size [29].  The 2 kb mRNA encodes the regulatory 
proteins Tat, Rev, and Nef, whereas the 4 kb mRNA encode Env, Vif, Vpu, and 
Vpr.  In addition to the presence of splice sites, the regulation of HIV-1 alternative 
splicing depends on the interplay of three main factors: first, the strength of the 
cis-sequence elements adjacent to the splice sites in the pre-mRNA [30]; second, 
the interaction of host factors of the hnRNP A1 or hnRNP H families with 
negative cis-regulatory elements called exonic splicing silencers which results in 
repression of upstream weak 3’-splicing sites [28, 31]; and third, the binding of 
SR (seine/arginine) proteins to positive splicing enhancer elements promoting the 
recognition of 3’- and 5’-splicing sites [32].  This complex regulatory network 
leads not only to multiple mRNA species but also to large differences in the 
relative abundance of each of them, which seems to be decisive for viral 
replication.  
 
1.6 HIV-1 translation initiation 
Despite much progress in understanding of the HIV-1 replication cycle and 
pathogenesis over the last two decades, little is known about how HIV-1 
translation initiation is regulated.  As noted above, the interaction between the 
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primary HIV-1 transcript and the cellular splicing and processing machineries 
produces nearly 30 distinct capped and polyadenylated HIV-1 RNA species [33].  
Although each HIV-1 RNA contains a unique 5’-untranslated region (5’UTR) that 
varies in length and structure, all of them share the first non-coding 289 
nucleotides.  Interestingly, ribosomal scanning and translation initiation are 
inhibited by the presence of highly conserved and structured motifs located within 
this region such as TAR, poly(A) signal, primer binding site, dimerization signal, 
and the splicing donor site [34-37].  As a result, unspliced and spliced HIV-1 RNA 
are thought to be poor substrates for efficient cap-dependent translation, and 
suggests that HIV-1 translation initiation could be controlled through the 
presence of internal ribosome entry sites (IRES) within the 5’UTRs [38]. 
Nevertheless, contradictory results have been obtained in this regard.  Using 
bicistronic reporter constructs, two recent studies have identified IRES containing 
sequences within the 5’UTR and the gag coding sequence [39, 40].  On the other 
hand, at least three independent studies have concluded that an IRES was not 
present in the HIV-1 unspliced RNA [34-36].  An intriguing possibility comes from 
the fact that alternative splicing creates different 5’UTRs with distinctive RNA 
secondary structures [38], which in turn could be specifically recognized by 
cellular or viral factors that are capable of differentially modulating viral gene 
expression.  An example of this paradigm is provided by the viral protein Gag 
and the host protein La autoantigen.  Gag binds to the packaging signal 
sequence within its 5’UTR and inhibits translation at high concentrations, 
controlling the equilibrium between translation and packaging [41]; whereas La 
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autoantigen binds to TAR and promotes translation from mRNA containing the 5’ 
HIV-1 leader sequence [42].  Lack of consistent results from the limited number 
of reports has called for more studies on the regulation of translation initiation of 
HIV-1 RNA, one of the few under-studied fields in the molecular biology of HIV.   
 
1.7 Regulation of HIV-1 replication and pathogenesis by Tat, Rev and Nef 
1.7.1 Tat 
HIV-1 gene expression is temporally and spatially controlled by a cascade of 
sequential regulatory interactions between viral and host proteins.  The first level 
of regulation occurs at transcription.  Tat binds to the viral promoter through its 
direct interaction with a stem-loop target sequence of the nascent RNA transcript 
called TAR [21, 37].  In addition, Tat targets the cellular kinase P-TEFb (cyclin T1 
and CDK9) to the TAR-Tat complex.  The functional consequence of the Tat-
TAR-p-TEFb complex is the phosphorylation of the C-terminal domain of RNA 
Polymerase II, which greatly enhances its processivity from the LTR promoter 
[43, 44], leading to the activation of HIV-1 gene expression.  HIV-1 mainly 
replicates in activated T lymphocytes in vivo and in vitro [45]; likewise, the ability 
of peripheral blood lymphocytes to support HIV-1 replication correlates directly 
with induction of cyclin T1 and CTD kinase activity upon activation [46, 47], 
allowing the virus to change from a latent to a replication-active state.      
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1.7.2 Rev 
The second level of regulation occurs at the post-transcriptional level.  In higher 
eukaryotes, only completely spliced mRNA transcripts are exported by the 
constitutive mRNA export pathway into the cytoplasm for translation, while intron-
containing mRNA is confined in the nucleus [48].  As mentioned before, more 
than 30 different viral mRNA species are present in infected cells.  These RNA 
species include 9-kb unspliced full length transcripts that encode Gag and Gag-
Pol; 4-kb singly (singly) spliced mRNA that encodes for Env, Vif, Vpr or Vpu; and 
2-kb multiply (completely) spliced mRNA that encodes for Tat, Rev and Nef.  In 
order to export the incompletely spliced and unspliced RNA to the cytoplasm for 
the synthesis of structural viral proteins and viral genome, HIV-1 has evolved not 
only to generate these species by inefficient alternative splicing [29, 49, 50], but 
also to have the capability to export them from the nucleus to the cytoplasm.  The 
latter is accomplished by expression of Rev protein [22, 23].  Because of this, 
HIV-1 replication cycle can be divided into two phases: a Rev-independent phase 
and a Rev-dependent phase. 
 
1.7.2.1 Functional domains of Rev 
Rev is a 18 kDa predominantly nuclear phosphoprotein [23, 51, 52] and 
constantly shuttles between the nucleus and the cytoplasm [53].  Two functional 
domains have been delineated in Rev.  The arginine-rich N-terminal domain 
controls three functions of Rev: a) Binding to Rev response element (RRE), a 
highly structured RNA sequence present in all incompletely spliced and unspliced 
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RNA [22, 54]; b) Nuclear and nucleolar localization [55, 56]; and c) Rev 
oligomerization [57, 58].  The C-terminal domain contains a stretch of leucine-rich 
amino acid residues and functions as a nuclear exportation signal (NES) [23, 55].  
Productive HIV-1 replication requires efficient Rev nucleo-cytoplasmic shuttling 
activity [59-61]. 
 
1.7.2.2 Rev cytoplasmic-nuclear shuttling cycle 
The Rev nucleo-cytoplasmic shuttling utilizes the cellular nuclear import and 
export pathways.  Following Rev translation, the shuttling cycle is initiated by 
nuclear importation of Rev mediated by importin-β (Fig. 3) [62, 63].  Presumably, 
interaction of importin-β with Ran-GTP induces disassembly of the importin-
β/Rev complex and releases Rev into the nucleoplasm [62, 63], where Rev binds 
in a cooperative manner to the stems IIB and IID of RRE through protein-protein 
and protein-RNA interactions.  The NES of Rev interacts with chromosome 
maintenance gene 1 (CRM1), a member of the importin-β family receptors [64].  
CRM1 interacts with Ran-GTP, establishing the appropriate 
Rev/RRE/CRM1/RanGTP Ribonucleoprotein (RNP) complex, which is targeted 
for efficient export through the nuclear pore complex (NPC) [22, 23, 65-68].  It is 
assumed that Rev is released in the cytoplasm upon RanGTP hydrolysis; 
however, the exact mechanism of this process remains unknown.  Leptomycin B, 
a CRM-1 inhibitor prevents its interaction with Rev’s NES and inhibits Rev 
nuclear export [69, 70].  Ran plays two roles during nucleo-cytoplasmic 
transportation of the target cargos.  First, it provides energy via GTP hydrolysis.   
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Figure 3.  Rev-mediated nuclear exportation of HIV-1 RNA.  After translation, 
Rev is imported to the nucleus by importin-β through interaction via its arginine-
rich domain.  Once in the nucleus, Rev oligomerizes and interacts with the RRE 
present in intron-containing HIV-1 RNA.  Then, the Rev-RRE RNP complex binds 
to the nuclear exportation factor CRM1through the NES of Rev.  CRM1 localizes 
to the nuclear pore complex and promotes exportation of the Rev/RRE/CRM1 
complex.  A cellular RanGDP/RanGTP gradient generated by cytoplasmic 
RanBP1 and nuclear RCC1 provides the energy for the transport and regulates 
the association and dissociation of CRM1 and Rev.  Additional Rev interacting 
proteins are indicated.   
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This is necessary for translocation across the pore.  Second, it also provides the 
directionality through the gradient of RanGTP/RanGDP that exists across the 
nuclear membrane [71].  The gradient is maintained by the guanine nucleotide 
exchange factor (GEF), regulator of chromosome condensation 1 (RCC1), the 
Ran GTPase-activating protein, and Ran binding protein 1(RanBP1).  Because 
RCC1 is an exclusive nuclear protein, GDP is only exchanged to GTP in the 
nucleus.  In contrast, RanGAP and RanBP1 are localized predominantly in the 
cytoplasm; therefore, GTP hydrolysis mainly occurs in this compartment [72]. 
 
1.7.2.3 Cellular proteins interacting with Rev 
In addition to CRM1, other cellular proteins have been identified to be directly 
involved in the Rev-mediated nuclear export pathway, such as eIF-5A [73], hRIP 
[74-76], DDX3 [77], and Sam68 [78].  Eukaryotic initiation factor 5A (eIF5A) 
stimulates ribosomal peptidyltransferase activity and it was also identified as a 
NES binding protein.  Further studies have shown that several mutants of eIF5A 
and antibodies directed to eIF5A specifically abrogate nucleo-cytoplasmic 
translocation of HIV-1 Rev (Fig. 3) [79, 80].  hRIP was cloned as a NES-
interacting protein through a yeast two hybrid screening, it has been shown to be 
a critical cellular cofactor for Rev function and HIV-1 replication, presumably 
promoting release of HIV-1 RNA from the perinuclear region [75, 76]. DDX3, a 
nucleo-cytoplasmic shuttling ATP-dependent DEAD box RNA helicase has been 
shown to bind CRM1 and to localize to nuclear membrane pores.  Its knockdown 
significantly blocks Rev-RRE function [77].  However, the in vivo significance of 
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these factors in Rev nuclear export of HIV-1 RNA is not fully understood yet.  The 
function of Sam68 in the Rev-RRE exportation cycle will be discussed in more 
detail in the following sections. 
 
1.7.3 Nef 
1.7.3.1 Structural and functional aa residues in  Nef 
Nef is a 206 amino acid (aa) protein and has a molecular weight of ~25-33 kDa 
(Fig. 4).  It is post-translationally modified by phosphorylation and by 
myristoylation of its N-terminus, which partially targets Nef to the cellular 
membrane [16].  Structurally, Nef contains a flexible, non-folded region of ~70aa 
in length, and a well conserved and folded core domain of ~120aa residues [81].  
The core domain contains a consensus SH3 domain-binding sequence (PXXP), 
which mediates Nef binding to Src-family proteins (Src, Lyn, Hck, Lck, Fyn), 
regulating their kinase activities [82-85].  Nef also posseses an arginine-rich motif 
(RR105), which mediates its interaction with PAK protein and subsequently 
regulates T cell activation and cytoskeletal rearrangement [86].  The flexible 
regions of Nef contain an acidic region (EEEE62-65) required for its paranuclear 
localization and for its ability to down-regulate MHC-I cell surface expression 
[87].  Additionally, three pairs of amino acid residues (W57/L58, L164/L165, and 
D174/D175) have proven to be essential for CD4 down-modulation, by serving as a 
direct bridge between CD4 and the cellular endocytic machinery [87, 88]. 
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Figure 4.  Functional domains of HIV-1 Nef.  Each functional domain is 
represented by a distinct color: myristoylation signal, CD4 down modulation 
domains in light blue and red; MHC Class I down modulation in dark blue; SH3 
binding domain in green; and Pak2 binding domain in turquoise.  Relevant amino 
acids within those domains are also presented on the top.  
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1.7.3.2 Role of Nef in pathogenesis  
Nef is a major pathogenic factor for HIV-1 and simian immunodeficiency virus 
(SIV).  Deletion of the nef gene significantly reduces the pathology observed in 
SIV-infected rhesus macaques [89].  Furthermore, macaques infected with SIV 
encoding a nef gene with a point mutation codifing a premature stop codon 
rapidly restore the original open reading frame (ORF) [89].  In humans, infection 
with HIV-1 strains defective in the nef gene is correlated with non-progression 
from HIV-1 infection to AIDS [90-92].  The precise mechanisms by which Nef 
induces pathogenesis remain unclear.  It is proposed to involve: (1) evasion of 
the immune system by down regulation of CD4 [93-95] and MHC-I molecules [96, 
97], (2) activation of signaling pathways [98-100], and (3) enhancement of virus 
infectivity [101].  Finally, Nef-mediated down-regulation of CD3 surface 
expression seems to be critical for disease progression.  SIV non-pathogenic 
infection of natural hosts is characterized by efficient down-regulation of CD3 in a 
Nef-dependent manner, preventing T cell hyper-activation.  To the contrary, HIV-
1 Nef protein is unable to down-regulate CD3 expression during pathogenic 
infection [102]; albeit the later study only explains why SIV infection of natural 
hosts is not pathogenic, this studys emphasizes the relevance of Nef during the 
in vivo infection and disease progression.  Taken together, Nef is a required 
pathogenic factor during HIV-1 infection, and is a potential therapeutic target.  
The roles of Nef on HIV-1 pathogenesis have recently been thoroughly reviewed 
by Foster et al. [88]. 
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1.8 HIV vaccines and highly active anti-retroviral therapy (HAART)  
1.8.1 HIV vaccines 
The complexity of the HIV-1 replication cycle and the unique structural features 
of the envelope proteins have made development of preventive vaccines 
extremely difficult, although it still remains as one of the highest public health 
research priorities [103].  The initial efficacy trials have attempted but failed to 
induce appropriate antibody responses using recombinant envelope protein 
gp120 [104, 105].  Probably, the broad array of HIV-1 isolates, with diverse 
envelope glycosylation patterns contribute to these failures [106].  The difficulty 
to elicit broad neutralizing antibody responses led to changes in the approaches 
towards development of non-protective vaccines that would elicit strong T cell 
responses and delay disease progression.  Recently, the first proof-of-concept 
trial known as STEP, which used an adenoviral vector-based vaccine with 
peptides from Gag/Pol/Nef proteins, was prematurely terminated due to 
disappointing results [107].  This MRKad5 HIV-1 candidate vaccine did not 
prevent the infection nor had an impact on early plasma viral levels.  In addition, 
individuals with prior immunity to adenovirus showed a higher risk to be infected 
when compared to the placebo group [103].  This recent failure has raised 
important questions regarding the T cell vaccine approach in light of new insights 
on the pathogenesis of HIV-1.  For example, if the main target of HIV-1 infection 
is CD4+CCR5+ T cells, the same cells that a vaccine is designed to activate and 
expand, how likely is it that immunological memory would protect the host from T 
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cell depletion [108]?  At this point, the HIV-1 vaccine field is in a confusing time. 
Novel approaches are required to overcome unprecedented obstacles. 
 
1.8.2 HAART    
Despite continuous disappointments in HIV-1 vaccines, development of anti-
retroviral drugs has drastically changed the face of disease progression from an 
uniformly fatal illness to a manageable chronic disease, reducing AIDS-related 
mortality by 80-90% in developed countries [109, 110].  Currently, 21 of the 23 
anti-retroviral drugs approved by the Food and Drug Administration (FDA) target 
the viral enzymes from the Pol gene: RT (11), PR (9), and IN (1). 
Nucleoside/nucleotide analogs and non-nucleoside inhibitors are the two classes 
of RT inhibitors (Fig. 2). The mechanism of action is to terminate DNA elongation 
during reverse transcription shortly after viral entry.  PR inhibitors target the 
catalytic site of PR, preventing polypeptide processing and resulting in production 
of non-infectious viral particles.  Raltegravir, the sole IN inhibitor recently 
introduced inhibits the strand transfer activity during the integration process.  The 
other two anti-retroviral drugs are Enfuvirtide which targets a gp41 region of the 
viral envelope, hampering the membrane fusion process; and maraviroc, a CCR5 
antagonist that prevents the cells from being infected [110, 111].  The initial 
clinical treatment regimen usually includes a nucleotide analogue RT inhibitor or 
a PR inhibitor, plus two nucleoside RT inhibitors [109].  Although successful 
therapy can reduce viral replication to undetectable levels in plasma, current 
treatment approaches can not eradicate the virus; furthermore, active viral 
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replication can continue undetected in lymphoid tissue of the gut, with 
progressive deleterious effects [112].  The emergence of multidrug-resistant 
viruses due to a high rate of mutation in the viral genome is still a major concern, 
which highlights the relevance to create new and safer compounds.  Importantly, 
not a single therapeutic agent targeting the HIV-1 regulatory proteins Tat, Rev or 
Nef has yet been developed.  Moreover, the fact that Nef plays a relevant role in 
disease progression and that Nef is expressed despite prolonged and clinically 
successful anti-retroviral treatment makes Nef an ideal target for future therapy 
development [113]. 
 
2. STRESS GRANULES 
2.1 RNA granules 
In 1993, an influential study reported that microinjected fluorescently labeled 
myelin basic protein mRNA localized in subcellular granule-like domains in 
oligodendrocytes, and that the structures were persistent, heterogenous in size 
and transported along microtubules [114].  This work represented the first 
characterization of mRNA movements in living cells and suggested that non-
random localization of mRNA to granule-like structures was an important 
regulatory mechanism in cytoplasmic mRNA metabolism.  Currently, it is well 
accepted that mRNAs are packaged and transported in ribonucleoprotein (RNP) 
particles, which are now referred as RNA granules (RG) [115].  In recent years, 
multiple cytoplasmic RG have been reported in eukaryotic cells.  RG are RNP 
macromolecular structures that can contain ribosomal subunits, translation 
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factors, mRNA decay enzymes, poly (A) RNA and RNA binding proteins (RBP) 
[116]; their main function is to transport and regulate the spatial and temporal 
translation of specific mRNA transcripts [116, 117].  The best described RG to 
this date are: neuronal granules (NG) [115, 117], germ cell granules (GCG) [116], 
stress granules (SG) [118] and P bodies [119]; nevertheless, novel types of RG 
are continuously being reported [120].  Although the components and functions 
of each RG are different, all of them share two common features: first, they all 
contain translationally repressed mRNA; and second, multiple RBP can be found 
in more than one granule [116, 117].  Since the present work focuses on SG, SG 
function, composition, and assembly are discussed in detail below.  
 
2.2 Biological functions 
Cytoplasmic granules involved in the regulation of translation during heat shock 
were initially identified in the cytoplasm of tomato cells [121].  Since then, 
functionally similar structures were identified in mammalian cells, and were 
named stress granules (SG) [122].  Unlike other granules, SG are not present in 
unstressed cells, but are rapidly (30 min) induced upon exposure to a variety of 
stressful stimuli (oxidative stress, heat shock, osmotic stress) [122].  Under 
stressful conditions, mRNAs encoding housekeeping proteins are selectively 
targeted to SG where they are translationally arrested; allowing the cell to 
prioritize the synthesis of proteins involved in the stress response (e.g. molecular 
chaperones) [123].  Even though the sequestration of housekeeping mRNAs is 
still considered a key function of SG, recent studies have shown that these 
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complex structures play additional roles in stressed cells [124].  First, studies 
have shown that RNA and RBP constantly shuttle into and out of SG; Moreover, 
SG and P bodies are dynamically linked structures.  Therefore, SG are currently 
considered a triage center where mRNA is redirected to reinitiation of translation, 
decay (P bodies) or storage [125-127].  Second, proteins involved in apoptotic 
signaling pathways are sequestered in SG under stressful conditions, enabling 
SG to modulate cell metabolism and survival [128-131].  Finally, the finding that 
SG also contains RNA-induced silencing complexes (RISC) has led to the 
proposal that RBP within SG may also regulate microRNA-induced translational 
silencing under stress [132, 133].     
 
2.3 Composition 
SG are composed of RNA, RBP and proteins that are not linked to RNA 
metabolism.  Recently, a new classification for SG protein components has been 
proposed, in which they are divided into 4 classes based on their biological 
function and type of recruitent to SG [124]. 
 
Class I:  This class includes stalled pre-initiation complexes targeted to SG, 
which include small but not large ribosomal subunits, translation initiation factors 
(eIF3, eIF4A, eIF4B, eIF4E, eIF4G), poly(A)-binding protein (PABP), and RNA 
transcripts [124, 134, 135].  These are considered universal markers for SG and 
the core of this cellular structure. 
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Class II:  It is composed of RBPs involved in translational regulation and/or 
mRNA stability and decay.  These proteins are considered reliable SG markers, 
although they may not be universal components.  Some protein members in this 
class include: TIA-1 [122], HuR [136], FMRP [137], ZBP1 [138], TTP [125], 
pumilio [139], smaug [140], ataxin [140], staufen [141], musashi [142], DDX3 
[143], PMR-1 [144], PCBP2 [145] and argonaute [132].  This list continues to 
rapidly grow.  It is important to mention that over-expression of some of these 
proteins result in spontaneous SG assembly. 
 
Class III:  It consists of RBPs that regulate aspects of RNA metabolism other 
than translation or mRNA decay, such as alternative splicing, mRNA 
transportation, or editing.  Members of this class include: G3BP [146], FAST 
[125], Caprin-1 [147], Proline-rich transcript in the brain protein [148], RHAU 
[149], hMex-3B [150] ,TDRD3 [151], SMN [152], LINE 1 ORF1p [153], MLN51 
[154], Lin28 [155], SRC3 [156], APOBEC3G [157], IP5K [158], NXF7 [159], Grb7 
[136], and hnRNP A1 [160].  As is the case for the previous class, some of these 
proteins induce spontaneous SG assembly when over-expressed. 
 
Class IV: This is a newly discovered class.  It includes RBP and proteins that are 
not related to RNA metabolism, they are recruited to SG through “piggy-back” 
interactions with SG core components.  For example, plakophilin 3 is recruited to 
SG by G3BP [161]; TIA-1 binds to FAST [128], SRC3 [156], KSRP [162], and 
PMR1 [144] promoting their recruitment to SG.  Other members of this class 
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include: TRAF2 [129], DIS1 [163], RACK1 [130], and RSK2 [131].  Some of these 
proteins are not considered reliable SG markers, since their localization is 
directly dependent on other proteins.  
  
2.4 Assembly   
2.4.1 Inhibition of translation initiation 
Unsuccessful translation initiation leads to actively translating ribosomes to run 
off specific transcripts, generating mRNP complexes composed of mRNA and 
small ribosomal subunits (stalled preinitiation complexes), followed by polysome 
disassembly and the emergence of SG (Fig. 5).  Inhibition of translation initiation 
and SG assembly can be induced by the phosphorylation of eIF2α [123, 164, 
165] or by the eIF2α phosphorylation-independent inhibition of ribosome 
recruitment [166, 167].  
 
2.4.1.2 eIF2α phosphorylation-dependent  
During the translation initiation process, eIF2α delivers the tRNAMet to the AUG 
start codon in a GTP-dependent manner.  eIF2B is a guanine nucleotide 
exchange factor (GEF) that recharges GDP-charged eIF2α with GTP and allows 
this process to occur.  Phosphorylation of eIF2α Ser51 results in eIF2B inhibition 
leading to decreased levels of eIF2±GTP±tRNAMet, stalled cap-dependent 
translation initiation, and SG assembly [122, 134]. 
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Figure 5.  A SG assembly model.  The process of SG assembly can be divided 
into three sequential steps.  Step 1: Inhibition of translation initiation allows the 
elongating ribosomes to run off transcripts, generating a pool of stalled 
preintiation complexes, a core component of SG.  Step 2: SG nucleator proteins 
(green, blue and red circles) bind to specific stalled preinitiation complexes and 
initiate primary aggregation through homotypic interactions, then primary 
aggregates are cross-linked by heterotypic interactions between SG nucleator 
proteins during secondary aggregation; in addition, non-core proteins (orange 
square) are recruited to SG by a “piggy-back” mechanism.  Step 3: Within mature 
SG, transcripts are subjected to triage; they are escorted by SG proteins to P 
bodies for degradation, retained by RBP in SG for storage, or passively move 
back to polysomes for active translation.   
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Different stressful conditions force eukaryotic cells to halt protein synthesis 
through eIF2α phosphorylation.  In mammalian cells, four eIF2α kinases monitor 
the environment for noxious elements.  PERK [PKR (RNA-dependent protein 
kinase)-like ER kinase] is activated in response to misfolded protein in the ER; 
HRI (heme-regulated eIF2α kinase) is a sensor of heme depravation and 
oxidative stress; PKR (protein kinase R) is a double stranded RNA dependent 
kinase activated during viral infection; and GCN2 (general control non-
derepressible-2), which senses amino acids levels through uncharged tRNA and 
triggers eIF2α phosphorylation during amino acid depravation [168].  Activation of 
each one of these kinases by thapsigargin treatment (ER stress-PERK) [135], 
arsenite treatment (oxidative stress-HRI) [169], viral infection (PKR) [170], or 
proteasome inhibition (GCN2) [164] has been shown to potently induce SG 
assembly (Fig. 5). 
 
2.4.1.3 eIF2α phosphorylation-independent  
Ribosome recruitment to the mRNA template during cap-dependent translation is 
facilitated by the 5’-cap structure, eIF4F, eIF4B and eIF4H.  eIF4F is composed 
of three subunits: eIF4E, which binds the 5’ cap structure; eIF4G, a scaffold 
protein that promotes the binding between the mRNA template and the 
preinitiation complex through interactions with eIF4E and eIF3; and eIF4A, an 
ATP-dependent RNA helicase, which unwinds secondary structure within the 
5’UTR of mRNAs, facilitating ribosome recruitment.  eIF4B and eIF4H increase 
the processivity of eIF4A [171].  Two recently described compounds Pateamine 
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A and hippuristanol inhibit translation initiation through a direct inhibitory 
interaction with eIF4A [172], leading to SG assembly even in phospho-deprived 
eIF2α (A51/A51) mutant cells, indicating that eIF2α phosphorylation can be 
dispensable for SG assembly [166, 167].  In concordance, cleavage of eIF4G by 
protease 2Apro during poliovirus infection results in cap-dependent translation 
inhibition and induction of short-lived SG [167].  Finally, over-expression of 
multiple proteins induces SG formation, independently of eIF2α phosphorylation.  
These proteins are known as SG nucleator proteins [124] and share two 
important characteristics: first, all of them bind to RNA; and second, they all have 
the capacity to self-associate (homotypic interactions).  It is hypothesized that 
these proteins prevent ribosome recruitment by directly competing for 48S 
complexes before initiation is completed, changing the equilibrium between pre-
initiation complexes and polysomes and nucleating SG through their self 
association properties [124].  
 
2.4.2 Primary and secondary aggregation 
The mechanism by which proteins and mRNA congregate to form mature SG is 
not clear, and our understanding is still in the early stage.  However, some 
models have been proposed based on previous studies.  Inhibition of translation 
initiation generates a pool of stalled preinitiation complexes, each one with 
specific binding motifs given by unique RNA sequences in each transcript.  At 
this point, multiple SG nucleator proteins such as TIA-1 or G3BP bind to specific 
stalled pre-initiation complexes according to the specificity through their RNA 
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recognition motifs (RRM), and homotypic interactions initiate primary aggregation 
of SG (Fig. 5) [118, 124].  Time-lapse microscopy studies have shown that SG 
assembly begins with formation of numerous small SG, which fuse into larger 
granules to form a mature structure [125].  Consequently, it is believed that after 
primary aggregation, heterotypic protein-protein interactions between different 
SG nucleator proteins cross-link smaller granules forming larger structures, 
which can then recruit Class IV proteins through a “piggy back” mechanism [124].    
 
2.4.3 Triage of mRNA 
Initially thought to be passive compartments for mRNA storage, SG are now 
considered to be a dynamic triage center that sorts mRNA for storage, decay, or 
reinitiation under stressful conditions [173].  The initial recognition of the dynamic 
nature of SG came from early experiments in which treatment with 
cyclohexamide, a translation elongation inhibitor and polysome stabilizing 
compound resulted in SG disassembly, revealing that SG and polysomes are in  
 a dynamic equilibrium [127].  Subsequent fluorescence recovery after 
photobleaching (FRAP) studies have further corroborated this notion, by showing 
that proteins and RNA rapidly and continuously shuttle in and out of SG [125, 
127, 174].  Additionally, different scaffold proteins such as FAST, TTP, BRF1 or 
CPEB1 have been shown to promote frequent, dynamic and stable contacts 
between SG and P bodies [125, 126].  The fate of each mRNA within SG (decay, 
storage, reinitiation) seems to be determined by SG protein components and 
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RNA binding motifs within each transcript.  For example, ZBP1 retains and 
stabilizes target mRNA within SG, preventing mRNA transfer to P bodies for 
degradation [138], whereas TTP and BRF1 preferentially bind to transcripts with 
AU-rich elements (ARE) and promote mRNA decay by escorting them from SG 
to P bodies [125].  On the other hand, Mollet et al. [174] have reported that 
mRNA preferentially transits from SG to polysomes, suggesting that the mRNA 
flow to reinitiation is a passive event and is not mediated by RBP. 
 
2.5 SG and viral infections 
In addition to the fundamental role of SG in the translational repression of host 
mRNA, different lines of evidence also suggest that the SG is an important 
structure for viral re-programming of the host translation machinery and cellular 
antiviral defense [124, 175].  Mouse embryonic fibroblasts (MEF) lacking TIA-1 
protein are SG deficient and produce significantly higher titers of viruses when 
infected with vesicular stomatitis virus (VSV), Sindibis virus and herpex simplex 
virus-1 (HSV-1) [176].  Moreover, infection with poliovirus [177], West Nile virus 
(WNV) [178], dengue virus [178], Semliki forest virus (SFV) [179] and rotavirus 
[180] inhibits SG formation at late stages of the infection by specifically targeting 
SG core components.  For instance, WNV and Sendai virus encode an RNA that 
sequesters TIAR and inhibits SG assembly [124, 178]; Poliovirus protease 3C 
cleaves G3BP protein preventing SG formation at later infection, and expression 
of a cleavage-resistant G3BP protein results in persistence of SG and inhibition 
of viral replication [177]; and Rotavirus protein NS3 promotes the relocation of 
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PABP-1 from the cytoplasm to the nucleus inhibiting SG assembly, despite 
potent phosphorylation of eIF2α during infection [180].  Finally, mouse hepatitis 
coronavirus (MHV) induces SG assembly, which negatively impacts its 
replication capacity through an unknown mechanism [181].  All of the above 
suggest that SG function as a cellular antiviral defense mechanism, and that 
viruses specifically encode factors that help them evade the SG-mediated 
antiviral effect. 
 
Even though some reports have linked cellular proteins involved in HIV-1 
replication or anti-retroviral host factors with SG, the role of SG on HIV-1 
replication is not clear.  APOBEC3G, a well described cellular retroviral inhibitor 
incorporates into HIV-1 virions and inhibits replication by deaminating cytidines in 
the HIV-1 RNA minus strand, leading to lethal hyper-mutated reverse transcripts. 
HIV-1 Vif protein binds APOBEC3G and induces its degradation, preventing its 
incorporation into virions and allowing normal viral replication to continue [182]. 
Two recent studies have demonstrated that APOBEC3G binds to HIV-1 RNA and 
Vif, and moves with them between translationally active polysomes, SG and P 
bodies [157, 183].  The functional relevance of this finding has yet to be 
determined.  In addition, DDX3, a highly conserved helicase, which is absolutely 
required for Rev-mediated nuclear exportation of unspliced HIV-1 RNA [77], also 
localizes to SG and P bodies during stress, and its over-expression leads to SG 
assembly, suggesting a possible role of SG during the metabolism of unspliced 
RNA in the cytoplasm [143, 149].  Finally, in a similar fashion to poliovirus 
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infection, it has been reported that infection of CD4+ cells with HIV-1 leads to a 
profound inhibition on cap-dependent translation, due to proteolytic cleavage of 
eIF4G by HIV-1 PR [184], suggesting that HIV-1 infection may also lead to SG 
assembly.  Nevertheless, to date, there are no reports directly implicating SG 
assembly in modulation of HIV-1 gene expression or its replication cycle.    
 
3. SAM68 
3.1 Historical considerations 
Sam68 was initially identified as a tyrosine phosphorylated protein associated 
with the p120-RasGTPase activating protein (RAS-GAP) in cells transformed 
with the oncogenes of the tyrosine kinase family including v-Src and called p62 
[185, 186].  In 1992, human p62 was purified using affinity chromatography from 
NIH-3T3 cells transformed with Src using anti-phosphotyrosine antbodies, and 
the cDNA encoded a 443 aa polypeptide [187].  Two years later, five 
independent groups identified p62 as a SH3 binding protein [188-192].  Since 
p62 was a Src substrate during mitosis and migrated at 68 kDa, it was renamed 
Sam68.  A number of Sam68 orthologues and homologues have been cloned 
from different species [193, 194], showing a high degree of amino acid sequence 
conservation within the putative functional domains [195].  Sam68 is a RBP 
which contains a single ribonucleoprotein particle K homology (KH) domain 
embedded in a larger evolutionary conserved domain, the GSG (GRP33, Sam68 
and GLD1) domain [196].  The GSG domain-containing proteins belong to the 
STAR (Signal Transduction and Activators of RNA) family of proteins [195, 196].  
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Sam68 is the prototype member, since it has been shown to link signal 
transduction pathways with RNA metabolism [197].  Other members of the STAR 
family include: GLD-1, GRP33, QKI, SLM-1, SLM-2, How, Kep-1, and SF-1 [196].  
 
3.2 Sam68 functional domains        
As mentioned above, Sam68 contains a KH domain flanked by conserved N- and 
C-terminal sequences (Fig. 12) with RNA binding activity and the signaling motifs 
referred to as the GSG (GRP33, Sam68, GLD-1) domain.  A number of RNA 
targets have been identified for the Sam68 GSG domain, including poly(U), 
poly(A), A/U-rich sequences such as UAAA and UUUA, and several mRNA [190, 
198, 199].  In addition, GSG domains confer the ability to STAR family proteins to 
form homomultimers [200].  
 
Sam68 has six proline-rich domains (P0-P5), three in the N-terminal region (P0-
P2), and three in the C-terminal region (P3-P5), which are binding sites for SH3 
and WW domain-containing proteins (Fig. 12).  Sam68 has been shown to 
interact with SH3 domains of Vav [201], PRMT2 [202], grb2 [203], Grap [203, 
204], p85 PI3K [205], PLCγ-1 [206], Itk [207], Nck [208], and Sik/BRK [209]. 
Sam68 proline-rich motifs P3 and P4, associate with WW domain-containing 
Formin Binding Proteins FBP21 and FBP30 [210].  
 
The C-terminal region of Sam68 contains 16 tyrosine residues, which are sites of 
phosphorylation of multiple tyrosine kinases [188, 189, 191, 209, 211].  Tyrosine-
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phosphorylated Sam68 associates with numerous SH2-containing proteins 
including Src family kinases [188-191, 212].  These observations are consistent 
with the concept that Sam68 may function as an adapter protein [189, 205]. 
Additionally, tyrosine phosphorylation of Sam68 regulates its subcellular 
localization [213] and its ability to bind RNA [209]. 
 
The predominantly nuclear localization of Sam68 is dictated by a non-
conventional nuclear localization signal (NLS) embedded in the last 24 amino 
acids of its C-terminal domain (Fig. 12) [214].  Single point mutations at amino 
acids residues 429 and 439, or deletion of the entire C-terminal 24 amino acids 
results in cytoplasmic localization [78, 214, 215].  Moreover, phosphorylation of 
tyrosine 440 is required for Sam68 nuclear localization [213], suggesting that 
signaling pathways may regulate Sam68 subcellular localization. 
 
Finally, STAR family proteins including Sam68 contain RGG boxes, which are 
important in the regulation of RNA metabolism and are potential sites for arginine 
methylation [216].  Sam68 interacts with protein arginine methyltransferase I 
(PRMT I) in vivo, and it is methylated in multiple arginine residues [217]. 
Interestingly, hypomethylated Sam68 is localized in the cytoplasm, whereas 
methylated Sam68 is located in the nucleus [217]; since methylation is an 
irreversible post-translational modification, it is suggested that methylation is part 
of a maturation process during nuclear importation. 
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3.3 Sam68 function 
Although a considerable amount of information on the molecular biology of 
Sam68 has been accumulated during the last decade, its physiological functions 
are not fully understood.  Like other RBP, Sam68 seems to be a multifunctional 
protein.  To date, Sam68 has been reported to regulate almost every aspect of 
RNA metabolism: transcription [218], splicing [219], polyadenylation [220], 
nuclear exportation [221], translation [222, 223], as well as signal transduction 
[224].  Moreover, Sam68 is also implicated in a significant number of other 
important cellular processes including cell cycle regulation, apoptosis, 
tumorigenesis, bone metabolism, and normal brain function [225-227].  Based on 
the relevance to the current work, only the role of Sam68 in some aspects of 
mRNA metabolism will be discussed in detail in the following sections. 
 
3.3.1 Nuclear function of Sam68 
3.3.1.1 Alternative splicing 
In 1999, Sam68 was identified to interact and to co-localize in nuclear dots with 
the nuclear splicing associated protein YT521 [228].  Since then, multiple 
interactions between Sam68 and splicing factors such as: U2AF [229], SAFB2 
[230], hnRNP A1 [219], ASSP1 [231], and Bim [232] have been reported.  As 
rSLM-2 protein interacts with YT521-B and regulates the splice site selection of 
CD44 exon v5 [233], Sam68 could be part of a signal transduction pathway that 
can influence splice site selection. 
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CD44 
Sam68 was defined as the first splicing regulator protein that links signal 
transduction with alternative splicing [197].  Matter et al. have shown that 
activation of the Ras-ERK pathway in T lymphocytes triggers the phosphorylation 
of Sam68 by ERK-1/2, which leads to inclusion of the variable exon v5 of CD44 
in a Sam68-dependent manner [197].  Further studies have shown that Sam68 is 
part of a multiprotein complex with Bim [232], Srm160 [234] and ASSP1 [231], 
which regulates splice site recognition and/or spliceosome assembly, leading to 
CD44 v5 exon inclusion.  Expression of CD44 isoforms containing exon v5 
correlates with enhanced malignancy and invasiveness of some tumors [235]. 
Interestingly, Sam68 haploinsufficiency delays the onset of mammary 
tumorigenesis and metastasis [226], but whether this is the result of 
dysregulation of CD44 expression remains to be determined.    
 
Bcl-x 
Sam68 has been implicated in the regulation of cell cycle progression and 
apoptosis [198, 218, 236, 237].  Apoptosis and alternative mRNA splicing are 
tightly linked processes. Splicing of mRNAs encoding apoptotic factors can yield 
proteins with opposite roles during apoptosis [238].  For instance, the 
antiapoptotic factor Bcl-x(L) and the proapoptotic factor Bcl-x(s) are produced 
from the Bcl-x transcript through alternative splicing [239].  Recently, it has been 
demonstrated that Sam68 binds to Bcl-x mRNA in vivo; furthermore, depletion or 
phosphorylation of Sam68 leads to accumulation of Bcl-x(L), whereas its up-
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regulation in association with hnRNP A1 increase the leves of Bcl-x(s), which 
correlates with induction of apoptosis [219]. 
 
HIV-1 
To date, a role of Sam68 in the regulation of HIV-1 splicing has not been 
identified [220], despite multiple reports linking Sam68 with HIV-1 RNA 
metabolism.  
 
3.3.1.2 Exportation of retroviral unspliced RNA 
Sam68 was first demonstrated to bind Rev and RRE in vitro and/or in vivo, and to 
be capable of substitute and synergize with HIV-1 Rev protein in 1999 [78]. 
Moreover, Reddy et al. [78] have shown that unlike Rev-mediated exportation, 
Sam68/RRE-mediated transactivation is insensitive to leptomycin B, a CRM-1 
specific inhibitor.  As a result, it was proposed that Sam68 activated Rev via a 
CRM-1-independent pathway.  The relevance and specificity of Sam68 
interaction with RRE remains controversial, since Sam68 in cooperation with 
RNA helicase A and TAP [240] can facilitate exportation of intron-containing RNA 
in the absence of RRE, but in the presence of different retroviral RNA exportation 
elements such as: CTE, RxRE, ERRE, and RRE2 [222, 240-242]. 
Using a substractive cloning strategy, our group has shown that HIV-1 
expression down-regulates Sam68 expression in human astrocytes [243].  
Additionally, human astrocytes constitutively express a lower level of Sam68.  
Elevation of the endogenous levels of Sam68 in astrocytes considerably restores 
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HIV-1 Rev function, and modestly increases HIV-1 virus production.  Contrary to 
the previous report, we and others showed that Sam68 is unable to substitute for 
Rev [221, 222]; furthermore, leptomycin B disrupts the CRM-1 complex in 
Rev/Sam68-expressing cells, suggesting that Sam68 facilitates Rev nuclear 
exportation through a CRM-1-dependent pathway [221].  In support of a CRM-1-
dependent process, recent independent reports have shown that Sam68 is 
absolutely required for Rev function and HIV-1 production, its down-modulation 
causes exclusive nuclear retention and co-localization of Rev and CRM-1, 
resulting in significant inhibition in HIV-1 replication [221, 244]. 
 
 To further complicate our understanding of Sam68’s role in HIV replication cycle, 
Sam68 has been reported to enhance p24 expression from a gag-pol reporter 
plasmid containing a CTE [222].  However, Sam68 over-expression increases 
the levels of cytoplasmic gag-pol RNA only by two fold, but protein expression by 
~45 fold, suggesting that Sam68 may provide a “mark” that affects the 
cytoplasmic fate of specific mRNA [222].  In agreement with this finding, Mclaren 
et al. have reported that Sam68 promotes 3’-end processing (cleavage, 
polyadenylation) of HIV-1 unspliced mRNA, in the absence of a significant 
increase in the level of unspliced viral RNA in the cytoplasm [220].  Despite the 
controversy regarding the role of Sam68 in the nuclear exportation pathway of 
HIV RNA transcripts, two biochemical features of this process have been 
independently validated.  First, Sam68 binding to RNA is required for 
transactivation of Rev function [222, 245].   As mentioned before, Sam68 binds 
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RNA through its single KH domain [190, 198, 199] and a RG rich region that 
confers non-specific RNA binding activity of Sam68 [245].  Sam68 mutants 
defective for RNA binding activity (ΔKH or ΔRG) fail to functionally promote 
nuclear exportation of intron-containing RNA [222, 245].  Moreover, tyrosine 
phosphorylation of Sam68 by p59fyn and Sik/BRK inhibits its ability to bind RNA 
[222, 246], and also abolishes its capacity to enhance RRE and CTE function 
[222, 245].  Second, Sam68 binds to Rev in vitro and in vivo [78, 243].  Reddy et 
al. [78] have shown that Sam68 and Sam68Δ330-433, but not Sam68Δ1-329 
GST fusion proteins interact with Rev protein in vitro.  Our group has also shown 
that Sam68 forms a complex with Rev in vivo, and that the nuclear exportation 
signal (NES) of Rev and the region between aa residues 321 and 410 of Sam68 
are directly involved in the protein-protein interaction [243].  This suggests that 
sequences centered around residues 321 to 329 may play a critical role in 
Sam68 interaction with Rev.  Additionally, other functionally relevant in vivo 
interactions between Rev and other STAR family proteins have been reported 
[247].  
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3.3.1.3  C-terminal inhibitory mutants 
The early finding that Sam68 mutants lacking the C-terminal domain are located 
in the cytoplasm and inhibit HIV-1 replication has been independently validated 
[78, 248, 249].  However, the underlying mechanism of this phenomenon has not 
been determined.  One early study has shown that C-terminal mutants impede 
Rev nuclear localization [78], while another showed that this mutant sequesters 
RRE containing RNA from the translational apparatus in perinuclear bundles 
[248].  Sam68 proteins with point mutations within the NLS localize in the 
cytoplasm and inhibit Rev/RRE transactivation [213, 215], suggesting that 
cytoplasmic localization, but not the structural changes as a result of amino acid 
deletions, is a requirement for inhibition of HIV-1 replication.  Recently, our group 
for the first time has provided direct evidence that Sam68 mutants inhibit HIV-1 
replication by blocking Rev-dependent nuclear export of HIV-1 viral RNA [249].  
Moreover, the domain between aa269 and aa321 is required but not sufficient for 
HIV-1 Rev inhibition.  Interestingly, the preliminary unpublished work from our 
group has also shown that Sam68 C-terminal mutants not only inhibit Rev-
dependent gene expression, but also repress Rev-independent gene expression 
in the context of HIV-1 replication, providing an important tool for understanding 
how Sam68 regulates HIV-1 RNA metabolism in the cytoplasm.  
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3.3.2 Cytoplasmic function of Sam68 
Sam68 has a predominant nuclear localization.  However, during certain 
conditions and cellular states, Sam68 localizes to the cytoplasm, suggesting a 
possible role in signal transduction and RNA metabolism in this cellular 
compartment.  
 
3.3.2.1 Role of Sam68 in signal transduction 
Sam68 contains several protein-protein interaction domains and associates with 
multiple signaling molecules of the T cell receptor (TCR) [250], leptin receptor 
[251] and insulin receptor [252] pathways.  Sam68 has been found to be tyrosine 
phosphorylated upon TCR activation by p59fyn [246, 253],  ZAP70 [202], and Itk 
[250, 254], promoting complexes with various signaling proteins such as grb2 
[203], Grap [203, 204], p85 PI3K [205], PLCγ-1 [206], and p120GAP [255, 256].  
Importantly, Sam68 is tyrosine phosphorylated and recruited to signaling 
complexes in PBMC from HIV-1 infected individuals, probably due to the 
increased numbers of activated T cells in the periphery [257].  Sam68 and its role 
on signaling transduction will not be discussed in more detail.  For a thorough 
review on the topic refer to Najib et al. [224]. 
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3.3.2.2 Sam68: a translational regulator and cytoplasmic RNA granule 
component   
As mentioned above, RNA granules (RG) are RNP macromolecular structures 
involved in the regulation of mRNA transport, translation and mRNA decay [116, 
117].  Although the content and function of each RNA granule is different, all of 
them contain repressed mRNA, and multiple RBP can be found in more than one 
granule [116, 117].  
 
3.3.2.2.1 Sam68 and germ cell granules 
Germ cells have multiple types of RNA granules that contain translationally 
repressed mRNA [258].  Germ cell granules (GCG) direct the timing of maternal 
mRNA translation during a transcriptionally silent period in early embryogenesis 
[259, 260].  GCG contain polyadenylated mRNA, RNA binding proteins involved 
in translation and decay, and translation initiation factors [116].  A recent report 
has shown that Sam68 localizes to the cytoplasm of mouse oocytes and slowly 
accumulates in the nucleus upon fertilization.  Moreover, inhibition of translation 
in one cell embryos leads to Sam68 accumulation in cytoplasmic granules that 
also contain RNA and translational initiation factors [261].  These results suggest 
that Sam68 is involved in translational regulation of maternal RNA.  In addition, 
during meiotic divisions of mouse spermatocytes, Sam68 translocates to the 
cytoplasm and associates with polysomes, which stresses the possible role of 
Sam68 in translational regulation during gametogenesis [262]. 
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3.3.2.2.2 Sam68 and neuronal granules      
Neuronal granules (NG) are RNP particles that regulate the spatial and temporal 
translation of specific mRNA in neurons.  NG contain mRNA, small and large 
ribosomal subunits, translational initiation factors, and RBP that regulate 
translation [116, 117, 263].  Sam68 has been shown to localize to stationary RNA 
granules in the somatodendritic domain of unstimulated hippocampal and cortex 
neurons, where it associates with dendritic polysomes [264-266].  In addition, 
neuron depolarization leads to a significant increase of Sam68 containing 
granules with anterograde and retrograde movement in dendrites [264], which 
also correlates with strong induction in the translation efficiency of the recently 
identified Sam68 mRNA target: eEFA1 [223].  Interestingly, in concordance with 
previous HIV-1 studies [248, 267], cytoplasmic mutant Sam68Δ410 localizes in 
NG and leads to translational repression of eEF1A [223].  Further supporting its 
role as a spatial and temporal translational regulator is an early report that shows 
Sam68 co-localization with actin mRNA in motile edges of fibroblasts  [268].  
 
3.3.2.2.3 Sam68 and stress granules 
To date, little is known about the role of Sam68 in host response to external 
stress.  However, several lines of indirect evidence suggest that Sam68 could be 
recruited into SG.  First, GLD-1 is targeted to cytoplasmic particles that resemble 
P bodies and SG in C. elegans [269].  Second, Sam68 translocates and 
accumulates in cytoplasmic granules during stressful conditions such as 
poliovirus infection, ischemia, and puromycin treatment, which are also known to 
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promote SG assembly [167, 261, 270-272].  Likewise, treatment with urate 
crystals results in Sam68 cytoplasmic localization in neutrophils [273].  Finally, 
previously well-characterized SG components interact with Sam68 directly or 
indirectly.  For instance, Sam68 interacts directly in vivo with FAST [274] and 
hnRNP A1 [160]; and forms a unique RNP complex with KSRP and intron 6 of 
the β-tropomyosin gene [275].  The role of Sam68-containing RNA granules in 
regulation of HIV-1 gene expression is not known. 
 
Summary of the background and the hypothesis 
Approximately 34 million people are currently infected with HIV worldwide.  In the 
absence of a successful preventive vaccine, HAART is the only option for these 
infected individuals today.  Nevertheless, despite the success of HAART in 
reducing viral replication and prolonging the lifespan of HIV-1-infected 
individuals, HAART can not eradicate the virus from the body;  Moreover, 
multidrug-resistant viruses are still a major concern in clinical settings.  
Therefore, development of innovative therapeutic strategies against HIV-1 
remains a priority.  Importantly, not a single therapeutic agent targeting the 
pathogenic viral factors Tat, Rev or Nef has been developed.  Previous studies 
from our group have shown that the cellular protein Sam68 is absolutely required 
for efficient HIV-1 replication, and that Sam68-NLS deleted mutants potently 
inhibit Rev-mediated nuclear exportation and HIV-1 gene expression through a 
yet to be determined cytoplasmic process [221, 243, 249].  Sam68 is a 
multifunctional RNA binding protein involved in every aspect of RNA metabolism 
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including translation.  Recent reports indicate that Sam68 and its cytoplasmic 
mutants are active components of cellular structures involved in translational 
repression called RNA granules.  Therefore, our underlying hypothesis is that 
Sam68 NLS-deleted mutants inhibit HIV-1 gene expression and replication 
though a cytoplasmic process involving RNA granules.   
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MATERIALS AND METHODS 
 
MATERIALS 
Media and supplements 
Dulbecco’s modified eagle’s medium (DMEM), Roswell Park Memorial Institute 
1640 (RPMI-1640) medium, and Hank’s balanced solution (HBSS) were 
purchased from Lonza (Walkersville, MD).  Penicillin-streptomycin-glutamine 
(100X), and 0.25% Trypsin-EDTA (1X) were purchased from GIBCO (Grand 
Island, NY).  Fetal bovine serum (FBS) was purchased from Hyclone (Logan, 
UT).  Plasmocin was purchased from Invivogen (San Diego, CA).  OPTI-MEM 
reduced serum media was purchased from Invitrogen (Carlsbad, CA).  Ampicilin 
sodium salt, kanamycin sulfate, imidazol and chloranphenicol were purchased 
from United States Biological (Swampscott, MA).  All the culture media described 
below were prepared in house.  Luria Broth (LB) liquid medium contained 
0.01g/ml Bacto Tryptone, 0.005 g/ml Bacto yeast extract, 0.005 g/ml NaCl, and 1 
mM NaOH.  LB solid culture plates were prepared by adding 15 g Bacto agar to 
1L of LB liquid medium.  Working concentrations of antibiotics for liquid and solid 
LB were as follows: ampicilin 100 μg/ml, kanamycin 50 μg/ml, chloranphenicol 20 
μg/ml.  Super Optimal Broth (SOB) contained 0.02 g/ml of Bacto Tryptone, 0.005 
g/ml of Bacto yeast extract, 0.5 mg/ml NaCl, 10 mM MgCl2, and 10 mM MgSO4. 
Super Optimal Broth with catabolite repression (SOC) contained 100% SOB 
medium and 20 mM glucose.  Liquid YPD medium contained 0.02 g/ml of Difco 
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peptone, 10 mg/ml of yeast extract, and 2% dextrose, pH 5.8.  Synthetic defined 
(SD) liquid media contained 0.6 mg/ml of complete amino acid supplement 
mixture minus histidine-leucine-tryptophan-uracil from Bio101 (Vista, CA), and 
2% dextrose, pH 5.8.  YPD and SD solid culture plates were prepared by adding 
20 g Bacto agar to 1L of YDP or SD liquid medium, respectively.     
 
Antibodies 
Mouse anti-JR-CSF Nef (1:750, donated by Dr. K. Krohn and Dr. V. Ovod), 
mouse anti-Tat (1:500, donated by Dr. J. Karn) and mouse anti-Rev antibodies 
(1:500, donated by Dr. A. Szilvay) were obtained from the National Institutes of 
Health (NIH) AIDS Research and Reference Reagent Program.  Sheep anti-Rev 
(1:2500) was from Fitzgerald (Concord, MA).  Mouse anti-HA (1:1000), goat 
polyclonal anti-eIF3 (N20, 1:75), goat polyclonal anti-TIA-1, rabbit and mouse 
anti-Sam68 (1:1000), phycoerythrin (PE)-conjugated rabbit α-mouse IgG (1:175), 
PE-conjugated donkey anti-goat, fluorescein isothiocyanate (FITC)-conjugated 
donkey α-goat (1:50), FITC-conjugated goat α-mouse (1:50), rhodamine (Rh)-
conjugated mouse α-rabbit (1:75), Rh-conjugated goat α-rabbit (1:50), and Rh-
conjugated bovine anti-mouse (1:75) were from Santa Cruz Biotechologies 
(Santa Cruz, CA).  Rabbit anti-GFP (1:250) was from Clontech (Mountain View, 
CA).  Mouse anti-β-actin (1:3500), anti-sheep Horse Radish Peroxidase (HRP), 
normal mouse IgG, and normal rabbit IgG were from Sigma (St. Louis, MO).  
Anti-mouse-HRP and anti-rabbit-HRP were from GE healthcare 
(Buckinghamshire, UK).  Anti-phospho-ERK 1/2 (1:1000), anti-ERK 1 (1:1000), 
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anti-phospho-JNK (1:1000), anti-JNK (1:1000), anti-phospho-p38 (1:1000), anti-
phospho-eIF2α (Ser51) (1:1000), and anti-eIF2α antibodies (1:1000) were from 
Cell Signaling technologies (Danvers, MA).  Mouse anti-G3BP (1:75) was from 
BD transduction laboratories (Franklin Lakes, NJ).  Anti-human MHC-I hybridoma 
supernatant was a generous gift from Dr. Janice Blum (Indiana University). 
 
Reagents 
Poly(A)x(dT) and random hexamers were purchased from Roche (Indianapolis, 
IN).  Actinomycin D (Act D), propidium iodide (PI), RNase A, phytohemagglutinin 
(PHA), o-nitrophenyl β-d-galactopyranoside (ONPG), poly-L-Lysine, polybrene, 
isopropyl-beta-D-thiogalactopyranoside (IPTG), phenylmethanesulphonylfluoride 
(PMSF), adenosine periodate oxidized (AdOx), and 4’,6’-diamidino-2-
phenylindole (DAPI) were from Sigma.  [Methyl-3H]-thymidine 5’triphosphate was 
from PerkinElmer (Boston, MA).  [-32P] dCTP specific activity ~800 Ci/mmol, 
and [γ-32P] ATP specific activity ~7000 Ci/mmol were from GE Healthcare 
(Piscataway, NJ).  D-threo-[dichloroacetyl-1-14C] chloranphenicol, Ficoll-PaqueTM, 
and ECL chemiluminescence reagent for Western blot detection were from 
Amersham Biosciences (Piscataway, NJ).  Restriction endonucleases were from 
New England Biolabs (Beverly, MA).  T4 DNA ligase and T4 polynucleotide 
kinase with their respective 10X reaction buffers were from USB (Cleveland, 
OH).  TRIZOL, Superscript III reverse transcriptase, and lipofectamine 2000 were 
from Invitrogen.  Mounting solution fluoromount-G was from SouthernBiotech 
(Birmingham, AL).  Bactotryptone, Bacto Yeast Extract, Bacto peptone, Bacto 
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agar for LB bacteria culture and YDP culture media were from Becton Dickinson 
(Sparks, MD).  Complete amino acids supplement mixture minus histidine-
leucine-tryptophan-uracil for SD culture medium was from Bio101.  RNasin 
RNase inhibitor and deoxynucleotide triphosphates (dNTPs -dATP, dCTP, dTTP, 
and dGTP-) were from Promega corporation (Madison, WI). Sodium arsenite was 
from Sigma-Aldrich (Germany).  Protease inhibitor cocktail set V, EDTA-Free and 
G418 sulfate were from Calbiochem (LaJolla, CA).  Ni-NTA agarose was from 
Qiagen (Valencia, CA).  Coomassie Blue was from Bio-Rad laboratories 
(Hercules, CA).  NCp7(1-71) and NCp7(12-53) purified proteins generated by 
peptide synthesis were kindly provided by Dr. Jean Luc Darlix (École Normale 
Supérieure de Lyon, France).  All other chemicals were from Fisher (LaGrange, 
KY). 
 
Biotechnology Systems   
The Expand high fidelity PCR system and Expand long template PCR system 
were from Roche.  The AmpliTaq Gold PCR system was from Applied 
Biosystems (Branchburg, NJ).  The Quickchange II Site directed mutagenesis kit 
and Strataclone PCR cloning kit were from Stratagene (Cedar Creek, TX).  The 
TOPO TA cloning kit was from Invitrogen.  The plasmid DNA purification kits, the 
firefly and renilla luciferase assay systems, the Wizard SV Gel and PCR clean-up 
system for purification of DNA fragments from agarose gels, and the Wizard DNA 
clean-up system for purification of PCR products were from Promega 
Corporation.  Nucleofector V kit for Jurkat cell transfection and human T cell 
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Nucleofector Kit for PBMC transfection were from Amaxa biosystems 
(Gaithersburg, MD).  Bio-Rad DC Protein Assay was from Bio-Rad Laboratories. 
Centricon 50 spin columns for protein concentration and desalting were from 
Millipore (Billerica, MA).  Microspin columns 6-50 for purification of radioactively 
labeled oligonucleotides were from Amersham Biosciences. 
 
METHODS 
Cells and cell cultures 
Cell lines 
Human embryonic kidney 293T cells, African green monkey kidney COS-7 cells, 
cervical carcinoma Hela cells, and Jurkat lymphocytic cells were purchased from 
the American Tissue Culture Collection (ATCC, Manassas, VA). 
 
Stable cell lines 
A killing curve for Hela cells was performed to establish Hela.cDNA3 and 
Hela.∆410 stable expressing cell lines.  Briefly, 1.5 x 104 Hela cells were plated 
in triplicate in a 96-well plate and incubated 24 hr to reach 30% confluency.  At 
this point, the medium was replaced with fresh DMEM medium containing 
increasing concentrations of G418 (0 μg/ml, 100 μg/ml, 200 μg/ml, 300 μg/ml, 
400 μg/ml, 500 μg/ml, 600 μg/ml, 700 μg/ml, 800 μg/ml, 900 μg/ml, 1000 μg/ml, 
1200 μg/ml), and cell survival was determined during a period of 6 days.  The 
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medium was replaced every 48 hr.  The appropriate concentration of G418 for 
selection of stable expressing cells was determined to be 500 μg/ml. 
 
Four million Hela cells were plated in a 10-cm a tissue culture plate and 
incubated for 24 hr until a 70-90% cell confluency was reached.  Ten micrograms 
of cDNA3 or HA.∆410 DNA plasmids were transfected into these cells using 
lipofectamine 2000 (Invitrogen) according to the manufacturer’s instructions.  
Twenty four hours after transfection, the medium was replaced with fresh DMEM 
medium containing 500 μg/ml of G418, and the cells were incubated for a period 
of two weeks to select stable expressing cells, the medium was replaced every 
48-72 hr. 
Competent cells for cloning and for protein production 
GC5TM chemically competent E. coli for cloning, and BL21 E. coli for protein 
production were purchased from GeneChoice (Frederick, MD). 
 
Cell cultures 
293T, COS-7, and Hela cells were maintained in DMEM supplemented with 10% 
fetal bovine serum (FBS), 100 units/ml of penicillin G sodium, 100 μg/ml of 
streptomycin sulfate, 0.292 mg/ml of L-glutamine, and 5 μg/ml of plasmocin, at 
37oC with 10% CO2.  Hela.cDNA3 and Hela.∆410 stable expressing cell lines 
were maintained in DMEM supplemented with 10% FBS, 100 units/ml of 
penicillin G sodium, 100 μg/ml of streptomycin sulfate, 0.292 mg/ml of L-
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glutamine, and 300 μg/ml of G418, at 37oC with 10% CO2.  Jurkat cells were 
maintained in RPMI 1640 medium supplemented with 10% FBS, 100 units/ml of 
penicillin G sodium, 100 μg/ml of streptomycin sulfate, 0.292 mg/ml of L-
Glutamine, and 5 μg/ml of plasmocin, at 37oC with 5% CO2.   
 
Isolation and culture of peripheral blood mononuclear cells    
Peripheral blood (PB) was obtained from the Indiana Blood Center (Indianapolis, 
IN).  Isolation of PBMC was performed by the Ficoll-Paque density gradient 
centrifugation.  Briefly, 10 ml of PB were mixed with 20 ml of HBSS, transferred 
to 50 ml conical tubes, and then 15 ml of Ficoll-Paque was added to the bottom 
of the tube slowly.  Six 50 ml conical tubes containing the mixture were 
centrifuged at 785g with no brake at room temperature (RT).  The white layer 
with mononuclear cells was then transferred to a clean 50 ml conical tube, the 
volume was brought up to 50 ml with HBSS, followed by centrifugation at 440g 
for 5 min.  The washing step was repeated twice.  Thereafter, the cells were 
counted, suspended at a density of 2.5 x 106 cells/ml, and cultured in RPMI 1640 
medium supplemented with 10% FBS, 100 units/ml of penicillin G sodium, 100 
μg/ml of streptomycin sulfate, 0.292 mg/ml of L-glutamine, 3 μg/ml of 
phytohemagglutinin (PHA), and 50 units/ml of IL-2, at 37oC with 5% CO2.  The 
medium was changed every two days during the length of the experiment.    
 
 57
Plasmids 
Reporter viruses: pNL4-3.Luc(env) and pNL4-3.Luc(nef) reporter viruses were 
previously generated in our laboratory (unpublished).  pNL4-3.Luc(env) was 
constructed by inserting the firefly luciferase (F Luc) gene in-frame at the nt. 
6310 of NL4-3 genome (GenBank # AF 324493) with a stop codon at the 3’-end 
of the Luc gene.  A linearized NL4-3 was obtained by PCR using the NL4-3 as 
the PCR template and the primers 5’-TCC CCC GGG AGC ACT ACA GAT CAT 
CAA TA-3’ and 5’-GCT CTA GAA CAG AAA AAT TGT GG TCA C-3’, while the 
Luc gene was obtained by PCR using the pGL3-basic (Promega Corporation) as 
the template and the primers: 5’-TCC CCC GGG GAA GAC GCC AAA AAC ATC 
AA-3 and 5’-GCT CTA GAA TTA CAC GGC GAT C-3’.  Both DNAs were 
digested with Sma I and Xba I and ligated to obtain pNL4-3.Luc(env).  Similarly, 
pNL4-3.Luc(nef) was constructed by inserting the Luc gene in frame at nt. 8795 
of NL4-3 genome with a stop codon at the 3’-end of the Luc gene.  The primers 
for NL4-3 were 5’-TCC CCC GGG GCC ACC CAT CTT ATA GCA AAA T-3’ and 
5’-GCT CTA GAA AGT GGT CAA AAA GTA GTG TGA-3’, and the primers for 
the Luc gene were the same as above.  Both DNAs were digested with Sma I 
and Xba I and ligated to obtain pNL4-3.Luc(nef). 
 
Sam68 mutants: HA-tagged Sam68 and deletion mutants HA.410, HA.321, 
HA.269, HA.269-321, HA.269-321; as well as GFP.Sam68, RFP.Sam68, and 
RFP.410 were previously constructed in our laboratory and described 
elsewhere [221, 249]. GFP.410 was previously generated in our laboratory 
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(unpublished).  Briefly, 410 was obtained by PCR using HA.Sam68 as the PCR 
template and the primers 5’-GGG GTA CCA TGC AGC GCC GGG ACG AC-3’ 
and 5’-GGA ATT CTT AAG CTT CAT AAG AAT CTT GAA C-3’.  The PCR 
product and the pEGFP-C1 vector (Clontech, Carlsbad, CA) were digested with 
Sac I and EcoR I and ligated to obtain GFP.410.  GFP.269-321, and GFP.269-
321 were previously generated in our laboratory (unpublished).  Briefly, for 
GFP.269-321, GFP.Sam68 and HA.269-321 were digested with EcoR V and 
Hind III, the fragment obtained from HA.269-321 was inserted into the digested 
GFP.Sam68 backbone to obtain GFP.269-321.  For GFP.269-321, the 269-321 
fragment was PCR amplified using HA.269-321 as a template and the primers 5’- 
TAA TAC GAC TCA CTA TAG G-3’ and 5’- CGC GGG CCC TTA TCC CCT TAC 
TGG TGT ACC-3’.  The PCR product and pEGFP-N3 (Clontech) were digested 
with EcoR I and Sma I and ligated to obtain GFP.269-321.  GFP.321, and 
GFP.269 were constructed as follows: 321 and 269 fragments were PCR 
amplified using GFP.Sam68 as the PCR template and the same forward primer 
5’-TCG AGC TCA AAT GCA AGC GCC GGG ACG AC-3’, with respective 
reserve primers 5’- CCG GAA TTC TTA TCC CCT TAC TGG TGT ACC ACG 
TAC C-3’ or 5’- CCG GAA TTC TTA ATC ATC CAT CAT ATC CGG TAC TAG-3’. 
The PCR program used was: 94oC for 4 min, 10 cycles of 94oC for 45 sec, 58oC 
for 45 sec and 72oC for 1:30 min, followed by 35 cycles of 94oC for 55 sec, 62oC 
for 1 min and 72oC for 1.5 min, and one cycle of 72oC for 7 min.  The PCR 
products and the pEGFP-C1 vector (Clontech) were digested with Sac I and 
EcoR I and ligated to obtain GFP.269 and GFP.321.  HA- and GFP-tagged 
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KH and 410KH were constructed in the context of respective parental 
plasmids HA/GFP.Sam68 or HA/GFP.410, using the QuickChange Site-
Directed Mutagenesis kit (Stratagene), and with the primers 5’-CCT GTC AAG 
CAG TAT CCC AAG CTT CGC AAA GGT GGA GAC CC-3’ and 5’-GGG TCT 
CCA CCT TTG CGA AGC TTG GGA TAC TGC TTG ACA GG-3’.  The PCR 
program used was: 95oC for 1 min, followed by 18 cycles of 95oC for 50 sec, 
55oC for 1 min and 68oC for 7 min, and one cycle of 68oC for 7 min.  Finally, 
RFP.321, RFP.269, and RFP.269-321 were constructed by digesting 
GFP.321, GFP.269, and GFP.269-321 with EcoR I and Sac I, followed by 
ligation of the respective fragments to the previously digested pDsRed-C1 
(Clontech) backbone.    
 
pNL4-3 minigenes: tat, rev, nef, and nef deletion minigenes were constructed 
using pNL4-3 as a backbone and template.  pNL4-3 contains unique restriction 
sites for BssH II (nt. 711) and Hpa I (nt. 8650).  tat minigene sequence (nt. 711-
744, 5777-6044, 8396-8650), and nef minigene sequence (nt. 711-744, 5976-
6044, 8396-8650) were chemically synthesized and cloned into the pUC57 
backbone (Genscript, Worcester, MA).  Both tat and nef minigenes were 
generated by cloning tat and nef minigene fragments from pUC57 into the 
corresponding BssHII and HpaI site of pNL4-3.  rev minigene and nef deletion 
minigenes were generated with a QuickChange site-directed mutagenesis kit 
(Stratagene).  rev minigene was obtained using tat minigene as a template and 
the primers 5’-GAG GGG CGG CGA CTG GTT TGT TTC ATG ACA AAA-3’ and 
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5’-TTT TGT CAT GAA ACA AAC CAG TCG CCG CCC CTC-3’.  The PCR 
program used was: 95oC for 1 min, followed by 18 cycles of 95oC for 50 sec, 
55oC for 50 sec and 68oC for 8 min, and one cycle of 68oC for 7 min.  nef 5UTR 
minigene was constructed using nef  minigene as a template and the primers  5’-
TGA CCA CTT GCC ACC CAT CTT ATA CCA GTC GCC GCC CCT CGC CTC 
TTG-3’ and 5’-CAA GAG GCG AGG GGC GGC GAC TGG TAT AAG ATG GGT 
GGC AAG TGG TCA-3’.  The PCR program used was 95oC for 1 min, followed 
by 18 cycles of 95oC for 50 sec, 55oC for 50 sec and 68oC for 7.5 min, and one 
cycle of 68oC for 7 min.  Finally, nef 3’UTR minigene  was constructed using nef  
minigene as a template and the primers  5’-GAG TAC TTC AAG AAC TGC TGA 
AAT AAA GCT TGC CTT GAG TGC-3’ and 5’-GCA CTC AAG GCA AGC TTT 
ATT TCA GCA GTT CTT GAA GTA CTC-3’, with a PCR program of 95oC for 1 
min, followed by 18 cycles of 95oC for 50 sec, 55oC for 50 sec and 68oC for 7.5 
min, and one cycle of 68oC for 7 min. 
 
Yeast three hybrid plasmids: pIIIA/MS2-2, pACTII, pAD-IRP, pBTM116, and 
pIIIA/IRE-MS2 were kindly provided by Dr. Marv Wickens of University of 
Wisconsin, Madison.  Hybrid proteins ∆410, ∆269, and ∆KH with LexA DNA 
binding domain were previously constructed in our laboratory (unpublished), in 
the context of the plasmid pBTM116.  pACTII/MS2 was generated by digesting 
pBTM116/MS2-2 with BamH I to liberate MS2 sequence, followed by ligation to 
the previously digested pACTII, right orientation of the insert was confirmed by 
Sal I digestion.  pSCA-nef-3’UTR was constructed using the Strataclone PCR 
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cloning kit (Stratagene), and the primers 5’-TCC CCC GGG GAG GCT TAA GCA 
GTG GGT TC-3’ and 5’-TCC CCC GGG CAT CGA GCT TGC TAC AAG GG-3’.  
For pMS2-Nef-3’UTR and pMS2-Nef-3’RTU, pSCA-nef-3’UTR was digested with 
EcoR I, and the appropriate DNA fragment was ligated into previously digested 
pIIIA/MS2-2, the orientation of the insert was checked with Sac I digestion.       
 
Other plasmids: pcDNA3-βGal was constructed by digesting pCMVβ plasmid 
(Clontech) with Not I, and then the β-galactosidase gene was cloned at the Not I 
site of pcDNA3 (Invitrogen).  pTopoSam68 was constructed using the TOPO TA 
PCR cloning kit (Invitrogen), and the primers 5’-CGG AAT TCC AGC GCC GGG 
ACG ACC CCG-3’ and 5’-ATC CGC TCG ATT AAT AAC GTC CAT ATG GGT G-
3’, with a PCR program of 94oC for 45 sec, 10 cycles of 94oC for 45 sec, 57oC for 
45 sec and 72oC for 1.5 min, followed by 30 cycles of 94oC for 45 sec, 61oC for 1 
min, and 72oC for 1.5 min, and one cycle of 72oC for 7 min.  For pETSam68 
(pHis-Sam68), pTopoSam68 was digested with EcoR I, and the appropriate DNA 
fragment was ligated into previously digested pET30a(+) vector (Novagen, 
Gibbstown, NJ), the orientation of the insert was checked with EcoR V and 
BamH I digestion.  For GFP-hdcp-1α, the hdcp1-α ORF was amplified using full-
length hdcp-1α cDNA  (Open Biosystems, Huntsville, AL) as the PCR template 
and the primers 5'- CCG GAA TTC TCA TAG GTT GTG GTT GTC TT-3' and 5'-
GTC GAG CTC AAG AGG CGC TGA GTC GAG-3', with a program of 94oC for 
30 sec, 10 cycles of 94oC for 30 sec, 51oC for 45 sec, and 72oC for 1.5 min, 
followed by 25 cycles of 94oC for 30 sec, 60oC for 45 sec, and 72oC for 1.5 min, 
 62
and one cycle of 72oC  for 7 min.  The PCR products and the pEGFP-C1 vector 
(Clontech) were digested with Sac I and EcoR I and ligated to obtain GFP hdcp-
1α.  Tat-myc and Nef-myc were previously generated in our laboratory 
(unpublished).  pHCMVG was a kind gift from Dr. Joseph Sodroski of Harvard 
School of Medicine.  The constitutively active MEK plasmid (pCA-MEK) was 
kindly provided by Dr. Lawrence Quilliam (Indiana University School of Medicine).  
The following plasmids were obtained from the NIH AIDS Research and 
Reference Reagent Program, Division of AIDS, NIAID, NIH: pNL4-3 by Dr. M. 
Martin, pYK-JR CSF by Dr. I. SY. Chen, pLAI.2 by Dr. K. Peden, pSG3.1 by Dr. 
S. Ghosh, pYU2, p90CF402.1.8  by B. Hahn, p89.6 by Dr. R. Collman, and pMJ4 
by Dr. T. Ndung’u.  GFP.TIA-1, GFP.hnRNP A1, GFP.PABP, and GFP-G3BP 
plasmids were kindly provided by Dr. Sonia Guil and Dr. Javier Caceres [160].  
The bicistronic vector pCMV-rLuc-HIV-1IRES-fLuc was kindly provided by Dr. 
Ann Brasey and Nahum Sonenberg [40]. 
 
Bacterial transformation 
Twenty five microliters of GC5TM competent cells were mixed with 0.5-1 μl of 
DNA ligation reaction, and incubated in ice for 30 min.  After heat-shocking the 
cells for 45 sec in a 42oC water bath, 450 μl of RT SOC medium were added to 
the mixture, and then incubated at 37oC for 1 hr with shacking at 240 rpm.  Two 
hundred to four hundred microliters of culture were spread out evenly on an agar 
plate containing the appropriate selection antibiotic.  The plate was incubated in 
a 37oC incubator overnight (O/N).  
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Cell transfections 
Calcium phosphate precipitation 
Plasmid DNA was transfected into 293T cells with the standard calcium 
phosphate precipitation method.  For a 10-cm tissue culture plate, 2-4 x 106 cells 
were plated and incubated for 24 hr until a 70-90% cell confluency was reached.  
At this point, 500 μl of a mixture of 20 μg of plasmid DNA and 0.24 M CaCl2 was 
added dropwise into 500 μl of a 2X HEPES (50 mM Hepes, 10 mM KCl, 280 mM 
NaCl, 1.5 mM Na2HPO4, 12 mM glucose, pH 7.1) solution.  The transfection 
mixture was incubated on ice for 20 min, and added dropwise into 293T cells.  
After 16 hr of incubation, medium was replaced with fresh complete DMEM.  The 
cells were further incubated for 24-48 hr and then gene expression was 
examined.  When using a different tissue culture plate, the number of cells and 
all solutions were scaled down proportionally to the surface area of the plate.  
 
Lipofectamine 
Plasmid DNA was transfected into COS-7 and Hela cells using lipofectamine 
2000 (Invitrogen) according to the manufacturer’s instructions.  For a 12-well 
tissue culture plate, 24 hr before transfection, 0.5-2.5 x 105 cells were plated in 
1ml of complete DMEM without antibiotics, so that cells reached 80-90% 
confluent at the moment of transfection.  At this point, 4.0 μg of plasmid DNA and 
2-4 μl of lipofectamine were mixed gently with 100 μl of OPTI-MEM in two 
separate 1.5 ml tubes, and incubated for 5 min at RT.  The diluted DNA and 
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lipofectamine mixtures were combined and further incubated for 20 min at RT.  
Thereafter, the transfection mixture was added dropwise into the cells, and after 
16 hr of incubation the medium was replaced with fresh complete DMEM.  
Twenty-four to forty-eight hours after the medium was changed, gene expression 
was examined.  When using a different tissue culture plate, the number of cells 
and all solutions were scaled proportionally to the surface area of the plate.  
 
Annealed oligonucleotide duplex control and Sam68 siRNAs were purchased 
from Dharmacon (Lafayette, CO), Sam68 siRNA targeting sequence was 5'-CGG 
AUA UGA UGG AUG AUA U-3', as described previously [234].  SiRNAs were 
transfected into 293T cells using lipofectamine 2000 (Invitrogen) according to the 
manufacturer’s instructions.  For a 24-well tissue culture plate, 24 hr prior to 
transfection, 1.5-2.5 x 105 cells were plated in 0.5 ml of complete DMEM without 
antibiotics, so that cells will be 80-90% confluent at the moment of transfection. 
At this point, 50-200 nM of SiRNA and 1 μl of lipofectamine were mixed gently 
with 50 μl of OPTI-MEM in two separate 1.5 ml tubes, and incubated for 5 min at 
RT.  The diluted SiRNA and lipofectamine mixtures were combined and further 
incubated for 20 min at RT.  Thereafter, the transfection mixture was added 
dropwise into the cells, and after 16 hr of incubation the medium was replaced 
with fresh complete DMEM.  Twenty-four to forty-eight hours after the medium 
was changed, gene expression was examined.  When using a different tissue 
culture plate, the number of cells and all solutions were scaled proportionally to 
the surface area of the plate.  
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Nucleofector 
For Jurkat T cells: Plasmid DNA was transfected into Jurkat T cells using 
Nucleofector V kit (Amaxa biosystems) according to the manufacturer’s 
instructions.  Forty-eight hours before transfection, cells were plated at a density 
of 0.25 x 106 cells/ml in complete RPMI 1640 medium, so that cells reached a 
density of 0.5-1.5 x 106 cells/ml at the moment of transfection.  An aliquot of the 
cell suspension was used to determine de exact cell density, and the volume of 
the cell suspension required to obtain 1.0 x 106 per sample was centrifuged at 
90g for 10 min.  The supernatant was discarded and the pellet was suspended in 
RT Nucleofector Solution V to a final concentration of 1.0 x 106 /100 μl.  
Thereafter, 100 μl of the cell suspension solution were mixed with 4.0 μg of 
plasmid DNA and transfer to an Amaxa certified cuvette.  The cuvette was then 
inserted into the Nucleofector and the program X-05 was used to electroporate 
plasmid DNA into Jurkat T cells.  Finally, the cell suspension solution was 
transferred to a 12-well plate containing 500 μl of pre-warmed complete RPMI 
1640 medium and further incubated for 24 hr.  At this point gene expression was 
determined or HIV-1 infection was performed.   
 
For PBMC: Plasmid DNA was transfected into PBMC cells using human T cell 
Nucleofector Kit (Amaxa biosystems) according to the manufacturer’s 
instructions.  Freshly isolated PBMC were cultured at a density of 2.5 x 106 
cells/ml for four days in complete RPMI 1640 suplemented with 3 μg/ml PHA, 
and 50 units/ml IL-2.  An aliquot of the cell suspension was used to determine the 
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exact cell density, and the volume of the cell suspension required to obtain 6.0 x 
106 per sample was centrifuged at 200g for 10 min.  The supernatant was 
discarded and the pellet was suspended in RT human T cell Nucleofector 
Solution to a final concentration of 6.0 x 106/100 μl.  Thereafter, 100 μl of the cell 
suspension solution were mixed with 3.0 μg of plasmid DNA and transfer to an 
Amaxa certified cuvette.  The cuvette was then inserted into the Nucleofector and 
the program T-20 was used to electroporate plasmid DNA into PBMC.  Finally, 
the cell suspension solution was transferred to a 12 well plate containing 500 μl 
of pre-warmed complete RPMI 1640 medium and further incubated for 48 hr.  At 
this point HIV-1 infection was performed.   
 
Reporter gene assays 
β-Galactosidase activity assay 
Cells were harvested in ice-cold phosphate-buffered saline (PBS) and pelleted at 
2000g for 5 min. Cell pellet was suspended in cell lysis buffers for luciferase or 
chloramphenicol acetyltransferase (CAT) reporter assays, incubated for 30 min 
in ice, and then centrifuged at 12000g to remove cell debris, and supernatants 
were used as cell extracts to perform the different reporter assays.  To perform β-
Galactosidase assay, 10 μl of cell extracts, 3 μl of 100 X Mg2+ solution (0.1 M 
MgCl2, 4.5 M β-mercaptoethanol), 66 μl of 1 X ONPG (4 mg/ml ONPG in 0.1 M 
Sodium phosphate, pH 7.5), and 201 μl of 0.1 M sodium phosphate (57.7 ml 1 M 
Na2PO4 and 42.3 ml of 1 M NaH2PO4, pH 7.5) solution were mixed.  The mixture 
 67
was incubated at 37oC for 30 min.  Then, the optical density of the reaction 
containing the released o-nytropenyl was measured at 405 nm in a microplate 
reader (Molecular devices, Sunnyvale, CA). 
 
Luciferase activity assay 
Firefly luciferase or Renilla luciferase activities were measured using the 
luciferase assay systems form Promega corporation according to the 
manufacturer’s instructions.  Briefly, cells were harvested in ice-cold PBS and 
pelleted at 2000g for 5 min.  Cell pellet was suspended in 100-500 μl of 1X firefly 
or renilla luciferase lysis buffers, incubated for 30 min in ice, and then centrifuged 
at 12000g to remove cell debris, supernatants were used as cell extracts.  Eighty 
microliters of firefly or renilla luciferase substrate were mixed with 20 μl of cell 
extract, and then the luciferase activity was determined using an Opticomp 
Luminometer (MGM Instruments, Hamden, CT) in the form of count per min 
(cpm).  To discard variations due to differences in transfection efficiency, each 
value was normalized to the β-galactosidase activity. 
  
Chloramphenicol acetyltransferase activity assay 
Cells were harvested in ice-cold PBS and pelleted at 2000g for 5 min, the cell 
pellet was then suspended in 100-500 μl of 0.25 M Tris-HCl, pH 8.0.  The cell 
suspension was submitted to three cycles of freezing and thawing, and 
centrifuged at 12000g to remove cell debris, supernatants were used as cell 
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extracts.  To perform CAT assay, 50 μl of cell extracts, 1 μl of D-threo-
[dichloroacetyl-1-14C] chloranphenicol, 5 μl of 5 mg/ml B-coenzyme A, 12.5 μl of 
1 M Tris-HCl, pH 8.0, and 34 μl of H2O were mixed.  The mixture was incubated 
at 37oC for 1 hr.  Two hundred microliters of 2, 6, 10, 14 tetra-methyl 
(TMPD)/Xylene (2:1) solution were added to the mixture, and after 1 min of 
vigorous vortexing the solution was centrifuged at maximum speed for 2 min. The 
top phase was then transferred to a scintillation vial, and radioactive activity was 
determined using a Beckman LS6000IC Scintillation counter (Fullerton, CA).  The 
β-galactosidase activity was used to normalize differences in transfection 
efficiency among transfections. 
 
Reverse transcriptase (RT) activity assay 
One milliliter of cell culture supernatants was centrifuged at 4oC for 1.5 hr at 
14000g.  The virus pellet was suspended in 10 μl of dissociation buffer (0.25% 
Triton-X-100, 20% glycerol, 0.05 M Tris-HCl pH 7.5, 1 mM DTT, and 0.25 M KCl) 
followed by three cycles of freezing and thawing.  A forty microliter mixture of 34 
μl of RT assay buffer (0.083 M Tris-HCl pH 7.5, 0.008 M DTT, 0.0125 M MgCl2 
and 0.083% Triton-X-100), 1 μl of 3H dTTP, and  5 μl of 5 units/ml of Poly (A)x(dt) 
was added to the above 10 μl virus suspension.  The total 50 μl mixture was 
incubated at 37oC for 1 hr and then spotted onto DE81 filters (Whatman, 
England).  After three washes with 2XSSC (0.3 M NaCl, 0.03 M sodium citrate, 
pH 7.0), radioactivity of each filter was determined in a Beckman LS6000IS 
scintillation counter, and the virus titer was expressed as cpm per ml.  
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HIV-1 stock preparation and infection of Jurkat T cells and PBMC 
The HIV-1 virus used in this study was the VSV-G pseudotyped NL4-3.Luc(env) 
virus.  Two to four million 293 T cells were plated in a 10-cm tissue culture plate 
and transfected with 3 μg of pHCMVG expressing the VSV-G envelope and 18 
μg of pNL4-3.Luc(env) by standard calcium phosphate transfection.  Forty-eight 
to seventy two hours after transfection, culture supernatants were harvested, 
centrifuged briefly to remove cell debris, and stored at -80oC.  The virus titer was 
determined by the RT assay. 
 
Three million Jurkat T cells and 18 x 106 PBMC, that were previously transfected 
by the nucleofector method, were centrifuged at 90g and 200g, respectively. The 
cell pellet was suspended in 1ml of DMEM medium containing 50 x 105 cpm of 
VSV-G pseudotyped NL4-3.Luc(env) virus, 8 μg/ml polybrene, and incubated for 
6 hr at 37oC, 5% CO2, with periodic flicking to suspend the cells.  The cells were 
centrifuged briefly as above, and washed one time with 10 ml of PBS to remove 
remaining free viruses.  The infected cells were then suspended in 10 ml of 
complete RPMI 1640 medium, and allowed them to grow for 48 hr before they 
were harvested and assayed for Nef expression by Western blot analysis, and 
MHC-I cell surface expression by flow cytometry.  
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Immunoblotting 
Cells were harvested in ice cold PBS and pelleted at 2000g for 5 min, and unless 
otherwise indicated, cell pellets were suspended in 2 vol. of RIPA buffer (10 mM 
NaHPO4, 150 mM NaCl, 1% Triton X-100, 0.1% sodium dodecyl sulfate, 0.2% 
sodium azide, 0.5% sodium deoxycholate, 0.004% sodium fluoride, 1 mM sodium 
orthovanadate, and 1x protease inhibitor cocktail) and incubated on ice for 30 
min.  Whole-cell lysates were obtained by centrifugation at 12000g to remove cell 
debris, and the protein concentration was determined using a Bio-Rad DC 
protein assay kit (Bio-Rad).  An equal amount of protein (15-100μg) in the whole 
cell lysates was separated by 7.5-15% sodium dodecyl sulfate-polyacrylamide 
gel electrophoresis (SDS-PAGE), and then electrotransfered to the HyBond-P 
membrane (Amersham).  The membranes were blocked for one hour in 5% milk 
in TBST buffer solution, followed by probing with specific primary antibodies and 
then appropriate HRP-labeled secondary antibodies.  Chemoluminescence 
visualization was performed using an ECL system (Amersham).  Relative levels 
of protein were determined by densitometric scanning of the blots using the 
housekeeping gene β-actin as an internal standard.  In case that phosphorylated 
proteins were to be detected, cells were lysed in phosphorylation lysis buffer (30 
mM Tris-HCl pH 7.4, 150 mM NaCl, 1% Triton X-100, 0.1% SDS, 10 mM EDTA, 
1 mM sodium orthovanadate, 160 mM sodium fluoride, 10 mM sodium 
pyrophosphate).   
 
 
 71
Soluble and insoluble cell fractions preparation 
One percent Triton-X-100 soluble and insoluble cell fractions were prepared as 
previously described [276, 277].  Briefly, 2 x 106 were washed in ice-cold PBS 
and suspended in 250 μl of ice-cold cell lysis buffer (20 mM Tris, pH 7.5, 5 mM 
EDTA, 1% Triton X-100, 150 mM NaCl and 1x protease inhibitor cocktail) and 
incubated on ice for 30 min.  The samples were then centrifuged at 20,000g at 
4oC for 20 min.  The supernatant was removed and saved as the soluble fraction.  
The pellet was washed three times in cell lysis buffer, then suspended in 70 μl of 
4 X SDS-PAGE sample buffer (8% SDS, 0.4 M DTT, 0.25 M Tris.HCl, pH 6.8, 
40% glycerol and 0.1% bromophenol blue) and incubated at 60oC for 30 min.  An 
equal volume of soluble and insoluble fractions was boiled for 5 min, separated 
by SDS-PAGE, followed by Western blot analysis as described above.  
 
Immunoprecipitation  
Cells were washed with ice-cold PBS and suspended in 2 vol. of low stringency 
cell lysis buffer (50 mM Tris HCl, pH 7.5, 120 mM NaCl, 0.25% NP40, 4 mM 
sodium fluoride, 1 mM sodium orthovanadate, 0.2 mM EDTA, 0.2 mM EGTA, 
10% glycerol, and 1x protease inhibitor cocktail) and incubated on ice for 30 min.  
Cell lysates were obtained by centrifugation and removal of the cell debris.  Cell 
lysates of about 0.8-1.2 mg of total protein were incubated with 1 μg normal IgG 
(Sigma), polyclonal anti-Sam68 (Santa Cruz), goat anti-TIA-1 (Santa Cruz), or 
mouse anti-G3BP (BD transduction laboratories) at 4oC for 16 hr with constant 
rocking.  Then, 25 μl of protein A or protein A/G agarose beads (Upstate 
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Biotechnologies, Temecula, CA) were added to the lysates and further incubated 
for additional 2 hr.  The agarose beads were then washed twice with 500 μl of the 
low stringency buffer and suspended in 60 μl of 4X SDS-PAGE sample buffer, 
followed by SDS-PAGE and Western blot analysis as described above.  
 
RNA isolation, reverse transcription, and multiplex PCR 
Total cellular RNA was isolated from 293T cells 48 hr post-transfection using a 
TRIZOL reagent (Invitrogen) according to the manufacturer’s instructions.  Three 
micrograms of RNA were reverse transcribed at 50oC for 1 hr in a total volume of 
20 μl containing 10 mM dNTPs (Promega), 200 U of RNasin (Promega), 500 ng 
of random hexamers (Roche), and 200 U of Superscript III reverse transcriptase 
(Invitrogen).  Multiplex PCR was carried out using primers BSS 5'-GGC TTG 
CTG AAG CGC GCA CGG CAA GAG G-3’ and SJ4.7A 5'-TTG GGA GGT GGG 
TTG CTT TGA TAG AG-3’, as previously described [278], with modifications.  
Briefly, one microliter of the above reverse transcription reaction was used as the 
template for multiplex PCR in a total reaction volume of 50 μl containing 2.5 mM 
MgCl2, 0.2 mM dNTPs, 1 μM of each primer, and 1 U of AmpliTaq Gold (Applied 
Biosystems).  The PCR program was 30 cycles of 94oC for 30 sec, 60oC for 1 
min, and 72oC for 2 min.  Following denaturation at 94oC for 5 min, five 
microliters of the above PCR products were radiolabeled by 1, 2, 4, 6 or 8 
additional cycles of PCR in the presence of 7.5 μCi [α-32P]dCTP (specific activity 
~800 Ci/mmol, GE Healthcare).  The final PCR products were fractionated on an 
8% polyacrylamide/6 M urea denaturing gel, followed by drying of the gel for 30 
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min using a vacuum gel dryer (Pharmacia biotech, San Francisco, CA), and 
visualized by autoradiography.  In addition, the glyceraldehyde-3-phosphate 
deshydrogenase gene (GAPDH) was included in the RT-PCR as a loading 
control with GAPDH-specific primers: 5’-GAA GGT GAA GGT CGG AGT-3’ and 
5’-GAA GAT GGT GAT GGG ATT TC-3’, and a PCR program of 25 cycles of 
94oC for 1 min, 50oC for 1 min, and 68oC for 2 min, and one cycle of 72oC for 7 
min. 
 
Expression and purification of His-tagged Sam68 
Previously transformed BL21 bacteria with His-Sam68 plasmid were inoculated 
in 3 ml of LB media containing kanamacyn (Km), and incubated O/N at 30oC and 
225 rpm.  The O/N culture was then inoculated into 250 ml of LB Km+ media and 
growth at the same conditions until the OD600 reached 0.6.  At this point, protein 
expression was induced by adding IPTG to a final concentration of 1 mM to the 
bacteria culture, and further incubated at 37oC and 225 rpm for 2 hr.  The cell 
suspension was then pelleted at 2000g for 20 min, suspended in 12 ml of 
bacteria lysis buffer (50 mM NaH2PO4, and 300 mM NaCl, 2 mM PMSF), and 
cells were lysed in a French Press (Thermo electron corporation, Waltham, MA).  
Bacteria cell lysates were obtained by centrifugation (4oC/1200g/30 min) and 
removal of the cell debris.  From this point on, all the procedures were carried out 
at 4oC.  Ten milliliters of bacteria cell lysate were mixed with 1.5 ml of previously 
equilibrated Ni-NTA agarose (Qiagen), and incubated for 1 hr with constant 
rotation.  Bacteria cell lysates were let flow through, and the Ni-NTA agarose with 
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bound protein was washed with bacteria cell lysis buffer containing increasing 
concentrations of imidazol (20 mM, 40 mM, 60 mM, 80 mM and 100 mM).  His-
Sam68 protein was then eluted with bacteria lysis buffer containing 250 mM of 
imidazol.  To verify proper purification, 35 μl of each fraction were separated on 
7.5% SDS-PAGE, and stained with coomassie blue solution (10% acetic acid, 
40% methanol, and 0.5% coomassie blue) for 2 hr, and destained in 10% acetic 
acid O/N.  Finally, elution fractions containing purified His-Sam68 were 
concentrated and desalted by centrifugation at 4000g in a Centricon 50 column 
(Millipore).  
 
Oligonucleotide annealing assay (RNA chaperone assay) 
HIV-1 TAR(+) 5'-GGT CTC TCT TGT TAG ACC AGG TCG AGC CCG GGA GCT 
CTC TGG CTA GCA AGG AAC CC-3' and TAR(-) 5’-GGG TTC CTT GCT AGC 
CAG AGA GCT CCC GGG CTC GAC CTG GTC TAA CAA GAG AGA CC-3’ 
complementary oligonucleotides were synthesized, and purified (Operon 
Biotechnologies, Huntsville, AL).  TAR(-) oligonucleotide was radioactively 
labeled in a 50 μl reaction mixture containing 30 pmoles of TAR(-) 
oligonucleotide, 82.9 pmoles of  [γ-32P] ATP, 6 Units of T4 polynucleotide kinase, 
and 1 X T4 polynucleotide kinase buffer.  The reaction mixture was incubated at 
37oC for 30 min, and the reaction was terminated by incubation at 65oC for 10 
min.  Labeled 5’-end oligonucleotide was separated from precursor ATP by 
chromatography using the microspin 6-50 column (Amersham) according to the 
manufacturer’s instructions.  The in vitro annealing assay was carried out as 
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previously described, with modifications.  Briefly, 0.03 pmoles of TAR (+) 
oligonucleotide, 0.03 pmoles of  TAR (-) radioactively labeled oligonucleotide, 10 
μl of annealing buffer (20 mM Tris-HCl pH 7.0, 30 mM NaCl, 0.1 mM MgCl2, 10 
μM ZnCl2, and 5mM DTT), and increasing concentrations (2.5, 5, 12.5, 25, 50, or 
100 pmoles) of purified His Tagged Sam68 were mixed.  Increasing 
concentrations (0.75, 1.5, or 3.0 pmoles) of NCp7(1-71) or NCp7(12-53) were 
included as positive and negative controls, respectively.  The reaction mixture 
was incubated at 37oC for 2.5 min and stopped by adding 5 μl of stopping 
solution (20% glycerol, 30 mM NaCl, 20 mM EDTA pH 8.0, 0.2% SDS, 0.25% 
bromophenol blue, and 0.4 μg/μl of calf tRNA), and then single strand (ss) and 
double strand (ds) oligonucleotides were separated in a 12% native gel.  The gel 
was dried for 35 min using a vacuum gel dryer (Pharmacia biotech), and 
visualized by autoradiography. 
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Immunofluorescence staining 
Cells previously plated in pre-coated coverslips with poly-L-Lysine were fixed in 
4% paraformaldehyde (PFA) at RT for 25 min and permeabilized in 0.3% Triton 
X-100 for 5 min.  The cells were then blocked in 5% FBS/1% BSA at RT for 30 
min, followed by incubation with: rabbit polyclonal α-Sam68 (1:50), goat 
polyclonal α-TIA-1 (1:50), goat polyclonal α-eIF3 (1:50), mouse monoclonal α-
G3BP (1:75), or mouse monoclonal anti-HA (1:50) at RT for 16 hr.  Next, the 
cells were incubated with PE-conjugated rabbit α-mouse IgG (1:175), FITC-
conjugated goat α-mouse (1:50), FITC-conjugated donkey α-goat (1:50), Rh-
conjugated mouse α-rabbit (1:75), Rh-conjugated goat α-rabbit (1:50), Rh-
conjugated bovine α-rabbit (1:75) at RT for 2 hr.  Between each step, the cells 
were extensively rinsed in PBS.  To stain the nuclei, the cells were incubated in 
100-500 ng/ml of 4’,6’-diamidino-2-phenylindole (DAPI) at 37oC for 25 min.  
Fluorescence images were captured using a digital video imaging microscope 
system consisting of an Axiovert 200 M microscope with a 100 x 1.4 UVF 
objective and three different excitation/emission filters (D360/40-D460/50, 
D470/40-D535/40, D546/10-D590), and an Axiovision video camera (Carl Zeiss, 
Thornwood, NY).  Images were further processed to adjust contrast and 
brightness using the Adobe Photoshop software.  
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Fluorescence in situ hybridization (FISH) 
Nef-Cy3 oligonucleotide probe 5'-TGG GAG CAG TAT CTC GAG ACC TAG A-3' 
(nt. 8875-8900 of NL4-3) was synthesized, fluorescently labeled and PAGE 
purified (Operon Biotechnologies, Huntsville, AL).  FISH was performed in 293T 
cells 42 hr post-transfection.  Briefly, transfected cells were fixed with 4% PFA at 
RT for 30 min and then permeabilized with 70% ethanol at 4oC for 24 hr.  Then, 
the cells were rehydrated in 2X SCC (0.3 mM NaCl, 0.03 mM sodium citrate, pH 
7.0) and 50% formamide at RT for 10 min, and hybridized with 100 ng Nef-Cy3 
probe at 37oC O/N in a vol. of 40 μl containing 40 μg of E. coli  tRNA, 10% 
dextran sulfate, 50% formamide, 2X SCC, and 20 U RNasin.  The Nef-Cy3 probe 
was denatured at 80oC for 75 sec before it was added to the cells.  After 
sequential washes with 0.5X SCC and 0.1X SCC, each for 7 min at RT, 
fluorescent images were captured as above. 
 
Flow cytometry analysis 
MHC I surface expression in Jurkat T cells 
One million previously transfected and infected Jurkat T cells were suspended in 
ice-cold PBS, plated in 96-well round bottom plates and centrifuged at 300g for 5 
min.  The cells were then suspended and incubated in 50 μl of anti-human MHC-I 
hybridoma supernatant (Dr. J. Blum, Indiana University School of Medicine) for 
30 min at 4oC.  Next, the cells were incubated with PE-conjugated rabbit α-
mouse IgG (1:50), and incubated for 30 min at 4oC in the dark.  Between each 
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step, the cells were extensively washed with 0.1% BSA/0.035% sodium 
bicorbonate/0.02% sodium azide/HBSS.  Stained cells were then fixed in 2% 
PFA for 20 min at 4oC, washed with ice-cold PBS, and suspended in 200 μl of 
PBS.  MHC-I surface expression levels were determined using a BDFacscan 
Flow Cytometer from Beckton Dickinson (San Jose, CA) and analyzed using 
CellQuest Pro software, and presented in the form of histogram. 
 
Cell cycle 
One million cells of stable expressing cell lines Hela.cDNA3 and Hela.∆410 were 
suspended in ice-cold PBS, plated in 96-well round bottom plates and 
centrifuged at 700g for 10 min.  The cells were then stained in a solution 
containing 75 μl of propidium iodide (PI) staining solution (0.1 mg/ml PI, 0.6% 
NP-40) and 75 μl of RNase solution (RNase A 100 μg/ml) for 30 min in ice. 
Single cell DNA content for cell cycle analysis was determined using a 
BDFacscan Flow Cytometer (Beckton Dickinson) and analyzed using CellQuest 
Pro software. 
 
Yeast three hybrid assay 
The three yeast hybrid assay was performed in three stages: preparation of L40 
yeast competent cells, transformation of L40 yeast competent cells and liquid 
culture β-Gal assay with ONPG as a substrate. 
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Preparation of L40 yeast competent cells:  Four colonies of L40 yeast strain were 
inoculated in 1ml of YPD medium, transferred into a flask containing 50 ml of 
YPD medium, and incubated at 30oC for 24 hr at 250 rpm to reach a stationary 
phase.  An aliquot of the previous yeast culture was diluted in fresh YPD medium 
to produce an OD600= 0.25, and further incubated at 30oC for 3 hr with constant 
shaking at 250 rpm. Cultured cells were then centrifuged at 1000g for 5 min at 
RT, suspended in 25 ml of autoclaved water, then centrifuged again with the 
same parameters, and the pellet was suspended in 1.5 ml of freshly prepared, 
sterile 1X TE/LiAc solution (0.01 M Tris-HCl, 1mM EDTA, 0.1 M LiAc, pH 7.5).  At 
this point L40 yeast cells are competent for transformation.  
 
Triple transformation of L40 yeast competent cells: A 1.5 ml tube containing the 
following mixture was prepared for each triple transformation: 0.1 μg of each 
plasmid DNA (Hybrid protein 1, Hybrid protein 2, and Hybrid RNA), 0.1 mg of 
herris testes carrier DNA, 0.1 ml of L40 yeast competent cells, and 0.6 ml of 
sterile polyethylene glycol (PEG)/LiAc solution ( 40% PEG, 0.01 M Tris-HCl, 
1mM EDTA, 0.1 M LiAc, pH 7.5).  The mixture was incubated at 30oC for 30 min 
with constant shaking at 200 rpm; afterwards, 70 μl of DMSO were added and 
the cells were heat shocked in a 42oC water bath for 15 min, followed by a brief 
period of incubation in ice.  The cells were then briefly centrifuged for 5 sec at 
15500g, suspended in 100 μl of 1 X TE buffer (0.01 M Tris-HCl, 1mM EDTA), 
and the entire cell suspension solution was plated in SD minus histidine-leucine-
tryptophan-uracil agar plates.  The plates were incubated at 30oC for five days.  
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L40 yeast competent cells were transformed with different combinations of DNA 
plasmids, as shown in Table 1.  
 
Liquid culture β-Gal assay with ONPG as a substrate: The following was carried 
out for each SD agar plate containing triple transformed colonies.  Three 
separate colonies were inoculated in a tube containing 1.5 ml of SD minus 
histidine-leucine-tryptophan-uracil liquid media, and this was performed in 
triplicate (3 tubes, each with 3 inoculated colonies).  The cell suspensions were 
cultured O/N at 30oC with constant shaking at 250 rpm, then the entire O/N 
culture was inoculated into 5 ml of YPD and further cultured at 30oC (250 rpm) for 
5 hr until the OD600 reached 0.4.  At this point, 1.5 ml of cultured cells were 
added into each of three 1.5 ml tubes (triplicate), centrifuged at 15500g for 30 
sec, and the cell pellet was suspended in 1 ml of Z Buffer + β-mercaptoethanol 
solution (60 mM Na2HPO4-7H2O, 40 mM NaH2PO4-H2O, 10 mM KCL, 1mM 
MgSO4-7H2O, 0.27% v/v β-mercaptoethanol).  The cell suspension solution was 
centrifuged again, the pellet was suspended in 100 μl of a Z Buffer + β-
Mercaptoethanol solution, concentrating the cells 15 times, followed by one cycle 
of freeze and thaw in liquid nitrogen and in a water bath at 37oC.  Seven hundred 
microliters of Z Buffer + β-mercaptoethanol solution were added to each tube, 
followed by 0.16 ml of a Z Buffer + β-mercaptoethanol solution containing 4 
mg/ml ONPG, incubated at 30oC for 90 min, the reaction was stopped by adding 
400 μl of 1 M Na2CO3. Finally, 200 μl of the reaction containing the released o-
nytropenyl was measured at 405 nm in a microplate reader.    
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Data acquisition and statistical analysis 
All values expressed as mean  SEM.  Comparisons among groups were made 
using two-tailed Student’s t-test.  A p value of < 0.05 was considered statistically 
significant (*), and p < 0.01 highly significant (**). 
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Table 1. Plasmids used in yeast three hybrid assay  
Hybrid protein 1 Hybrid RNA Hybrid protein 2 
MS2 (pLexA-MS2) MS2 (pIIIA/MS2.2) IRP(pAD-IRP) 
MS2 (pLexA-MS2) MS2-IRE (pIIIA/IRE-MS2) IRP(pAD-IRP) 
   
MS2 (pACTII/MS2) MS2 (pIIIA/MS2.2) Δ410 (pBTM116.Δ410) 
MS2 (pACTII/MS2) MS2-nef 3'UTR Δ410 (pBTM116.Δ410) 
MS2 (pACTII/MS2) MS2-nef 3'RTU Δ410 (pBTM116.Δ410) 
   
MS2 (pACTII/MS2) MS2 (pIIIA/MS2.2) Δ269 (pBTM116.Δ269) 
MS2 (pACTII/MS2) MS2-nef 3'UTR Δ269 (pBTM116.Δ269) 
MS2 (pACTII/MS2) MS2-nef 3'RTU Δ269 (pBTM116.Δ269) 
   
MS2 (pACTII/MS2) MS2 (pIIIA/MS2.2) ΔKH (pBTM116.ΔKH) 
MS2 (pACTII/MS2) MS2-nef 3'UTR ΔKH (pBTM116.ΔKH) 
MS2 (pACTII/MS2) MS2-nef 3'RTU ΔKH (pBTM116.ΔKH) 
The yeast strain L40 was transformed with combinations of three DNA plasmids. 
Plasmids for hybrid protein 1 express a hybrid protein containing bacteriophage 
MS2 coat protein fused to LexA DNA binding domain.  Plasmids for hybrid 
protein 2 express a hybrid protein containing the protein to be tested fused to the 
Gal4 DNA-activation domain.  Plasmids for hybrid RNA express a RNA hybrid 
containing the RNA target for the MS2 coat protein and the nef 3’UTR or nef 
3’RTU (UTR in reverse orientation).  Each row represents the transformation of 
one combination of three different plasmids.  In parenthesis is the name of the 
plasmid given during its generation.  Iron Regulatory Protein (IRP), Iron 
Response Element (IRE). 
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RESULTS 
 
PART 1: Suppression of HIV-1 Nef translation by Sam68 mutant-induced 
Stress Granules and Nef mRNA sequestration 
1.1 Rev-dependent and Rev-independent reporter viruses 
Multiple independent studies have shown that Sam68 cytoplasmic mutant ∆410 
inhibits Rev-mediated nuclear exportation, and HIV-1 replication [78, 248, 249]. 
Early reports proposed a dominant-negative inhibitory mechanism, resulting in 
the retention of the wild-type Sam68 in the cytoplasm, preventing it from 
functioning in Rev-mediated nuclear export of HIV-1 RNA [78].  However, 
subsequent studies support an additional role of Sam68 and mutant ∆410 in 
cytoplasmic processes of HIV-1 RNA metabolism.  For instance, ∆410 is also 
shown to sequester incompletely spliced HIV-1 RNA from the translation 
machinery in perinuclear bundles [248].  Moreover, wild-type Sam68 is found to 
enhance cytoplasmic utilization of intron-containing RNA [222], and to be capable 
of localizing into the nucleus when it is co-expressed with NLS deleted inhibitory 
mutants [249].  Therefore, we decided to further dissect the relationship between 
∆410 presence in the cytoplasm and down-regulation of HIV-1 gene expression. 
As shown in figure 6, we constructed NL4-3.Luc(env) reporter virus using the 
same strategy as for NL4-3.CAT [279], which has the reporter gene cloned in-
frame into a defective env gene, so that we could use the Luc in this plasmid as 
an indicator for the expression of singly spliced HIV-1 RNA (Rev-dependent); and 
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Figure 6.  NL4-3, NL4-3.Luc(env) and NL4-3.Luc(nef) plasmids.  In NL4-
3.Luc(env), the Luc gene was cloned in frame into a non-functional env gene at 
nt position 6310 of the original NL4-3 plasmid.  In NL4-3.Luc(nef), the Luc gene 
was cloned in frame into a non-functional nef gene at nt position 8795 of the 
original NL4-3 plasmid.  
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NL4-3.Luc(nef) reporter virus, which has the Luc gene cloned in the place of HIV-
1 nef gene [13, 280, 281], so we could use it as an indicator for the expression of 
multiply spliced HIV-1 RNA (Rev-independent).  These unique reporter viruses 
represent a novel model to study differential regulation of HIV-1 gene expression. 
Thus, we are now able to discern between ∆410 inhibitory effects due to a 
hindered Rev nuclear exportation pathway, or to possible Rev-independent 
cytoplasmic inhibitory processes.  
 
1.2 Suppression of Rev-dependent and Rev-independent gene expression 
by a Sam68 mutant 410 lacking a nuclear localization signal 
To address the possible function of Sam68 mutants in cytoplasmic processes of 
HIV-1 replication, we transfected 293T cells with NL4-3.Luc(env) or NL4-
3.Luc(nef) in combination with Sam68 or 410 and determined HIV-1 production 
in the culture supernatants and Luc expression in the cells.  In agreement with 
other studies, the results showed that 410 completely abrogated HIV-1 
production in both NL4-3.Luc(env) and NL4-3.Luc(nef) transfected cells, while 
Sam68 had no significant effect (Fig. 7A & B).  As expected, 410 significantly 
inhibited Luc expression in NL4-3.Luc(env) transfected cells (Fig. 7C), as it 
inhibits Rev-mediated nuclear export of HIV-1 intron-containing singly spliced env 
RNA [78, 248, 249].  But, to our great surprise, 410 also inhibited Luc activity in 
NL4-3.Luc(nef) transfected cells by about ~70% (Fig. 7D), suggesting that the 
inhibitory mechanism of ∆410 mutant is a post-transcriptional gene regulatory 
cytoplasmic process, and at least in part, independent of Rev function. 
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Figure 7.  410 effects on HIV-1 replication and on Rev-dependent and Rev-
independent gene expression.  293T cells were plated in a 12-well plate at a 
density of 1.8 x 105 cells per well and transfected with 0.3 μg NL4-3.Luc(env) (A 
& C) or NL4-3.Luc(nef) (B & D), in combination with 0.9 μg of pcDNA3, Sam68 or 
410, and 0.05 μg of pcDNA3-βGal.  pcDNA3 was included as a control, and 
pcDNA3-βGal was used as a normalization control for reporter gene assay.  Cell 
culture supernatants were collected for the RT activity assay 42 hr after 
transfection (A & B), while the cells were harvested for the luciferase activity and 
β-Gal activity assays (C & D).  RT activity, Luciferase activity and β-Gal activity 
were determined as described in Materials and Methods.  Luciferase activity 
values of each sample were normalized to the β-Gal activity of each individual 
sample to correct for transfection variations.  RT activity and luciferease activity 
are determined in the form of counts per min (cpm).  The data were mean  
S.E.M of triplicates.  Comparisons among groups were made using two-tailed 
Student’s t-test. (**) p < 0.01. 
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1.3 Suppression of HIV-1 Nef expression by Sam68 mutant 410  
To ascertain that the previous observation was not an artifact due to intrinsic 
defects of these Luc reporter viruses, we transfected 293T cells with the original 
NL4-3 and increasing concentrations of Sam68 or 410 and determined Nef 
expression by Western blot analysis.  The results showed that 410 expression 
led to a decrease of 80% in Nef expression in a dose dependent manner, while 
Sam68 expression slightly increased Nef expression (Fig. 8A).  To determine 
whether this was only unique to NL4-3 Nef, we performed similar experiments 
with four additional HIV-1 isolates.  The results showed that 410 expression 
also suppressed Nef expression from HIV-1 isolates JRCSF, YU-2 and SG-3.1 
(Fig. 8B).  There was no reactivity of the anti-Nef antibody to LAI.2 Nef (Fig. 8B). 
Similarly, there was no reactivity of the anti-Nef antibody to Nef proteins from 
proviruses p90CF402.1.8, p89.6, and pMJ4 (Fig. 8C).  These results together 
showed that 410 suppressed Nef expression from different HIV-1 isolates.   
 
1.4 Effects of 410 on the splicing and stability of completely spliced HIV-1 
RNA 
Sam68 has been shown to regulate CD44, and bcl-x  alternative splicing [234], 
among others.  HIV-1 gene expression involves complex and extensive splicing  
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Figure 8.  410 effects on HIV-1 Nef expression.  A. 293T cells were plated in 
a 6-well plate at a density of 3.0 x 105 cells per well and transfected with 0.4 μg 
of NL4-3, and 0.4, 1.2, or 2.5 μg of HA-tagged Sam68 or 410.  pcDNA3 was 
used to equalize the total amount of DNA transfected among transfections.  The 
cells were harvested 42 hr after transfection, lysed in RIPA buffer, and 20 μg of 
each sample were separated by 12.5% SDS-PAGE followed by Western blot 
analysis using anti-Nef JRCSF, anti-HA or anti-β-actin.  Relative levels of Nef 
protein were determined using the housekeeping gene β-actin as an internal 
standard, and expressed below.  B. 293T cells were transfected with 0.4 μg of 
NL4-3, JRCSF, YU2, SG3.1, or LAI.2 and 2.5 g of Sam68 or 410.  Similar 
Western blot analysis was performed for Nef, Sam68 or 410, or β-actin.  C. 
293T cells were transfected with 0.4 μg of the following HIV-1 isolates: JRCSF, 
p90CF402.1, SG3.1, NL4-3, YU2, pMJ4 or p89.6.  Similar Western blot analysis 
was performed for Nef, using anti-Nef JRCSF. 
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of HIV-1 RNA.  Meanwhile, STAR family proteins and KH domain-containing 
proteins have been shown to regulate mRNA stability [282-285].  Thus, an 
intriguing possibility is that 410 may suppress Nef expression through inhibition 
of HIV-1 RNA splicing to generate the completely spliced RNA or through 
changes in the stability of these RNA.  However, due to the extensive sequence 
overlapping between all HIV-1 transcripts, it is not possible to individually amplify 
HIV-1 nef mRNA when all the HIV-1 RNA species are present.  Thus, to test this 
possibility, we adapted a semi-quantitative multiplex RT-PCR assay [286-288], 
which allows you to simultaneously amplify and radioactively label the different 
completely spliced HIV-1 RNA species in HIV-infected cells, and determined the 
effects of 410 on HIV-1 RNA splicing.  We first optimized the input amount of 
RNA and cDNA, the PCR cycling, and the number of PCR labeling cycles to 
ensure that the amplification products were in the linear range.  We determined 
that the optimal conditions were: three micrograms of total RNA, one microliter of 
reverse transcription reaction, and two PCR labeling cycles (Fig. 9A).  Then, we 
transfected 293T cells with NL4-3 and Sam68 or 410, and treated the cells with 
or without actinomycin D (Act. D, 7.5 μg/ml), a well characterized inhibitor of RNA 
Pol II elongation used during mRNA stability studies, for 10 hours, followed by 
isolation of total RNA and reverse transcription and multiplex PCR, as previously 
determined.  The results showed that compared to the cDNA3 transfection 
control, Sam68 and 410 both had minimal detectable effects on the RNA 
splicing pattern and the relative level of the completely spliced RNA (-Act. D,  
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Figure 9.  410 effects on the level and stability of multiply spliced HIV-1 
RNA.  A. 293T cells were plated in a 6-well plate at a density of 3.2 x 105 cells 
per well and transfecetd with 0.4 μg of NL4-3.  The cells were harvested 42 hr 
after transfection for total RNA isolation.  Three micrograms of total RNA was 
then reverse transcribed and subjected to multiplex PCR as described in detail in 
the Material and Methods sections.  The PCR products were labeled for 1, 2, 4, 
6, and 8 PCR cycles with 7.5 μCi [α-32P]dCTP, then separated on a 8% 
polyacrylamide/6 M urea denaturing gel, and visualized by autoradiography.  B. 
293T cells were plated in a 6-well plate at a density of 3.2 x 105 cells per well and 
transfecetd with 0.4 μg of NL4-3, and 2.5 μg of HA-tagged Sam68 or 410. 
Twenty eight hours post transfection the cells were either treated or not treated 
with 7.5 μg/ml of Actinomycin D for 10 hr.  The cells were then harvested for total 
RNA isolation.  Three micrograms of total RNA was then reverse transcribed, 
subjected to multiplex PCR, radioactively labeling, and separated as described 
above.  The PCR products were labeled for 2 PCR cycles with 7.5 μCi [α-
32P]dCTP. GADPH was included as a control.   
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Fig. 9B).  Similarly, there were no apparent differences in the RNA splicing 
pattern and the relative level of completely spliced RNA between cells treated 
with and without Act. D (Fig. 9B).  These results suggest that the Nef 
suppression by 410 is mediated by a mechanism different from alterations in 
HIV-1 mRNA transcription or splicing. 
 
1.5 Suppressed Nef expression as a gain of function in the cytoplasm for 
410 
As mentioned before, inhibition of HIV-1 replication by 410 has raised the 
possibility that 410 overrides endogenous Sam68 function through 
intermolecular association and subsequent sequestration in the cytoplasm, which 
in turn prevents endogenous Sam68 from entering into the nucleus and 
functioning in Rev-mediated nuclear export of HIV RNA.  However, our early 
studies have detected a significant level of Sam68 in the nucleus of cells that 
over-express 410 [249], suggesting that 410 functions, at least in part, through 
a gain of function in the cytoplasm.  Therefore, we hypothesized that if ∆410 
inhibits Nef expression through a classical dominant-negative mechanism, 
accordingly Sam68 knock-down should have similar effects.  To address this 
possibility, we utilized the small interference RNA (siRNA) strategy to knock 
down endogenous Sam68 and determined its effects on Nef expression.  We first 
showed that Sam68 siRNA was very effective in knocking down endogenous 
Sam68 expression in 293T cells (Fig. 10A).  We then transfected 293T cells with 
NL4-3 and 100 nM control or Sam68 siRNA and determined Nef expression by  
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Figure 10.  Effects of Sam68 knock-down on HIV-1 Nef expression.  A. 293T 
cells were plated in a 6-well plate at a density of 3.0 x 105 cells per well and 
transfected with 200 nM control siRNA (Ctrl siRNA), or 75, 125, 175, or 200 nM 
Sam68 siRNA.  The cells were harvested 24 hr after transfection, lysed in RIPA 
buffer, and 20 μg of each sample were separated by 12.5% SDS-PAGE followed 
by Western blot analysis using anti-Sam68, or anti-β-actin.  B. 293T cells were 
plated as above and transfected with 100 nM control siRNA or Sam68 siRNA.  
The cells were then transfected with 0.6 μg NL4-3 24 hr after the first 
transfection, and continued to be cultured for additional 24 hr before harvesting 
the cells.  Similar Western blot analysis was performed using anti-Nef JRCSF, 
anti-HA or anti-β-actin. 
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Western blot analysis.  Nef expression exhibited no difference between cells 
expressing control or Sam68 siRNA (Fig. 10B).  To further confirm these findings, 
we transfected 293T cells with control or Sam68 siRNA and 24 hours later with 
NL4-3.Luc(env) or NL4-3.Luc(nef) and determined HIV replication and Luc 
expression.  As previously shown [221, 244], Sam68 knockdown led to inhibition 
of HIV-1 production of both NL4-3.Luc(env) and NL4-3.Luc(nef) by about 50% 
over control siRNA transfection (Fig. 11A & B).  To a similar extent Sam68 
knockdown inhibited Rev-dependent Luc expression in NL4-3.Luc(env) 
transfected cells (Fig. 11C).  In contrast, Rev-independent Luc expression in 
NL4-3.Luc(nef) showed no significant changes between control siRNA and 
Sam68 siRNA transfected cells (Fig. 11D).  Taken together, these results support 
the notion that Sam68 is an essential cellular co-factor for Rev function and 
suggest that 410 effects on Nef expression is a gain of function of this mutant in 
the cytoplasm. 
 
1.6 Requirement of Sam68 domain between aa269 and aa321 for Nef 
suppression  
Structurally, Sam68 contains the heteronuclear ribonucleoprotein particle K 
homology (KH) domain, an RG-rich region, proline-rich domains (P0 to P5), a 
tyrosine-rich domain, and a nuclear localization signal (NLS) (Fig. 12). Our early 
studies have shown that a domain located between amino acid residues 269 and 
321 of Sam68 is directly involved in 410-induced inhibition of HIV-1 replication 
[249].  To determine the roles of this domain on 410-induced Nef suppression,  
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Figure 11.  Effects of Sam68 knock down on HIV-1 replication and on Rev- 
dependent and Rev-independent gene expression.  293T cells were plated in 
a 12-well plate at a density of 1.75 x 105 cells per well and transfected with 100 
nM of control siRNA or Sam68 siRNA.  Twenty four hours later the cells were 
transfected with 0.35 μg of NL4-3.Luc(env) (A & C) or NL4-3.Luc(nef) (B & D), in 
combination with 0.05 μg of pcDNA3-βGal.  pcDNA3-βGal was used as a 
normalization control for reporter gene assay.  Cell culture supernatants were 
collected for the RT activity assay 36 hr after transfection (A & B), while the cells 
were harvested for the luciferase activity and β-Gal activity assays (C & D).  RT 
activity, luciferase activity and β-Gal activity were determined as described in 
Materials and Methods.  Luciferase activity values of each sample were 
normalized to the β-Gal activity of each individual sample to correct for 
transfection variations.  RT activity and Luciferease activity are determined in the 
form of counts per min (cpm).  The data were mean  S.E.M of triplicates. 
Comparisons among groups were made using two-tailed Student’s t-test. (*) p < 
0.05, (**) p < 0.01. 
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we constructed a panel of HA/GFP-tagged Sam68 mutants (Fig. 12), co-
transfected them in combination with NL4-3 into 293T cells, and determined Nef 
expression by Western blot analysis.  Similarly to 410, 321 with deletions of 
P4, P5 and NLS also suppressed Nef expression, whereas 269 containing 
additional deletion of P3 and the RG rich region had no effects on Nef expression 
(Fig. 13A).  Moreover, 269-321 that contains the NLS did not affect Nef 
expression, nor did the 269-321 domain alone.  Similar results on Nef expression 
were obtained with a panel of HA-tagged Sam68 and its mutants (Fig. 13B).  
These results suggest that both exclusive cytoplasmic localization, and the 
aa269-321 domain that contains the P3  and the RG rich region are required for 
Nef suppression.   
 
1.7 Sam68 structure and its RNA chaperone activity 
Previous results have shown that HIV-1 Nef suppression by ∆410 is not at the 
level of transcription [78], splicing (Fig. 9B), or due to induced mRNA degradation 
(Fig. 9B), suggesting that ∆410 might be exerting a deleterious effect on HIV-1 
nef mRNA translation efficiency.  The efficiency of translation of different mRNA 
depends on the degree of secondary structure in their 5’UTRs; highly structured 
5’UTRs abrogate translation by obstructing ribosomal movement to the initiation 
codon [289].  Interestingly, nef mRNA contain a long and structured 5’UTR (Fig. 
21B).  RNA chaperone proteins are a class of proteins and ubiquitous in living 
organisms; they help RNA molecules reach their more stable conformation, and  
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Figure 12.  GFP-tagged Sam68 or its mutants.  P: proline-rich domain; KH: KH 
domain; RG: arginine-glycine rich domain; and NLS: nuclear localization signal. 
The single lines in GFP.Δ269-321 and GFP.269-321 represent deleted regions. 
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Figure 13.  Effects of Sam68 deletion mutants on HIV-1 Nef expression.  A. 
293T cells were plated in a 6- well plate at a density of 3.0 x 105 cells per well 
and transfected with 0.4 μg of NL4-3, and 2.5 μg of GFP-tagged Sam68 or its 
mutants.  The cells were harvested 42 hr after transfection, lysed in RIPA buffer, 
and 20 μg of each sample were separated by 12.5% SDS-PAGE followed by 
Western blot analysis using anti-Nef JRCSF, anti-GFP or anti-β-actin.  Relative 
levels of Nef protein were determined using the housekeeping gene β-actin as an 
internal standard, and expressed below.  B. 293T cells were transfecetd with 0.4 
μg of NL4-3, and 2.5 μg of HA-tagged Sam68 or its mutants.  Similar Western 
blot analysis was performed for Nef or β-actin. 
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they participate in every step of RNA metabolism: transcription, splicing, 
transport, and translation [290].  Well characterized chaperones include FMRP, 
hnRNP A1, La protein, and HIV-1 NCp7, among others [290].  Importantly, 
among all the functional protein classes, RNA chaperones possess the highest 
frequency of intrinsically disordered regions [291].  Based on all of the above, we 
hypothesized that Sam68 might be a RNA chaperone, and that when present in 
the cytoplasm (∆410), it maintains the structure of nef mRNA 5’UTR, preventing 
ribosomal scanning, mRNA unwinding, and translation. 
 
To test this hypothesis, we first determined the degree of intrinsic disorder in 
Sam68 protein.  For this purpose, we used the recently described DisProt VL3-H 
predictor [292].  We found that Sam68 contained 51.7% of its aa residues within 
uninterrupted disordered regions (Fig. 14), as is the case for multiple well 
characterized RNA chaperones [291]; moreover, the region between aa280 to 
aa354 is a well limited highly disordered region (Fig. 14), suggesting that Sam68 
may have chaperone functions, and that the inhibitory domain between aa269 to 
aa321 might be essential for this process.  Multiple in vitro and in vivo assays 
have been developed to determine the activity of RNA chaperones [293].  One of 
those assays measures the capacity of these proteins to rapidly promote the 
annealing of complementary oligonucleotide strands (in vitro annealing assay) 
(Fig. 15B).  To determine if Sam68 is in fact a RNA chaperone, we initially 
purified bacterial expressed His-tagged Sam68 by affinity chromatography (Fig. 
15A), and then performed the in vitro annealing assay with His-Sam68, and  
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Figure 14.  Prediction of intrinsically disordered regions in Sam68.  
Disordered regions in Sam68 protein were predicted using the Disprot VL3-H 
predictor.  An amino acid with a disorder score above or equal to 0.5 is 
considered to be in a disordered environment, while below 0.5 to be ordered.  
The (Y) axis represents probability of disorder, while the (X) axis represents the 
residue number.  
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Figure 15.  in vitro oligonucleotide annealing capability of Sam68.  A. His- 
tagged Sam68 was expressed on BL21 bacteria and purified as detailed in the 
Materials and Methods section.  Then, 35 μl (right) or 5 μl (left) of each fraction 
were separated by 7.5% SDS-PAGE followed by coomassie blue staining (right) 
or Western blot analysis (left) using anti-Sam68.  (*) His-Sam68, (**) degradation 
products of His-Sam68.  B. in vitro oligonucleotide annealing by HIV-1 NC.  
Complementary TAR(+) (red) and radioactively labeled TAR (-) (blue) 
oligonucleotides were mixed in the presence of increasing concentrations (0.75, 
1.5, 3.0 pmoles) of RNA chaperone NCp7(1-71) or its inactive mutant NCp7(12-
53), incubated at 37oC for 10 min followed by separation in a 12% native gel, and 
visualized by autoradiography.  C. in vitro oligonucleotide annealing by Sam68.  
Similar assay was performed at 37oC for 2.5 min in the presence of increasing 
concentrations of purified His-Sam68 (2.5, 5, 12.5, 25, 50, or 100 pmoles); 
NCp7(1-71) or NCp7(12-53) were included as positive and negative controls, 
respectively.  
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NCp7(1-71) or NCp7(12-53), as positive and negative controls, respectively.  As 
previously reported, NCp7(1-71) promotes rapid oligonucleotide annealing and 
NCp7(12-53) mutant protein failed to do so (Fig. 15B & C).  However, Sam68 
failed to promote annealing of complementary oligonucleotides at 37oC, despite 
using high concentrations of purified protein.  These results suggest that under 
these conditions Sam68 does not have chaperone activity, despite its high 
predicted intrinsic disorder, and that its ability to suppress Nef expression does 
not likely involve Sam68-directed mRNA folding. 
 
1.8 Localization of Sam68 mutants 410 and 321 in perinuclear granule-
like structures.  
We next examined the intracellular localization of these mutants using the panel 
of GFP fusion proteins (Fig. 12), to determine if there is any particular association 
between localization and Nef suppression.  We expressed these GFP fusion 
proteins in COS-7 cells, as the size of these cells is relatively larger when 
compared to the size of 293T cells, which made these cells an ideal platform for 
such experiments.  As expected, full-length Sam68 that contains the intact NLS 
was detected in the nucleus, and 410, 321, and 269 that all lack the NLS 
were localized in the cytoplasm (Fig. 16A).  Moreover, 269-321 was expressed 
in the nucleus, while the 269-321 domain was detected throughout the cells (Fig. 
16A).  Of note was that inhibitory 410 and 321 mutants appeared in a unique 
granule-like structure in the cytoplasm, whereas a non-inhibitory mutant 269  
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Figure 16.  Subcellular localization of GFP tagged Sam68 and its mutants. 
A.  COS-7 were plated in a 24- well plate at a density of 0.75 x 105 cells per well 
and transfected with 0.3 μg GFP-tagged Sam68 or its mutants.  The cells were 
fixed in 4% PFA 24 hr after transfection, and then stained in PBS containing 100 
ng/ml DAPI for nuclei.  Localization of GFP fusion proteins was visualized and 
captured using a Zeiss immunofluorescence microscope.  The images were 
representative of each GFP fusion protein.  B. Ten random fields were counted 
for a total number of 100 transfected cells in each well and for the number of 
cells exhibiting a granule-like structure, which were used to calculate the 
percentage of the granule-containing cells.  The data were mean  S.E.M.  
Comparisons among groups were made using two-tailed Student’s t-test (**) p < 
0.01. 
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showed an evenly cytoplasmic distribution, a typical pattern of cytoplasmic 
protein (Fig. 16A).  The apparent association between formation of the granule-
like structure and Nef suppression prompted us to quantitate the percentage of 
the structure-containing cells in each transfection.  More than 85.67  2.49% of 
the 410-transfected cells exhibited the structure, while the structure was 
detected in 54.33  3.30%  of the 321 transfected cells (Fig. 16B).  Both were 
significantly higher than GFP alone (9.67  2.05%), Sam68 (18.33  2.36%), 
269 (24.67  4.50%), 269-321 (7.00  1.63%) and 269-321 (4.67  1.70%).  
There were no significant differences among cells expressing GFP alone, 
Sam68, 269, 269-321 and 269-321.  These results suggest an association 
between Nef suppression and formation of the granule-like structure. 
 
1.9 410 localization into stress granules  
Stress granules (SG) have been shown to regulate gene expression at the 
translational level in response to a variety of external stimuli [123].  Our findings 
that 410 expression resulted in Nef suppression and formation of a granule-like 
structure prompted us to determine whether 410 expression directly induced 
stress granules.  We transfected COS-7 cells with HA-tagged 410, in 
combination with three GFP-tagged SG markers, GFP-G3BP, GFP-TIA-1, or 
GFP-hnRNP A1.  G3BP and TIA-1 induce SG assembly when over-expressed in 
the absence of external stress stimuli [124], while hnRNP A1 is localized into the 
SG only under stress conditions [160].  We then briefly exposed the transfected 
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cells to sodium arsenite (ARS), a widely used oxidative stressor.  We performed 
immunofluorescence staining for 410 localization using an anti-HA epitope 
antibody.  As expected, G3BP and TIA-1 were localized in the SG irregardless of 
ARS treatment (Fig. 17A & B), whereas hnRNP A1 was expressed in the nucleus 
of cells in the absence of ARS treatment and was re-localized into the SG when 
the cells were exposed to ARS (Fig. 17C).  In contrast, 410 was found to be 
localized in the granule-like structure in all these three co-transfections, and ARS 
treatment did not affect this localization.  Moreover, co-localization analysis 
revealed that 410 was co-localized with G3BP and TIA-1 in both ARS-treated 
and untreated cells and only with hnRNP A1 in ARS-treated cells (Fig. 17A-C), 
confirming that the granule-like structures induced by 410 expression are SG.  
To exclude the possibility that 410-induced SG formation results from over-
expression of these SG markers, we transfected 293T cells with GFP.410 and 
performed immunofluorescence staining for endogenous TIA-1 using an anti-
human TIA-1 antibody.  Similarly, 410 was co-localized with endogenous TIA-1 
in the SG, even though a majority of the TIA-1 protein was detected in the 
nucleus (Fig. 18A).  Localization of 410 in SG was further confirmed using other 
endogenous SG markers such as: eIF3 and G3BP (Fig. 18B & C).  Previously, 
It has been determined that SG are in a dynamic equilibrium with polysomes, 
therefore treatment with polysome stabilizing agents (cyclohexamide-CHX) 
dissolves SG [124].  Thus, we transfected cells with GFP.410 and treated these 
cells with CHX and determined the status of SG.  Similarly to GFP.TIA-1 and 
GFP.G3BP-expressing cells, CHX treatment led to SG disappearance in 410-
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induced granules (Fig. 19A).  However, it is important to mention that while GFP-
TIA-1-positive SG dissolved very efficiently, GFP.G3BP positive and GFP.410 
positive SG disappeared only in a percentage of the cells, in concordance with 
previous findings that argue that SG with different protein composition behave 
differently.  Lastly, we determined whether 410 was also localized in the 
processing bodies (P bodies), as P bodies share and exchange many structural 
components with SG and regulate protein translation and/or mRNA degradation 
in the cytoplasm [125].  We transfected COS-7 cells with a GFP-tagged P body 
marker hdcp-1α [294] and HA-tagged 410 and performed similar 
immunofluorescence staining for 410.  We also treated cells with ARS as a 
control, as ARS is known to increase the size and number of P bodies.  There 
was no co-localization between hdcp-1α and 410 in both ARS-treated and 
untreated cells (Fig. 19B).  Taken together, these results demonstrate that 410 
expression induces SG formation and suggest that SG formation likely 
contributes to 410-mediated Nef suppression. 
 
1.10 Specificity of 410-induced Nef suppression  
To ensure expression of all HIV-1 genes, HIV-1 full-length RNA transcripts 
undergo extensive splicing to generate various smaller RNA species.  But all 
share the same 289-nt 5’-leader sequence that starts with TAR [37].  The fact 
that 410 completely blocks HIV-1 replication raises the possibility that 410 
negatively regulates the translation efficiency of all HIV-1 RNAs including the nef  
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Figure 17.  410 co-localization with stress granules markers G3BP, TIA-1, 
and hnRNP A1.  COS-7 were plated in a 24-well plate at a density of 0.75 x 105 
cells per well and transfected with 0.35 μg HA-tagged 410 and 0.35 μg GFP-
G3BP (A), GFP-TIA-1 (B), or GFP-hnRNP A1 (C).  Twenty four hours after 
transfection, the cells were treated with or without 0.5 mM sodium arsenite (ARS) 
for 1 hr, fixed in 4% PFA, and then stained with an anti-HA antibody followed by 
a PE-conjugated secondary antibody.  The nuclei were counterstained with PBS 
containing 100 ng/ml DAPI.  The images were representative of each co-
transfection.  Co-localization of SG markers and 410 was shown in the column 
marked as “Merge”.   
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Figure 18.  410 co-localization with endogenous stress granules markers 
TIA-1, eIF3η, and G3BP.  293T were plated in a 24-well plate at a density of 1.5 
x 105 cells per well and transfecetd with 0.35 μg of GFP-tagged 410.  Twenty 
four hours after transfection, the cells were treated with or without 0.5 mM 
sodium arsenite (ARS) for 1 hr, fixed in 4% PFA, and then stained with anti-TIA-1 
(A), anti-eIF3η (B), and anti-G3BP (C) antibodies followed by a PE-conjugated 
secondary antibodies.  The nuclei were counterstained with PBS containing 100 
ng/ml DAPI.  The images were representative of each co-transfection.  Co-
localization of SG markers and 410 was shown in the column marked as 
“Merge”. 
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Figure 19.  Functional behavior of 410-induced SG and 410 co-
localization with P bodies marker hdcp-1α.  A. 293T were plated in a 24- well 
plate at a density of 1.5 x 105 cells per well and transfected with 0.35 μg of 
GFP.TIA-1, GFP.G3BP or GFP.410.  Twenty four hours after transfection, the 
cells were treated with ARS as above, with 100 μg/ml cyclohexamine for 90 min, 
or the combination of both.  The cells were then fixed in 4% PFA, and 
counterstained in PBS containing 100 ng/ml DAPI for nuclei.  Microscopic 
analysis was carried out as above.  B. COS-7 were plated in a 24- well plate at a 
density of 0.75 x 105 cells per well and transfected with 0.35 μg HA-tagged 410 
and 0.35 μg GFP.hdcp-1α.  The cells were processed, and analyzed for co-
localization as previously described.     
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RNA.  To address this possibility, we took advantage of a bicistronic reporter 
gene system [40].  The reporter gene system has the 5’-HIV-1 leader sequence 
inserted between the ORFs of Renilla Luc gene (R Luc) and Firefly Luc gene (F 
Luc) and is under the control of the CMV promoter (Fig. 20A).  F Luc expression 
is used as a measure of the translation efficiency of the HIV-1 5’ leader sequence 
with R Luc to normalize the transfection variations.  Thus, we transfected 293T 
cells with this reporter gene and Sam68 or 410 and determined the activity of F 
Luc and R Luc.  The results showed that there was no significant difference in 
the F Luc/R Luc ratio between Sam68 and 410 transfections, although both 
appeared to be slightly higher than the cDNA 3 control (Fig. 20B).   
 
HIV-1 accessory proteins Nef, Tat and Rev are all encoded by completely spliced 
RNA, which contain a significant sequence overlap (Fig. 21A).  Thus, it was 
necessary to determine whether 410 has similar suppressive effects on Tat and 
Rev expression.  To address this specificity issue, we constructed tat, rev and 
nef minigenes (Fig. 21A & B) and compared 410 effects on their expression.  
We transfected each of these minigenes with Sam68 or each of its mutants and 
determined the minigene expression using Western blot analysis.  In agreement 
with our earlier findings (Fig. 13A & B), both 410 and 321 suppressed Nef 
expression (Fig. 21C).  However, 410 and 321 had little effects on Tat and 
Rev expression (Fig. 21C).  
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Figure 20.  Effects of ∆410 on the translation efficiency of the RNA 
containing the 289 nt. 5’ leader sequence of HIV-1.  A. Scheme of the 
bicistronic vector cDNA3-R Luc-HIV 5’-F Luc.  B. 293T were plated in a 12- well 
plate at a density of 2.2 x 105 cells per well and transfected with 0.1 μg of 
cDNA3-F Luc-HIV 5’-R Luc and 0.6 μg of Sam68, 410, or cDNA3.  The cells 
were harvested 42 hr after transfection and assayed for F Luc and R Luc activity 
as detailed in Materials and Methods.  The ratio of F Luc to R Luc was used to 
measure the translation activity of HIV-1 5’-R leader sequence.  The data were 
mean  S.E.M. of triplicates.   
 
 121
 
 
 
 
 122
 
 
Figure 21.  Effects of ∆410 on tat, rev and nef minigene expression.  A. 
Scheme of NL4-3 proviral DNA and tat, rev, and nef minigenes.  Nucleotide 
location of the major alternative splicing sites that are used to generate the most 
abundant tat, rev and nef mRNA species, and the transcription initiation site are 
marked on top of the NL4-3 proviral DNA scheme.  Representation of tat, rev and 
nef minigenes are shown below, translation start and stop codes and their 
locations were also marked on top of each of the minigenes.  Different regions 
were marked with colors as follows: the region only present on tat mRNA was 
marked red, the region only present on tat and rev mRNA was marked light blue, 
and the region present in all tat, rev and nef mRNA was marked blue.  B. The 
secondary structure of the 5’UTR and 3’UTR of all minigenes were predicted by 
the RNAfold program.  The length in nucleotides for each 5’UTR and 3’UTR was 
given under each minigene.  A region present in nef 5’UTR but not in tat or rev 
5’UTRs was marked red.  C.  293T cells were plated in a 12- well plate at a 
density of 1.5 x 105 cells per well and transfected with 0.35 μg of tat minigene, 
0.18 μg of rev minigene, or 0.18 μg of nef  minigene,  in combination with 1.2 μg 
of HA-tagged Sam68 or its mutants.  In addition, 40 ng, or 10 ng of Tat-myc were 
included for rev minigene and nef minigene, respectively.  The cells were 
harvested 42 hr after transfection, lysed in RIPA buffer, and 20 μg of each 
sample were separated by 12.5% SDS-PAGE followed by Western blot analysis 
using anti-Nef JRCSF, or anti-β-actin. 
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To ascertain that the previous observations were not artifacts due to the use of 
NL4-3 tat, rev and nef minigenes, we wanted to determine the effects of ∆410 on 
Tat and Rev expression in the context of the original NL4-3.  However, in view 
that Tat is known to be a poor immunogen [295], and that we failed to directly 
detect Rev expression by Western blot analysis (Fig. 22A) or by 
immunoprecipitation (Fig. 22B), using different anti-Rev antibodies from 
commercial sources or NIH AIDS Reagents Program, we then considered using 
indirect functional assays.  Studies have shown that 410 directly inhibits Rev 
nuclear export function [78, 249], suggesting that this functional assay would not 
allow us to distinguish 410 effects on Rev function from 410 effects on Rev 
expression.  In contrast, 410 has been shown to have no effect on Tat 
transactivation activity of the HIV-1 LTR [78].  Thus, we performed an indirect Tat 
functional assay.  We first transfected 293T cells with LTR-CAT reporter plasmid 
and increasing concentrations of NL4-3, which served as a source of Tat and 
determined the optimal amount of NL4-3 to be 0.2 μg that gave rise to a linear 
response of LTR-CAT to Tat in this assay (Fig. 22C).  We then transfected 293T 
cells with LTR-CAT, NL4-3 (0.2 μg), and Sam68 or 410 and determined the 
CAT activity in these cells.  There were no differences in CAT activity among the 
cDNA3, Sam68 and 410 transfected cells (Fig. 22C).  These results suggest 
that 410 did not alter Tat or Rev expression and that the suppressive effects of 
410 were specific to Nef. 
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Figure 22.  Effects of ∆410 on NL4-3 Tat expression.  A. 293T cells were 
plated in a 60 mm plate at a density of 8.0 x 105 cells per plate and transfected 
with 7.0 μg of Rev-GFP (positive control), or 7.0 μg of NL4-3.  The cells were 
harvested 42 hr after transfection, lysed in RIPA buffer, and 100 μg of each 
sample were separated by 12.5% SDS-PAGE followed by Western blot analysis 
using anti-Rev-NIH, or anti-Rev-Fitzgerald antibodies.  B. 293T cells were 
transfected and lysed as above.  One milligram of cell lysate was then 
immunoprecipitated with anti-Rev-NIH antibody, followed by Western blotting 
using α-Rev-NIH antibody.  IgG heavy chain (**), and light chain (*).  C. 293T 
cells were plated in a 24-well plate at a density of 1.25 x 105 cells per well and 
transfected with 0.1 μg of LTR-CAT, 0.05 μg of pcDNA3-βGal, and 0.05, 0.1, 0.2, 
0.3 and 0.5 μg of NL4-3.  pcDNA3 was used to equalize the total amount of DNA 
transfected among transfections and pcDNA3-βGal was used to normalize 
variations of the transfection efficiency among the transfections.  The cells were 
harvested for the CAT activity assay 42 hr after transfection.  D. Similar 
experiments were performed as stated in C except that 0.1 μg of LTR-CAT, 0.2 
μg of NL4-3, and 0.6 μg of HA.Sam68, 410, or cDAN3 were transfected.  The 
data were mean  S.E.M of triplicates.  
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1.11 410 interaction with nef mRNA 3’UTR 
Our previous results suggest that nef mRNA contains a molecular determinant 
required for ∆410-mediated translational repression (Fig. 20-22).  As the primary 
sequences of tat, rev and nef mRNA extensively overlap (Fig. 21A); we then 
turned our attention to the 5’- and 3’-untranslated regions (5’UTR and 3’UTR) of 
these mRNA.  When we performed the secondary structure analysis of these 
mRNA using the RNAfold program [296], we found that both 5’UTR and 3’UTR 
regions of these mRNA significantly differed from each other in their secondary 
structure and length (Fig. 21B).  Of particular note is part of 5’UTR of nef mRNA 
that is absent in tat and rev mRNA (marked in red, Fig. 21B).  Thus, using nef 
minigene as an experimental model, we deleted this unique 5’UTR region from 
nef minigene (Fig. 23A).  Meanwhile, we also constructed a nef minigene mutant 
that was deleted of the entire 3’UTR of nef mRNA, which is also significantly 
different from those of tat and rev mRNA (Fig. 21B).  We then compared Nef 
expression from these nef minigene deletion mutants using the similar co-
transfection and Western blot analysis approaches.  The 5’UTR deletion showed 
little effects on 410- and 321-induced Nef suppression, while the 3’UTR 
deletion completely abolished Nef suppression by these two Sam68 mutants 
(Fig. 23B).  Further corroboration of these findings was that 410 or 321 did not 
suppress Nef expression from an expressing cassette that only contains the nef 
ORF (Fig. 23B).  These results show that 3’UTR of nef mRNA is the molecular 
determinant for the specificity of 410- and 321-induced Nef suppression. 
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Figure 23.  Effects of ∆410 on nef deletion minigene expression.  A.  The 
secondary structure of the 5’UTR and 3’UTR of nef deletion minigenes were 
predicted by the RNAfold program.  The length in nucleotides for each 5’UTR 
and 3’UTR was given under each minigene.  A region present in nef 5’UTR but 
not in tat or rev 5’UTRs was marked red.  B.  293T cells were plated in a 12-well 
plate at a density of 1.5 x 105 cells per well and transfected with 0.18 μg of nef  
minigenes, 1.2 μg of HA-tagged Sam68 or its mutants, and 10 ng of Tat-myc. 
The cells were harvested 42 hr after transfection, lysed in RIPA buffer, and 20 μg 
of each sample were separated by 12.5% SDS-PAGE followed by Western blot 
analysis using anti-Nef JRCSF, or anti-β-actin. 
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The above results from the minigene experiments (Fig. 23B) prompted us to 
further determine whether 410 bound to nef mRNA 3’UTR, and whether the 
binding was correlated with its suppressive effects.  We took advantage of a 
RNA-protein interaction-based yeast three hybrid reporter gene assay [297], 
which allows in vivo detection of RNA-protein binding.  This assay system 
consists of three components: one hybrid protein of bacteriophage MS2 coat 
protein fused to LexA DNA-binding domain, the other hybrid protein containing 
the protein to be tested fused to the Gal4 DNA-activation domain, and one hybrid 
RNA that has the RNA target for the MS2 coat protein as well as the RNA to be 
tested.  When these three components are introduced into and expressed in the 
appropriate yeast strain, direct binding of the test protein and the test RNA will 
activate the LacZ reporter gene expression in the yeast.  We constructed 410 
fusion expression plasmid and the MS2 RNA-nef mRNA 3’UTR hybrid RNA 
plasmid (MS2-nef 3’UTR).  We also constructed MS2-nef 3’RTU hybrid RNA 
plasmid in which the nef mRNA 3’UTR is in a reverse orientation and used it as a 
cognate control.  We also constructed two additional fusion expression plasmids, 
269 which only slightly induced SG formation and did not suppress Nef 
expression, and ∆KH which is a RNA binding deficient Sam68 mutant.  We then 
transfected respective plasmids into the yeast strain L40 and determined β-Gal 
activity of the transformants.  We also included iron regulatory protein (IRP) and 
its iron responsive element (IRE) RNA-binding target as positive controls in these 
experiments.  As expected, co-transfection of IRP fusion plasmid with MS2-IRE 
hybrid RNA activated LacZ gene expression and β-Gal activity (Table 2).  Co-
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transfection of 410 fusion plasmid and MS2-nef 3’UTR RNA plasmid activated 
LacZ gene expression and β-Gal activity, albeit to much less extent.  Importantly, 
there was no detectable β-Gal activity in co-transfection of 410 fusion plasmid 
and MS2-nef 3’-RTU and in all other co-transfections expressing the 269 or 
∆KH fusion plasmids.  Taken together, these studies show that 410 suppresses 
Nef expression through its specific binding to the 3’UTR of nef mRNA, and 
suggest that 410-induced Nef suppression likely result from nef mRNA 
localization and sequestration into SG through binding to 410 and subsequent 
being unavailable for protein translation. 
 
1.12 Lack of suppression of HIV-1 Nef by SG-inducing proteins TIA-1 and 
G3BP  
Over-expression of several RNA binding proteins induce SG formation, e.g., 
G3BP, TIA-1, TTP, Caprin-1, FAST, FRMP, LINE-1 ORF, and smaug [124].  
Thus, it is plausible to think that Nef suppression is the product of an unspecific 
phenomenon resulting from SG assembly; therefore, it was important to further 
ascertain whether expression of these SG inducing proteins also leads to Nef 
suppression.  We tested two well-characterized SG-inducing proteins that are 
also often used as SG markers, TIA-1 and G3BP.  We transfected 293T cells 
with NL4-3, in combination with GFP-TIA-1 or GFP-G3BP and determined Nef 
expression by Western blot analysis.  As expected, over-expression of TIA-1 and  
G3BP induced SG formation (Fig. 24A).  But, compared to the GFP control, 
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Table 2. Δ410 binding to 3'UTR of nef mRNA 
Hybrid protein 1 Hybrid RNA Hybrid protein 2 Relative β-Gal 
activity 
MS2 MS2 IRP 0 
MS2 MS2-IRE IRP 6.763 ± 0.429 
    
MS2 MS2 Δ410 ND 
MS2 MS2-nef 3'UTR Δ410 0.122 ± 0.025 
MS2 MS2-nef 3'RTU Δ410 ND 
    
MS2 MS2 Δ269 ND 
MS2 MS2-nef 3'UTR Δ269 ND 
MS2 MS2-nef 3'RTU Δ269 ND 
    
MS2 MS2 ΔKH ND 
MS2 MS2-nef 3'UTR ΔKH ND 
MS2 MS2-nef 3'RTU ΔKH ND 
The yeast strain L40 was transfected with hybrid protein 1, hybrid protein 2 and 
hybrid RNA expression plasmids as indicated.  The transformants were grown in a 
SD (Synthetic drop) plate lacking tryptophan, leucine, uracil, and histidine for 5 
days.  Fifteen colonies from each transformation were inoculated into the same 
liquid SD medium, triplicates of each inoculation were determined for the β-Gal 
gene expression using the liquid culture β-Gal assay.  Data are mean ± SEM. ND: 
No detectable β-Gal activity or no colony growth.  IRP (iron regulatory protein), IRE 
(iron regulatory element), RTU (UTR in reverse orientation).    
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expression of either TIA-1 or G3BP did not alter Nef expression (Fig. 24B).  
These results show that not every SG formation event results in Nef suppression 
and provide additional evidence to support the specificity of 410 toward to Nef 
(Fig. 20-23; Table 2). 
 
1.13 Localization of HIV-1 nef RNA transcripts in 410-induced SG 
Translational suppression often occurs as a result of SG formation and selective 
targeting of mRNA [138, 298].  Based on the previous findings (Fig. 20-23; Table 
2), we next determined whether this was indeed the case for 410-mediated Nef 
suppression.  We examined the intracellular distribution of HIV-1 nef RNA 
transcripts in 410-expressing cells.  We transfected 293T cells with HIV-1 NL4-
3, GFP.410, or both.  NL4-3 was used as the source for nef mRNA transcripts.  
We performed fluorescence in situ hybridization (FISH) using a nef-specific Cy-5-
labelled oligonucleotide probe.  This probe was designed to ensure a maximal 
specificity and accessibility to nef mRNA transcripts using an algorithm-based 
program for mRNA secondary structure [296].  As expected, nef-Cy5 was 
exclusively detected throughout the cytoplasm of cells that were only transfected 
with NL4-3, and only a background level of hybridization signals was detected in 
GFP.410-transfected cells (Fig. 25).  Co-expression of NL4-3 and GFP.410 
led to marked changes of nef-Cy5 localization to a more distinct cytoplasmic 
pattern and its co-localization with 410.  These results validate the  
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Figure 24.  Effects of SG-inducing proteins on Nef expression.  293T cells 
were plated in a 12- well plate at a density of 3.0 x 105 cells per well and 
transfected with 0.18 μg of NL4-3, and 1.25 μg of GFP.G3BP, or GFP.TIA-1. 
Forty two hours after transfection, the cells were either processed for 
immunofluorescence microscopic imaging for SG formation (A), or harvested, 
lysed in RIPA buffer, and 20 μg of each sample were separated by 12.5% SDS-
PAGE followed by Western blot analysis using anti-Nef JRCSF, or anti-β-actin 
(B). 
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Figure 25.  Effects of 410-induced SG formation on localization of nef RNA 
transcripts.  293T cells were plated in a 24-welll plate at a density of 1.25 x 105 
per well and transfected with 0.4 μg of GFP.410, 0.4 μg of NL4-3, or both.  
pcDNA3 was used to equalize the total amount of DNA among transfections.  
The cells were then processed for the fluorescence in situ hybridization as 
described in the Materials and Methods section, using 100 ng of a Cy5-labelled 
nef oligonucleotide.  The images were representative of each co-transfection.  
Co-localization of Cy5-nef and 410 was shown in the column marked as 
“Merge”.   
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notion that 410-mediated Nef suppression results from 410-induced SG 
formation and nef mRNA targeting and sequestration in SG. 
 
1.14 410 localization to SG and MHC-I expression in HIV-infected T 
lymphocytes 
CD4+ T lymphocytes are the natural target cells for HIV-1 infection.  Thus, we 
next determined whether 410 expression induced SG formation in Jurkat cells, 
commonly used CD4+ human T lymphocytes for HIV infection.  We transfected 
Jurkat cells with RFP-tagged 410, in combination with GFP-tagged SG markers 
GFP-G3BP or GFP-TIA-1.  We then performed the fluorescence microscopic 
imaging for RFP- and GFP-tagged proteins.  In agreement with our previous 
findings (Fig. 17 & 18), G3BP and TIA-1 co-localized with 410 in cytoplasmic 
SG in the absence of ARS treatment (panels “merge” and “inset”, Fig. 26). 
 
We next determined the effect of 410 on Nef expression in HIV-infected cells.  
To distinguish 410 effects on HIV-1 replication from those on Nef expression, 
we performed a single round infection assay that has previously been 
established to detect Nef expression in HIV-infected cells [100].  Initially, we 
determined the appropriate conditions to obtain optimum transfection efficiency, 
and Nef expression upon infection.  Thus, we established that 24 hours after 
transfection of Jurkat cells with either GFP or GFP.410, we were able to obtain 
transfection efficiencies of approximately 70%, cell viabilities of over 85%, and no  
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Figure 26.  410-induced SG formation in Jurkat T cells.  A. 1.5 X 106 Jurkat 
T cells were transfected with 0.35 μg of GFP.G3BP or GFP.TIA-1, in combination 
with 0.15 μg of RFP.410.  Forty two hours after transfection, the cells were 
plated in poly-L-Lysine precoated cover-slips and processed for microscopic 
imaging for detection of GFP and RFP.  Co-localization of GFP and RFP 410 
was shown in the columns marked as “Merge” along with high mag “insets”.  BF: 
bright field. 
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differences between GFP and GFP.410 transfections (Fig. 27A). In addition, 
infection with 50 x 105 VSV-G pseudotyped NL4-3.Luc(env) virus was 
ascertained to be an adequate viral titer for detection of Nef (Fig. 27B).  We then 
infected the transfected cells with replication defective VSV-G pseudotyped NL4-
3.Luc(env) virus and determined Nef expression by Western blot analysis 48 
hours post infection.  As shown in 293T cells (Fig. 8 & 13), 410 expression led 
to a decrease of Nef expression by about 40% in Jurkat cells (Fig. 27C).  In 
parallel, we performed cell surface staining and flow cytometry analysis for MHC-
I expression.  410 expression in HIV-infected cells showed a significant 
reduction in MHC I down-regulation, when compared to the cells expressing GFP 
only (Fig. 27D).  
 
To extend the physiological significance from the established CD4+ Jurkat to 
primary CD4+ lymphocytes, we performed similar experiments in human PBMC.  
The transfection efficiency was estimated to be about 55%, while the cell viability 
was about 70%.  Compared to the GFP control, GFP.410 suppressed Nef 
suppression by about 70% in these primary cells (Fig. 27E).   The difference in 
410-induced Nef suppression between Jurkats and human PBMC is likely due 
to the different susceptibility of these two cells to HIV-1 infection. 
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Figure 27.  410 effect on Nef expression in HIV-1 infected Jurkat T cells 
and PBMC.  A. Jurkat cells were transfected with GFP or GFP.410.  After 24 
hr, aliquots were taken to determine the transfection efficiency by microscopic 
imaging and the cell viability by the trypan blue staining.  BF: bright field.  B. Four 
million Jurkat cells were infected with increasing concentrations (12.5, 25, or 50 x 
105) of cpm RT count of VSV-G pseudotyped NL4-3.Luc(env) viruses.  The cells 
were harvested 48 hr after transfection, lysed in RIPA buffer, and equal amount 
of protein of each sample were separated by 12.5% SDS-PAGE followed by 
Western blot analysis using anti-Nef JRCSF, or anti-β-actin.  (C & D) Four million 
Jurkat cells were transfected with 8 μg of GFP or GFP.410 and then incubated 
for 24 hr.  Three million transfected cells were infected with 50,000 cpm RT count 
of VSV-G pseudotyped NL4-3.Luc(env) viruses.  The cells were harvested 48 hr 
after infection for Western blot analysis (C) and for cell surface staining for MHC-I 
followed by flow cytometry analysis (D). C. (*) degraded GFP.410; D.  Negative 
and positive MHC I staining were performed in mock transfected cells.  Only 
GFP-positive cells that were infected with VSV-G pseudotyped NL4-3.Luc(env) 
viruses were gated for MHC-I expression.  E. Freshly isolated human PBMC 
were cultured in the presence of PHA (3 μg/ml) and IL-2 (50 units/ml) for 4 days, 
and 18 x 106 were then transfected with 9 μg of GFP or GFP.410 expression 
plasmids, and incubated for 48 hr.  Transfected cells were then infected with 
VSV-G pseudotyped NL4-3.Luc(env) viruses for 6 hr, and harvested for Western 
blot analysis as described above in C. (*) degraded GFP.410.   
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1.15 Effects of 410 on cell viability and cell cycle 
Future studies on 410 as a possible therapeutic agent for HIV-1 infection will 
likely depend on its toxicity to cells.  Therefore, we also determined whether 
410 had any deleterious effects on cells.  We stably expressed 410 in Hela 
cells (Fig. 28A), and analyzed cell survival and cell cycle using the propidium 
iodide staining and flow cytometry.  There was no cell death in either cell line.  
Despite modest accumulation of cells at the G2 phase in 410 stably expressing 
cells, the ratio of G0G1 to (G2+S) was very similar between 410 cells and the 
control cells, which were 1.71 and 1.75, respectively (Fig. 28B).  These results 
further support possible translation of these findings into anti-HIV therapeutic 
development. 
 
Based on all of the above results, we concluded that 410 suppressed HIV-1 Nef 
expression through induction of SG formation and sequestration of HIV-1 nef 
mRNA transcripts from being translated to Nef protein.   
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Figure 28.  410 effects on the cell viability and cell cycle.  Hela cells were 
transfected with HA.410 or its backbone expression plasmid cDNA3, and then 
selected for stable transfectants under the selection of 0.5 mg/ml of G418 that 
was pre-determined for Hela cells for about 2 weeks.  Stable transfectants were 
then pooled and expanded as 410 and cDNA3 stable cell lines (A & B).  The 
cells were then harvested, and either lysed in RIPA buffer, and 80 μg of cell 
extract from each cell line were separated by 10% SDS-PAGE followed by 
Western blot analysis using anti-HA, or anti-β-actin (A); or stained with propidium 
iodide, followed by flow cytometry analysis for cell cycle analysis (B).  
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PART 2: Sam68 recruitment into Stress Granules in response to oxidative 
stress through complexing with TIA-1  
2.1 Recruitment of RFP-tagged Sam68 into SG in response to oxidative 
stress 
Sam68 is predominantly localized in the nucleus.  We previously showed that 
over-expression of Sam68 cytoplasmic mutants lacking the NLS results in SG 
formation (Fig. 17 & 18).  This led us to investigate the possibility that nuclear 
Sam68 protein is capable of being recruited to cytoplasmic SG under stress 
conditions.  To address this possibility, we took advantage of several well-
characterized GFP-tagged SG markers GFP.TIA-1, GFP.G3BP, GFP.PABP, or 
GFP.hnRNP A1.  As stated above, over-expression of G3BP and TIA-1 alone is 
sufficient to induce SG assembly [146, 299], while hnRNP A1 and PABP are 
recruited into SG only under stress conditions [160].  Thus, we transfected 293T 
cells with RFP-tagged Sam68 and each of these SG markers and exposed the 
cells to ARS.  We then determined Sam68 localization in these cells by 
immunofluorescence microscopic imaging.  As expected, expression of GFP.TIA-
1 and GFP.G3BP induced SG formation and localized in SG irregardless of ARS 
treatment (Fig. 29A & B).  In contrast, without ARS treatment, GFP.hnRNP A1 
was detected in the nucleus (Fig. 29C), and GFP.PABP was localized in the 
nucleus and cytoplasm, as it tends to accumulate in the nucleus when it is over-
expressed. (Fig. 29D) [300, 301], and there was no SG formation.  With ARS  
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Figure 29.  Localization of RFP-Sam68 into SG upon oxidative stress.  293T 
were plated in a 24- well plate at a density of 1.75 x 105 cells per well and 
transfected with 0.15 μg of RFP.Sam68 and 0.3 μg of GFP.TIA-1 (A), GFP.G3BP 
(B), GFP.hnRNP A1 (C), GFP.PABP (D), or GFP.hdcp1α (E).  Twenty four hours 
after transfection, the cells were treated with or without 0.5 mM ARS for 1 hr, 
fixed in 4% PFA, and then microscopic image analysis was performed for RFP 
and GFP.  The images were representative of each co-transfection.  Co-
localization of SG markers and RFP.Sam68 was shown in the column marked as 
“Merge”. 
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treatment, both GFP.hnRNP A1 and GFP.PABP were partially localized into the 
cytoplasm, importantly in SG.  In GFP.TIA-1- and GFP.G3BP-expressing cells, 
RFP.Sam68 was expressed in the nucleus as well as in the cytoplasm, and this 
localization pattern did not display any significant changes between ARS-treated 
cells and untreated cells (Fig. 29 A & B).  However, in GFP.hnRNP A1- and 
GFP.PABP-expressing cells, Sam68 was predominantly localized in the nucleus 
in the absence of ARS treatment.  In the presence of ARS treatment, Sam68 was 
not only detected in the cytoplasm, but also co-localized with GFP.hnRNPA 1 
and GFP.PABP in a percentage of the cells (Fig. 29 C & D).  These results 
suggest that Sam68 is recruited into SG in response to oxidative stress.   
 
We next determined whether Sam68 was also localized to other cytoplasmic 
RNA granules, such as P bodies, as SG and PB share many of their components 
[125].  Similarly, we transfected 293T cells with RFP.Sam68 and GFP-tagged 
hcdp1a, a well characterized P bodies marker [294], and determined their 
respective localization.  In the absence of ARS treatment, RFP.Sam68 remained 
in the nucleus, while hdcp1α was localized to P bodies.  In the presence of ARS 
treatment, RFP.Sam68 was partially re-localized to large cytoplasmic foci distinct 
from GFP.hdcp1α-labeled P bodies (Fig. 29E).  In concordance with the notion 
that SG and PB are dynamically linked [125], we found that RFP.Sam68-labeled 
SG were in close proximity to GFP.hdcp1α-labeled P bodies (Fig. 29E, inset).  
These results provide additional evidence to support the early finding that Sam68 
is conditionally recruited to SG. 
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2.2 Recruitment of endogenous Sam68 to SG in response to oxidative 
stress 
To ascertain that Sam68 possesses the capability of being recruited into SG 
under oxidative stress, we first compared intracellular localization of endogenous 
Sam68 in cells that were treated with ARS and untreated cells using 
immunofluorescence staining.  In untreated cells, Sam68 was predominantly 
localized in the nucleus.  But in the ARS-treated cells, Sam68 was found to be 
localized in both the nucleus and the cytoplasm in the form of cytoplasmic 
granules in a small percentage of the cells (Fig. 30A).  We next characterized 
these Sam68-containing cytoplasmic granules by double immunofluorescence 
staining for Sam68 and endogenous SG markers G3BP, eIF3, or TIA-1.  
Similarly, we treated 293T cells with ARS prior to the staining.  As expected, in 
the absence of ARS treatment, both endogenous G3BP and eIF3 were 
detected in the cytoplasm and endogenous TIA-1 and Sam68 in the nucleus, 
while ARS treatment resulted in enrichment of endogenous G3BP and eIF3 in 
SG and recruitment of endogenous TIA-1 into SG (Fig. 30B-D).  Meanwhile, in 
the presence of ARS treatment, endogenous Sam68 was partially localized with 
endogenous G3BP, eIF3 or TIA-1-labeled SG in the cytoplasm in a small 
percentage of the cells (Fig. 30B-D).  Taken together, these results strongly 
suggest that Sam68 is recruited to SG under oxidative stress. 
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Figure 30.  Localization of endogenous Sam68 into SG upon oxidative 
stress.  293T cells were plated and cultured for 24 hr to reach 60-70% 
confluence.  The cells were treated with 0.5 mM ARS (+ ARS) or without ARS (- 
ARS) for 1 hr prior to fixation, and then processed for double 
immunofluorescence staining using pairs of primary and secondary antibodies as 
specified below: A. rabbit anti-Sam68/Rh-conjugated goat anti-rabbit; B. rabbit 
anti-Sam68/Rh-conjugated goat anti-rabbit, mouse anti-G3BP/ FITC-conjugated 
goat anti-mouse; C. rabbit anti-Sam68/Rh-conjugated bovine anti-rabbit, goat 
anti-eIF3/FITC-conjugated donkey anti-goat; D. rabbit anti-Sam68/Rh-
conjugated bovine anti-rabbit, goat anti-TIA-1/FITC-conjugated donkey anti-goat.  
Co-localization of each SG marker with endogenous Sam68 was shown in the 
column marked as “Merge”. 
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2.3 Requirement of Sam68 proline (RG)-rich domain for its SG recruitment 
and eIF2 phosphorylation 
As mentioned before, Sam68 can be divided into several functionally distinct 
domains such as KH, proline-rich (P0-P5), tyrosine-rich, RG-rich, and NLS (Fig. 
12).  To define the molecular mechanisms whereby Sam68 is recruited to SG, we 
took advantage of a previous described panel of GFP-tagged Sam68 mutants 
containing various lengths of the C-terminal deletion (Fig. 12), and attempted to 
determine the structural requirement of Sam68 for its SG recruitment.  We 
transfected 293T cells with GFP.Sam68 or each of these mutants.  We then 
treated the cells with ARS and performed immunofluorescence staining for 
endogenous G3BP as the SG marker.  We also quantitated the GFP+ SG-
containing (G3BP+) cells in each transfection.  As shown previously (Fig. 17 & 
18), in the absence of ARS treatment, over-expression of only GFP.410 lacking 
the NLS and GFP.321 lacking NLS and P4-5 were capable of inducing SG 
formation, while GFP.Sam68, GFP.269 lacking NLS and P3-5, GFP.269-321 
lacking P3, and GFP.269-321 expression only P3 showed little SG induction (Fig. 
31A-F).  Compared to the untreated cells, ARS treatment increased GFP.Sam68 
localization in SG, i.e. GFP.Sam68/G3BP+ cells to 33.33  3.06% from 16.67  
4.04% (p = 0.017), GFP.410/G3BP+ cells to 89.33  3.07% from 72.67  3.06% 
(p = 0.006), GFP.321/G3BP+ cells to 84.00  4.00% from 62.67  8.33% (p = 
0.043). GFP.269/G3BP+ cells to 42.67  3.06% from 27.33  3.06% (p = 
0.001), GFP.269-321/G3BP+ cells to 6.67  3.06% from 4.00  2.00% (p = 
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0.135) and GFP.269-321/G3BP+ cells to 18.00  5.29% from 4.67  1.15% (p = 
0.029) (Fig. 31A-G).  These results demonstrated that proline (RG)-rich domain 
P3 between aa269 and aa321 was required but not sufficient for SG induction 
and recruitment and suggest that nuclear localization is a limiting factor for 
Sam68 recruitment to SG. 
 
Over-expression of mutant proteins may override the cellular protein-folding 
capacity and activate the unfolded protein response [302], which results in eIF2α 
phosphorylation and SG assembly.  Caprin-1 over-expression leads to eIF2α 
phosphorylation and SG formation through a mechanism involving its capacity to 
bind RNA via its RG-rich domain.  Thus, we next determined if SG induction by 
Sam68 cytoplasmic mutants was mediated by eIF2α phosphorylation.  We 
transfected 293T cells with GFP.Sam68 or each of its mutants and determined 
the phosphorylation status of eIF2α.  We also included GFP transfection with and 
without ARS treatment as eIF2α phosphorylation positive and negative controls, 
respectively.  As expected, GFP transfected cells treated with ARS resulted in 
the phophorylation of eIF2α (Fig. 32).  However, over-expression of Sam68 or 
each of its mutants did not induce eIF2α phosphorylation.  These results suggest 
that the capacity of Sam68 cytoplasmic mutants to induce SG is eIF2α 
phosphorylation-independent, reminiscent of other SG-inducing proteins which 
alter the equilibrium between mRNPs and polysomes and compete for 48S 
complexes before initiation is completed [124]. 
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Figure 31.  Requirement of specific Sam68 domains for its SG recruitment.  
(A-F).  293T were plated in a 24- well plate at a density of 1.75 x 105 cells per 
well and transfected with 0.2 μg of GFP-tagged Sam68 (A), or its deletion 
mutants containing various lengths of C-terminal deletion, i.e. 410 (B), 321 (C) 
or 269 (D), 269-321 lacking the domain of aa 269-321 (E), or 269-321 
expressing the domain of aa 269-321 (F), and then treated with 0.5 mM ARS (+ 
ARS) or without ARS (- ARS) for 1 hr prior to fixation.  The cells were then 
stained using a mouse anti-G3BP antibody followed by PE-conjugated goat anti-
mouse secondary antibody.  The cells were also counterstained in PBS 
containing 500 ng/ml DAPI for nuclei.  The images were representative of each 
transfection. Co-localization of G3BP with Sam68 or each mutant was shown in 
the column marked as “Merge”.  G.  Random 10 fields were counted for a total 
number of 100 transfected cells in each well, and the number of cells exhibiting 
GFP+G3BP+ SG was used to calculate the percentage of the GFP+ SG-
containing cells.  The data were mean  S.E.M.  Comparisons among groups 
were made using two-tailed Student’s t-test. 
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Figure 32.  Effects of GFP-tagged Sam68 or its mutants on eIF2α 
phosphorylation.  293T cells were plated in a 12- well plate at a density of 4.0 x 
105 cells per well and transfected with 0.4 μg of GFP-tagged Sam68 or each of 
its mutants as indicated.  The cells were harvested 42 hr after transfection, lysed 
in phosphorylation lysis buffer, and 45 μg of each sample were separated by 
15% SDS-PAGE followed by Western blot analysis using anti-eIF2, anti-
phosphorylated eIF2α (α-eIF2α-P), or anti-GFP antibodies.  Cells that were 
transfected with GFP and treated with 0.5 mM ARS or without ARS were 
included as positive and negative controls for eIF2α phosphorylation, 
respectively, in the Western blot analysis.  *: GFP-tagged proteins. 
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2.4 Role of Sam68 KH domain in its SG recruitment and aggregation 
Sam68 KH domain is involved in its RNA binding [198], self association [200], 
and translocation to the cytoplasm [303].  The RNA binding property is critical for 
SG localization of several RBP [124].  Moreover, a recent study has shown that 
removal of the RNA recognition motifs (RRM) from TIA-1 leads to large insoluble 
aggregates and as a result, abrogates the ability of TIA-1 to induce SG assembly 
[299].  Thus, we further determined the role of RNA binding, i.e. KH domain, on 
Sam68 SG recruitment.  To this end, we constructed two KH domain deletion 
mutants GFP.KH and GFP.410KH using GFP.Sam68 and GFP.410 as 
respective backbones (Fig. 33A).  We transfected 293T cells with GFP.KH or 
GFP.410KH, treated the cells with ARS, and performed immunofluorescence 
staining for G3BP as a SG marker.  We also included GFP.Sam68 and 
GFP.410 as controls in these experiments.  As shown above, GFP.410 co-
localized with G3BP in SG in the absence and presence of ARS treatment, 
whereas Sam68 localized to SG only in the cells treated with ARS (Fig. 33B & 
D).  In contrast, both GFP.KH and GFP.410KH failed to co-localize with 
G3BP in SG in the presence or absence of oxidative stress (Fig. 33C & E).  As 
previously reported [303], GFP.KH expression led to its localization in nuclear 
microaggregates (Fig. 33C), while GFP.410.KH was enriched in a single large 
perinuclear aggregate per cell (Fig. 33E).  These findings are reminiscent of the 
insoluble aggregates induced by over-expression of TIA-1 RRM mutants [299], 
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with the exception that 410KH-expressing cells displayed normal assembled 
SG under the ARS treatment.   
 
To further characterize the aggregation nature of these mutants, we transfected 
293T cells with GFP.Sam68 or each of its mutants including these two KH 
mutants, separated the cellular proteins into 1% Triton X-soluble or -insoluble 
fractions as previously described [276, 277], and performed Western blot 
analysis to compared the extent of their aggregation.  GFP.Sam68, GFP.410, 
and GFP.321 that were all localized to SG were detected in soluble and 
insoluble fractions (Fig. 34A).  In contrast, GFP.269 and GFP.269-321 which 
were rarely co-localized into SG were found mainly in the soluble fraction.  In 
agreement with immunofluorescence microscopic imaging (Fig. 33C & E), both 
GFP.KH and GFP.410KH were exclusively detected in the insoluble fractions 
(Fig. 34A). 
 
Since we found that KH mutants failed to bind to nef 3’UTR (Table 2), and to 
localize to SG (Fig. 33C & E), we hypothesized that neither of these mutants 
should have a deleterious effect on HIV-1 Nef expression.  Therefore, we 
transfected 293T cells with HIV-1 provirus NL4-3 and these KH deletion mutants 
as well as their respective backbones and performed Western blot analysis for 
Nef expression.  As previously shown [304], GFP.410 significantly suppressed 
and GFP.Sam68 slightly increased Nef expression (Fig. 34B).  In concordance, 
GFP.KH and GFP.410KH not only failed to suppress Nef  
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Figure 33.  Role of Sam68 KH domain in SG recruitment.  A. A scheme of KH 
domain deletion mutants: P: proline-rich domain; KH: KH domain; and NLS: 
nuclear localization signal.  The dotted lines represent deleted regions. (B-E). 
293T were plated in a 24- well plate at a density of 1.75 x 105 cells per well and 
transfected with 0.2 μg of GFP-tagged Sam68 (B), or its deletion mutants KH 
(B), 410 (C) or KH410 (E), and then treated with 0.5 mM ARS (+ ARS) or 
without ARS (- ARS) for 1 hr prior to fixation.  The cells were then stained using a 
mouse anti-G3BP antibody followed by PE-conjugated goat anti-mouse 
secondary antibody.  The cells were also counterstained in PBS containing 500 
ng/ml DAPI for nuclei.  The images were representative of each transfection.  Co-
localization of G3BP with Sam68 or each mutant was shown in the column 
marked as “Merge”.  Panel (C) was also used in Fig. 18C. 
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Figure 34.  Role of Sam68 KH domain in Sam68 solubility and HIV-1 nef 
mRNA translation.  A. 293T cells were transfected with GFP-tagged Sam68 or 
each of its mutants as indicated, then cell lysates were separated into soluble 
and insoluble fractions as described in Materials and Methods, followed by 
separation by 15% SDS-PAGE and Western blot analysis using anti-GFP or anti-
β-actin antibody.  B. 293T cells were plated in a 12- well plate at a density of 1.5 
x 105 cells per well and transfected with 0.2 μg of NL4-3, and 1.2 μg of GFP-
tagged Sam68 or its ∆KH mutants.  The cells were harvested 42 hr after 
transfection, lysed in RIPA buffer, and 20 μg of each sample were separated by 
12.5% SDS-PAGE followed by Western blot analysis using anti-Nef JRCSF, or 
anti-β-actin.  
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translation, but to the contrary increased Nef expression (Fig. 34B).  The 
mechanisms underlying increased Nef expression by Sam68 and these two KH 
deletion mutants deserves further investigation.  Taken together, these results 
suggest that Sam68 KH domain is not directly involved in SG induction by 
Sam68 cytoplasmic mutants or SG recruitment of Sam68, but is absolutely 
required for maintaining native and functional structure of Sam68 protein in the 
cells.    
 
2.5 Effects of Sam68 knockdown on SG assembly 
Expression of some cellular proteins is absolutely required for SG assembly, and 
knock-out of these proteins is associated with a muted SG response to multiple 
stress stimuli [146, 148, 169, 299].  The finding that Sam68 was recruited to SG 
while some of its mutants induced SG assembly raised the possibility that Sam68 
was an essential component of SG assembly.  To address this possibility, we 
utilized the small interference RNA (siRNA) strategy to knock-down endogenous 
Sam68 and determined its effects on SG formation under oxidative stress.  As 
shown before (Fig. 10A), compared to control siRNA, Sam68 siRNA was very 
effective in knocking down endogenous Sam68 expression (Fig. 35A).  We then 
transfected 293T cells with control siRNA or Sam68 siRNA, treated the cells with 
ARS, and performed immunofluorescence staining for G3BP as the SG marker.  
There were no apparent changes in the size or morphology of SG (Fig. 35B) and 
in the percentage of SG-containing cells between control siRNA and Sam68 
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Figure 35.  Effects of Sam68 knockdown on SG assembly.  A. 293T cells 
were plated at a density of 1.75 x 105 per well and transfected with 75 nM of 
control siRNA or Sam68 siRNA.  The transfection efficiency was estimated to be 
over 95%, determined by inclusion of a fluorescence-labeled control siRNA in the 
transfection.  The cells were harvested 24 hr after transfection for Western blot 
analysis using anti-Sam68 or anti-β-actin antibodies.  B. 293T cells were plated 
and transfected with control siRNA or Sam68 siRNA as above.  The cells were 
treated with 0.5 mM ARS (+ ARS) or without ARS (- ARS) for 1 hr prior to 
fixation.  The cells were then stained using a mouse anti-G3BP antibody followed 
by FITC-conjugated anti-mouse antibody.  Transfected cells were also stained 
with 500 ng/ml of DAPI for nuclei.  The images were representative of each 
transfection.  C. Quantitation of G3BP+ granules-containing cells in B.  Random 
10 fields were counted for a total number of 100 transfected cells in each well, 
and the number of cells exhibiting G3BP+ SG was used to calculate the 
percentage of SG-containing cells.  The data were mean  S.E.M of triplicate 
samples, which was expressed as percentage of the total number cells. 
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siRNA (Fig. 35C).  These results suggest that Sam68 is not an essential cellular 
cofactor for SG assembly, at least under the oxidative stress. 
 
2.6 Interaction of Sam68 with TIA-1 and its SG recruitment 
There are several possible ways by which a protein can be recruited into SG, and 
one of the common pathways is through interaction with constitutive core 
components of SG or so-called the “piggy-back” mechanism [124].  To 
investigate whether this was the case for Sam68 SG recruitment, we initially 
performed a BLAST search in a database, which predicts human protein-protein 
interactions [305], for possible interacting proteins for Sam68.  We obtained a list 
of 108 proteins as potential Sam68-interacting targets, among which was TIA-1.  
TIA-1 has been shown to recruit multiple proteins to SG through direct binding 
including FAST, a protein that has recently been shown to directly bind Sam68 
[274]; and KSRP, which forms a unique RNP complex with Sam68 and intron 6 
of the β-tropomyosin gene [275].  Thus, we focused on Sam68/TIA-1 interaction.  
We first transfected 293T cells with HA-tagged Sam68 (HA.Sam68), GFP.TIA-1, 
or both and performed immunoprecipitation (IP) followed by Western blotting 
analysis (WB).  We performed direct Western blot analysis for the input lysates to 
ensure comparable levels of protein expression among transfections (WB-input; 
Fig. 36A-C), as well as IP with control IgG antibody followed by WB with α-HA or 
α-GFP to ensure no non-specific background binding (WB-input; Fig. 36A).  IP 
with α-HA antibody followed by WB with α-GFP antibody showed complex 
formation between Sam68 and TIA-1 in cells co-expressing Sam68 and TIA-1 
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(WB-IP, 2nd panel; Fig. 36B), and α-HA antibody showed similar IP efficiency 
between cells expressing Sam68 alone and cells expressing both Sam68 and 
TIA-1 (WB-IP, 1st panel; Fig. 36B).  Conversely, IP with α-TIA-1 antibody followed 
by WB with α-HA antibody also showed that Sam68 complexed with TIA-1 in 
cells expressing both Sam68 and TIA-1 (WB-IP, 1st panel; Fig. 36C). Next, we 
determined whether there was complex formation between endogenous Sam68 
and endogenous TIA-1 using the similar IP/WB approach, we obtained similar 
results (Fig. 36D & E).   
 
To determine whether this complex formation between Sam68 and TIA-1 was 
responsible for Sam68 SG recruitment under oxidative stress conditions, we then 
characterized Sam68 interaction with TIA-1 using a similar panel of HA-tagged 
Sam68 and mutants.  We transfected 293T cells with HA.Sam68 or each of its 
mutants, in combination with GFP-TIA-1, and analyzed their binding to TIA-1 
using the similar IP/WB strategy.  We first performed WB with α-GFP or α-HA 
antibody to ensure a comparable level of Sam68 and each of its mutants and a 
comparable level of TIA-1 expression among transfections (WB-Input, Fig. 37A).  
We then performed IP with α-HA antibody followed by WB with α-GFP antibody 
as well as WB with α-HA antibody.  Similar to Sam68, 410 showed complexed 
formation with TIA-1, so did 321 but to a lesser extent (WB-IP, 1st panel; Fig. 
37A).  On the other hand, 269 or 269-321 did not show any complex formation 
with TIA-1, even though that Sam68 and all mutants showed no difference in the 
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Figure 36.  Complex formation between Sam68 and TIA-1.  (A-C). 293T cells 
were plated at a density of 2.0 x 106 per 35mm plate and transfected with 3.0 μg 
of HA.Sam68, 3.0 μg of GFP.TIA-1, or both and harvested 48 hr after 
transfection for cell lysates.  One milligram of cell lysates was then 
immunoprecipitated with 1.0 μg of normal IgG (A), anti-HA (B), or anti-TIA-1 (C) 
antibodies, followed by Western blotting using anti-HA or anti-GFP antibody (WB-
IP).  Equal amount of input lysates were directly blotted to ensure comparable 
Sam68 and TIA-1 expression among transfections (WB-Input).  *: reactive IgG 
bands. (D & E).  Cell lysates were prepared from 293T cells and blotted for 
endogenous Sam68 and TIA-1 expression (WB-Input), and 1.5 milligrams were 
immunoprecipitated with 1.0 μg of normal IgG, α-Sam68 (D), or α-TIA-1 (E), 
followed by Western blot analysis using anti-TIA-1 or anti-Sam68 antibodies 
(WB-IP).     
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IP  efficiency with α-HA antibody (WB-IP, 2nd panel; Fig. 37A).  These results 
showed that Sam68 domain 269-321 was involved in interaction with TIA-1.    
 
To further corroborate the role of the domain between aa269 and aa321 in TIA-1 
binding and its relationship to Sam68 SG recruitment, we transfected 293T cells 
with GFP-TIA-1 in combination with HA.410 or HA.269-321, followed by 
immunofluorescence staining using α-HA antibody.  As shown above, 410 was 
co-localized with TIA-1 in SG (Fig. 37B).  However, 269-321 remained in 
nucleus, even though that TIA-1 was detected in SG in the cytoplasm (Fig. 37B).  
Taken together, these results show that Sam68 domain aa269-321 (P3/RG-rich) 
is directly involved in Sam68 binding to TIA-1 and strongly suggest that Sam68 
interaction either in a direct or indirect manner is responsible for Sam68 
recruitment into SG.  
 
2.7 Interaction of Sam68 with G3BP 
Our previous results showed that Sam68 deletion mutant ∆321 is strongly 
recruited to SG (Fig. 31); however, it binds weakly to TIA-1 (Fig. 37A), 
suggesting that additional factors could be involved in Sam68 recruitment to SG. 
G3BP, which is absolutely required for SG assembly [146], was initially identified 
by its affinity to RAS-GAP SH3 domain [306], and was subsequently shown to 
associate with full length RAS-GAP only in growing cells and in an activated Ras 
dependent manner [307].  Interestingly, Sam68 also interacts with Ras- 
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Figure 37.  Complex formation between Sam68 deletion mutants and TIA-1.  
A. 293T cells were plated at a density of 2.0 x 106 per 35mm plate and 
transfected with 3.0 μg of HA.Sam68 or its mutants, and 3.0 μg of GFP.TIA-1, 
and harvested 48 hr after transfection for cell lysates.  One milligram of cell 
lysates were then immunoprecipitated with 1.0 μg of normal IgG, or anti-HA, 
followed by Western blotting using anti-HA or anti-GFP antibody (WB-IP).  Equal 
amount of input lysates were directly blotted to ensure comparable Sam68 or its 
mutants, and TIA-1 expression among transfections (WB-Input).  B. 293T were 
plated in a 24-well plate at a density of 2.5 x 105 cells per well and transfected 
with 0.3 μg of HA.410 or HA.269-321, and 0.3 μg of GFP.TIA-1.  The cells 
were then stained using an anti-HA antibody followed by PE-conjugated goat 
anti-mouse antibody.  Transfected cells were also stained with 500 ng/ml of DAPI 
for nuclei.  The images were representative of each transfection. 
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GAP only in mitotic cells, possibly through a third protein, yet to be identified 
[308].  Hence, it has been suggested that Sam68 and G3BP might cooperate in a 
pathway that links RAS-GAP and RNA [309].  Thus, we decided to determine if 
Sam68 and G3BP interacted in vivo.  We transfected 293T cells with HA.Sam68, 
GFP.G3BP, or both and performed IP followed by WB analysis.  IP with α-HA 
antibody followed by WB with α-G3BP antibody showed complex formation 
between Sam68 and G3BP in cells co-expressing Sam68 and G3BP (WB-IP, 2nd 
panel; Fig. 38B), and α-HA antibody showed similar IP efficiency between cells 
expressing Sam68 alone and cells expressing both Sam68 and G3BP (WB-IP, 
1st panel; Fig. 38B).  Conversely, IP with α-G3BP antibody followed by WB with 
α-HA antibody also showed similar results (WB-IP, 1st panel; Fig. 38C). 
Importantly, direct Western blot analysis for the input lysates showed comparable 
levels of protein expression among transfections (WB-input; Fig. 38A-C), and IP 
with control IgG antibody followed by WB with α-HA or α-G3BP did not show any 
non-specific background binding (Fig. 38A).  Next, we tried to determine whether 
the complex formation between HA.Sam68 and GFP.G3BP was RNA dependent, 
using a similar IP/WB approach in the presence of RNase, and we obtained 
similar results (Fig. 38D).  Finally, we failed to detect any complex formation 
between endogenous Sam68 and endogenous G3BP (Fig. 38E).  These results 
suggest that exogenous Sam68 and G3BP interact directly or indirectly in vivo in 
a RNA independent manner; however, since we were not able to detect an 
interaction between endogenous proteins, at this point we can not rule out the  
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Figure 38.  Complex formation between Sam68 and G3BP.  (A-C). 293T cells 
were plated at a density of 2.0 x 106 per 35mm plate and transfected with 3.0 μg 
of HA.Sam68, 3.0 μg of GFP.G3BP, or both and harvested 48 hr after 
transfection for cell lysates.  One milligram of cell lysates was then 
immunoprecipitated with 1.0 μg of normal IgG (A), anti-HA (B), or anti-G3BP (C) 
antibodies, followed by Western blotting using anti-HA or anti-G3BP antibody 
(WB-IP).  Equal amount of input lysates were directly blotted to ensure 
comparable Sam68 and G3BP expression among transfections (WB-Input).  *: 
reactive IgG heavy chain.  D. 293T cells were plated at a density of 2.0 x 106 per 
35mm plate and transfected with 3.0 μg of HA.Sam68 and 3.0 μg of GFP.G3BP, 
and harvested 48 hr after transfection for cell lysates.  One milligram of cell 
lysates were then immunoprecipitated with 1.0 μg of normal IgG, or anti-HA 
antibodies, in the presence of 0.1 μg/ml of RNase A, followed by Western blotting 
using anti-HA or anti-G3BP antibody (IP).  E. Cell lysates were prepared from 
293T cells and blotted for endogenous Sam68 and G3BP expression (WB-Input), 
and 1.5 milligrams were immunoprecipitated with 1.0 μg of normal IgG, or anti-
Sam68 antibodies, followed by Western blot analysis using anti-G3BP or anti-
Sam68 antibodies (WB-IP).     
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possibility that this is an artifact phenomenon due to overexpression of 
exogenous proteins.   
 
2.8 Effect of a protein methyltransferase inhibitor on Sam68 localization 
during oxidative stress 
Recent studies suggest that arginine methylation is important for SG assembly 
dynamics [151, 310].  Conversely, Sam68 subcellular localization has been 
shown to be tightly regulated by arginine methylation on its domain between 
aa269 to aa321.  Therefore, we decided to determine the effects of adenosine 
periodate (AdOx), a global inhibitor of protein methyltransferase activity, on 
Sam68 localization during oxidative stress.  We transfected cells with 
GFP.Sam68 and treated these cells with ARS, or ARS in combination with 
AdOX, and determined Sam68 localization to SG.  Our results showed that 
treatment with AdOX did not prevent Sam68 localization to cytoplasmic granules 
during oxidative stress (Fig. 39).  In the present work, we did not determine 
Sam68 methylation levels; and so, since methylation is an irreversible 
postranslational modification, it is reasonable to argue that during AdOX 
treatment a fraction of Sam68 proteins remained methylated, and that this 
fraction could be actively recruited to SG. Future studies should address this 
issue.  
 
Taken together all of the above results, we concluded that Sam68 was recruited 
to SG under oxidative stress in a small percentage of the cells, likely through a  
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Figure 39.  Effects of a protein methyltransferase inhibitor on Sam68 
localization under oxidative stress.  293T were plated in a 24-well plate at a 
density of 2.5 x 105 cells per well and transfected with 0.35 μg of GFP.Sam68. 
Twenty four hours after transfection, the cells were treated with 0.7 mM of AdOX 
for an additional 24 hr, and then treated with 0.5 mM ARS (ARS) or without ARS 
for 1 hr prior to fixation.  The cells were also counterstained in PBS containing 
500 ng/ml DAPI for nuclei.  Microspcopy analysis was carried out as above. 
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“piggy back” mechanism involving its interaction with TIA-1, the core SG 
component. 
 
PART 3: Role of the ERK pathway on eIF2α phophorylation and SG 
assembly under oxidative stress.  
Cellular growth, differentiation and programmed death are tightly regulated 
processes, and require sensing mechanisms and coordinated responses from 
biosynthetic pathways such as protein translation.  The negative effect of 
different forms of stress on cell growth and differentiation are well documented 
[311, 312].  Furthermore, treatment of cells with growth factors or mitogens 
increases protein translation, while multiple forms of environmental stresses have 
the opposite effect [313].  Therefore, it has been proposed that the protein 
biosynthetic pathway is in direct communication with growth/stress activated 
signaling cascades [314].  However, during physiological (epithelial surfaces) or 
pathological conditions (cancer-hypoxia), multi-cellular organisms are exposed 
simultaneously to stressful and growth stimuli, and the process by which cells 
make critical decisions regarding cell growth and death in this dual environment 
is not well understood yet. 
 
The mitogen-activated protein kinase (MAPK) superfamily consists of three main 
protein kinase families: the extracellular signal-regulated protein kinases (ERKs), 
the c-Jun N-terminal kinases (JNKs), and the p38 family of kinases.  The ERK 
module responds primarly to growth factors and mitogens, while JNKs and p38 
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families respond to environmental stresses and cytokines [315].  Consequently, it 
has been shown that ARS (oxidative stress) treatment leads to opposite effects 
on the MAPK cascades; it activates JNK and p38, while it blocks the ERK 
pathway through a activated p38 mediated process [316, 317].  Therefore, using 
the MAPK pathways and oxidative stress as a model, we set out to determine the 
effects of simultaneous growth (ERK activation) and stress (ARS) signals on a 
key regulator of the protein biosynthetic pathway (eIF2α) and on SG assembly. 
 
3.1 Effects of arsenite treatment on MAPK 
Previous studies have reported that ARS treatment of fibroblasts or 
cardiomyocytes prevents mitogen-induced phosphorylation of ERK-1/2, and that 
this effect is dependent on p38 activation [316, 317].  Therefore, we initially tried 
to establish if this phenomenon is also present in human embryonic kidney 293T 
cells.  Thus, we treated 293T cells with ARS for different periods of time up to 
one hour, and determined the activation of ERK-1/2, JNK, and p38 kinases by 
Western blot analysis using antibodies against the phosphorylated forms of the 
kinases.  Coordinately, JNK and p38 were potently activated between 10 and 20 
minutes after ARS treatment (5th & 7th panels; Fig. 40A; Fig. 43A); in contrast, 
ERK-1/2 phosphorylation declined rapidly (1st panel; Fig.40A; Fig. 43A).  Since 
our aim was to determine the role of the ERK pathway on eIF2α phosphorylation, 
we also determined eIF2α phophorylation status under these conditions using the 
same approach. As previously shown (Fig. 32B), eIF2α was rapidly  
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Figure 40.  Effects of arsenite treatment on MAPK activation and eIF2α 
phosphorylation.  A. 293T cells were plated in a 12-well plate at a density of 3.5 
x 105 cells per well, twenty four hours later the cells were treated with 0.5 mM 
ARS for 0, 10, 20, 30, 40, 50, and 60 min, then harvested, lysed in 
phosphorylation lysis buffer, and 45 μg of each sample were separated by 10% 
SDS-PAGE followed by Western blot analysis using anti-ERK-1, anti-
phosphorylated ERK-1/2 (ERK 1,2-P), anti-eIF2α, anti-phosphorylated eIF2α 
(eIF2α-P), anti-JNK, anti-phosphorylated JNK (JNK-P), anti-phosphorylated p38 
(p38-P), or anti-β-actin.  B. Relative levels of phosphorylated ERK-1/2 and eIF2α 
proteins were determined using total ERK-1 and eIF2α as internal standards, and 
expressed on the y axis.  The data were average of two independent 
experiments. 
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phosphorylated 10 minutes after ARS treatment was initiated (3rd panel; Fig. 40A; 
Fig. 43A).  Interestingly, we observed a gradual increase in JNK, p38, and eIF2α 
phosphorylation during the time frame of the experiment, whereas ERK-1/2 
dephosphorylation was abrupt and sustained (Fig. 40A & B; Fig. 43A).  These 
results further support the notion that the effects of ARS on MAPK and eIF2α are 
not cell type specific, and the similar but opposite kinetics of ERK 
dephosphorylation and eIF2α phosphorylation suggest a possible regulatory 
connection between the ERK pathway and eIF2α mediated translational control.  
 
3.2 Delayed eIF2α phosphorylation in cells expressing a constitutively 
active ERK 
Only two previous studies have reported a relationship between the ERK 
pathway and eIF2α phosphorylation.  Monick et al. have showed that alveolar 
macrophages exhibit a constitutively high ERK activity, which promotes 
hypophosphorylation of eIF2α and subsequently, general protein synthesis and 
cell survival [318]; meanwhile, Thiaville et al. have shown that in amino acid 
deprived hepatoma cells, MEK-ERK signaling is required for GCN2-dependent 
eIF2α phosphorylation [319].  To ascertain the role of the ERK pathway on eIF2α 
phophorylation in 293T cells under oxidative stress, we initially took advantage of 
the well documented phenomenon of ERK activation during serum starvation. 
We reasoned that by increasing the basal levels of ERK activation through serum 
deprivation, the kinetics of ERK dephosphorylation would be modified upon ARS 
treatment, allowing us to detect the impact of an active ERK pathway on eIF2α 
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phosphorylation status during oxidative stress (ARS).  Thus,  we serum starved 
293T cells and then treated the cells with ARS for different periods of time as 
stated above, and determined the phosphorylation levels of ERK-1/2, JNK, p38, 
and eIF2α by Western blot analysis.  Our results showed that JNK, p38, and 
eIF2α phophorylation kinetics were similar to those of 293T cells grown in media 
complete with serum (3rd, 5th, and 7th panels; Fig. 41A); in addition, rapid and 
potent dephosphorylation of ERK-1/2 was still observed (1st panel; Fig. 41A).  
These results suggest that inhibition of the ERK pathway by ARS treatment 
overrides the initial increase in the basal levels of activated ERK pathway. 
 
To overcome the potent downregulatory effect of ARS on ERK activation, we 
decided to hyper-activate the MEK-ERK portion of this signaling pathway by 
using a constitutively active MEK (CA-MEK) mutant [320] and to determine its 
effects on eIF2α phosphorylation under oxidative stress.  Thus, we transfected 
293T cells with CA-MEK, and then treated the cells with ARS in the same fashion 
as in our previous experiments (Fig. 40-41) followed by similar Western blot 
analysis.  As it was the case for untransfected cells, ARS treatment resulted in a 
gradual activation of JNK and p38 (5th & 7th panels, Fig. 42A; Fig. 43B); on the 
other hand, CA-MEK led to constant and stable high levels of phosphorylated 
ERK-1/2 (1st panel; Fig. 42A; Fig. 42B; Fig. 43B), overcoming the inhibitory 
effects of ARS treatment. Interestingly, the kinetics of eIF2α phosphorylation 
greatly differed from our previous results. In contrast to the rapid phosphorylation  
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Figure 41.  Effects of arsenite treatment on MAPK activation and eIF2α 
phosphorylation in serum starved cells.  A. 293T cells were plated in a 12- 
well plate at a density of 3.5 x 105 cells per well, twenty four hours later the cells 
were serum starved for additional 16 hr, and then treated with 0.5 mM ARS for 0, 
10, 20, 30, 40, 50, and 60 min.  Subsequently, the cells were harvested, lysed in 
phosphorylation lysis buffer, and 45 μg of each sample were separated by 10% 
SDS-PAGE followed by Western blot analysis using anti-ERK-1, anti-
phosphorylated ERK-1/2 (ERK 1,2-P), anti-eIF2α, anti-phosphorylated eIF2α 
(eIF2α-P), anti-JNK, anti-phosphorylated JNK (JNK-P), anti-phosphorylated p38 
(p38-P), or anti-β-actin.  B. Relative levels of phosphorylated ERK-1/2 and eIF2α 
proteins were determined using total ERK-1 and eIF2α as internal standards, and 
expressed on the y axis.  The data were average of two independent 
experiments. 
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Figure 42.  Effects of constitutively activated ERK expression on eIF2α 
phosphorylation under oxidative stress.  A. 293T cells were plated in a 12-
well plate at a density of 3.5 x 105  cells per well and transfected with 0.7 μg of 
CA MEK.  Thirty six hours later the cells were treated with 0.5 mM ARS for 0, 10, 
20, 30, 40, 50, and 60 min.  Subsequently, the cells were harvested, lysed in 
phosphorylation lysis buffer, and 45 μg of each sample were separated by 10% 
SDS-PAGE followed by Western blot analysis using anti-ERK-1, anti-
phosphorylated ERK-1/2 (ERK 1,2-P), anti-eIF2α, anti-phosphorylated eIF2α 
(eIF2α-P), anti-JNK, anti-phosphorylated JNK (JNK-P), anti-phosphorylated p38 
(p38-P), or anti-β-actin.  B. Relative levels of phosphorylated ERK-1/2 and eIF2α 
proteins were determined using total ERK-1 and eIF2α as internal standards, and 
expressed on the y axis.  The data were mean  S.E.M. 
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Figure 43.  Kinetics of MAPK and eIF2 phosphorylation during oxidative 
stress.  Representation of the phosphorylation kinetics of ERK-1/2 (purple), JNK 
(green), p38(red), and eIF2α (blue) in ARS treated 293T cells without (A), or with 
(B) a constitutively active ERK pathway.  
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observed in untransfected cells (Fig. 40 & 41; Fig. 43A), eIF2α remained hypo-
phosphorylated for the most part of the treatment, and an increase in its 
phosphorylation levels was only detected in the last time point evaluated (3rd 
panel; Fig. 42A & 42B; Fig. 43B). Taken together, these results suggest that the 
ERK pathway regulates eIF2α-mediated translational control under oxidative 
stress through a yet undetermined mechanism. 
 
3.3 Normal stress granules assembly in cells expressing a constitutively 
active ERK 
Based in our previous results, we hypothesized that ERK constitutive activation 
might lead to impaired SG assembly due to reduced levels of eIF2α 
phosphorylation.  Hence, we transfected 293T cells with CA-MEK mutant, and 
then treated the cells with ARS for one hour followed by immunofluorescence 
staining for endogenous G3BP as the SG marker.  As previously shown (Fig. 
30B), in the absence of ARS treatment, G3BP was detected widespread 
throughout the cytoplasm, but in SG upon ARS treatment.  Importantly, we did 
not observe a significant difference between the number of untransfected and 
CA-MEK transfected cells containing SG (Fig. 44).  These results suggest that 
ERK activation does not influence SG assembly; however, a definitive answer 
should come from future studies that will address the role of activation of the 
ERK pathway on the kinetics of SG assembly, during oxidative stress. 
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Figure 44.  Effects of constitutively activated ERK expression on SG 
assembly under oxidative stress.  293T were plated in a 24-well plate at a 
density of 1.75 x 105 cells per well and transfected with 0.35 μg of CA MEK (B), 
or left untransfected (A); and then treated with 0.5 mM ARS (+ ARS) or without 
ARS (- ARS) for 1 hr prior to fixation.  The cells were then stained using a mouse 
anti-G3BP antibody followed by PE-conjugated goat anti-mouse secondary 
antibody.  The images were representative of each condition.  Co-localization of 
G3BP with nuclei was shown in the column marked as “Merge”.   
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Based in all of the above, we concluded that ERK activation changes the kinetics 
of eIF2α phosphorylation under oxidative stress, through a yet undetermined 
mechanism.  
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DISCUSSION 
 
Summary of the results 
In the first part of the current study, using a pair of newly constructed NL4-3-
based luciferase reporter viruses, we revealed that expression of a Sam68 NLS-
deleted 410 mutant led to a significant decrease in Luc gene expression which 
was substituted for the HIV-1 nef gene (Fig. 7D) and HIV-1 Nef expression (Fig. 
8).  This mutant did not alter HIV-1 transcription, pre-mRNA splicing, RNA 
stability (Fig. 9B), or the translation of a reporter gene containing only the 5’ 
leader sequence of HIV-1 RNA (Fig. 20B).  Moreover, further removal of the 
domain between aa269 and 321 abrogated the suppressive effect (Fig. 13) and 
formation of a granule-like structure in the cytoplasm (Fig. 16).  The granule-like 
structure induced by this mutant was identified as a stress granule (SG) (Fig. 17 
& 18).  A novel minigene assay demonstrated that 410-induced suppression 
was specific to HIV-1 Nef through the uniquely structured 3’UTR of nef mRNA 
(Fig. 23).  This was further corroborated by the findings that 410 bound to the 
nef mRNA 3’UTR in a direct manner (Table 2).  Moreover, HIV-1 nef mRNA 
transcripts were co-localized with 410-induced SG (Fig. 25).  Importantly, SG 
induction and Nef suppression by 410 also occurred in the context of HIV-1 
infection of CD4+ T lymphocytes (Fig. 26 & 27).  Thus, we concluded that 410 
suppressed HIV-1 Nef expression through induction of SG formation and 
sequestration of HIV-1 nef mRNA transcripts from being translated to Nef protein.   
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Based on our previous results, in the second part of the present study, we 
demonstrated that both exogenous and endogenous Sam68 were recruited into 
SG in a percentage of the cells upon oxidative stress (Fig. 29 & 30).  Removal of 
the P3 (RG-rich) domain aa269-321, or the KH domain aa171-211, abrogated the 
ability of Sam68 to be recruited into SG and translationally repress Nef 
expression (Fig. 31; Fig. 33 & 34).  Moreover, Sam68 RNA binding deficient 
mutants (∆KH, ∆KH∆410) formed insoluble protein aggregates different from SG 
(Fig. 33 & 34).  Knock down of Sam68 expression had no effects on SG 
assembly (Fig. 35).  Importantly, Sam68 formed a complex with TIA-1 through 
the P3 (RG-rich) domain aa269-321, deletion of which prevented Sam68 
recruitment into SG (Fig. 36 & 37).  Thus, we concluded that Sam68 was 
recruited to SG under oxidative stress, likely through a “piggy back” mechanism 
involving its interaction with TIA-1, a core SG component. 
 
Finally, in an attempt to determine the effect of a growth signal (ERK activation) 
on eIF2α-mediated translational control during oxidative stress, we showed that 
ARS treatment had opposite effects on MAPK in 293T cells; while ARS gradually 
activated the p38 and JNK pathways in a time dependent manner; the ERK 
pathway was rapidly and potently inhibited (Fig. 40 & 41; Fig. 43A).  Moreover, 
hyper-activation of the ERK pathway by a constitutively active MEK mutant led to 
delayed eIF2α phosphorylation (Fig. 42 & 43B); however, this did not resulted in 
impaired SG assembly (Fig. 44).  Therefore, we concluded that ERK activation 
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changes the kinetics of eIF2α phosphorylation under oxidative stress through a 
yet undetermined mechanism.  
 
Distinct functions of Sam68 NLS-deleted mutants on HIV-1 gene expression 
Sam68 has been shown to be absolutely required for HIV-1 replication and Rev-
dependent gene expression [221, 243, 244] (Fig. 11A-C).  Sam68 possesses a 
non-conventional NLS at its C terminus, and deletion of this NLS results in 
Sam68 cytoplasmic localization [214], and impaired HIV-1 replication [78, 243]. 
Therefore, it is not surprising that inhibition of HIV-1 replication by Sam68 NLS-
deleted mutant 410 has been shown to behave in a dominant negative fashion, 
i.e., formation of dimer or oligomers between 410 and wild-type Sam68 and 
subsequent retention of the wild-type Sam68 in the cytoplasm, which in turn 
prevents wild-type Sam68 from functioning in Rev-mediated nuclear export of 
HIV RNA [78, 249].  However, different lines of evidence suggest additional roles 
for Sam68 cytoplasmic mutants; for instance, 410 was also shown to be co-
localized with unspliced and partially spliced HIV-1 RNA in perinuclear bundles 
and to sequester these RNA from the cellular translational machinery [248].  
Moreover, wild-type Sam68 promotes translation of intron containing RNA [222], 
and is also found in the nucleus when it is co-expressed with the NLS-deleted 
mutants [249].  The current study demonstrated that 410 suppressed HIV-1 Nef 
translation (Fig. 8).  Taken together, these studies have shown that 410 
negatively regulates HIV-1 replication at two distinct steps of the virus life cycle: 
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Rev-mediated nuclear export of incompletely spliced HIV-1 RNA and translation 
of HIV-1 nef mRNA in the cytoplasm. 
 
Inhibition of Nef expression by Sam68 NLS-deleted mutants in the 
cytoplasm 
Sam68 has been shown to regulate transcription, pre-mRNA alternative splicing, 
and translation [218, 219, 223, 234].  Thus, different nuclear or cytoplasmic 
mechanisms could explain 410-mediated Nef suppression.  Previous reports 
have determined that Sam68 or its mutants do not have inhibitory effects on the 
HIV-1 LTR promoter [78]; in concordance, our results showed little changes in 
the transcription levels of multiply spliced HIV-1 RNA (Fig. 9B).  Furthermore, 
∆410 did not change the splicing pattern, nor did it decrease the stability of these 
mRNA species (Fig. 9B).  These results suggest that Nef suppression is not due 
to a loss of function of wild-type Sam68 within the nucleus, but instead it is a gain 
of function for 410 in the cytoplasm.  This notion was further supported by the 
data obtained using a Sam68 siRNA, showing that Sam68 knockdown did not 
suppress Nef expression (Fig. 10B) or Luc expression when placed in the nef 
gene (Fig. 11D).  Subsequent studies on the structure-function relationship of 
Sam68 in terms of Nef suppression allowed three definitive conclusions: first, 
deletion of the Sam68 NLS, resulting in cytoplasmic localization, is required for 
this inhibition to occur (Fig. 13; Fig. 16A; Fig. 45A); second, RNA binding is 
mandatory since deletion of the KH domain abrogates the suppressive effect of 
NLS-deleted mutants (Fig. 34B & 45A); and third, Sam68 domain aa269-321 was  
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Figure 45.  Role of Sam68 domains on Nef suppression and stress granule 
recruitment/assembly.  P: proline-rich domain (gray); KH: KH domain (light 
blue); RG: arginine-glycine-rich domain (gray); and NLS: nuclear localization 
signal (light green).  The roles of each domain on Nef suppression (A) or stress 
granule (SG) recruitment/assembly (B) are indicated (boxes) 
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indispensable but not sufficient for Nef suppression by 410 and 321 mutants 
(Fig. 13 & 45A).  The roles of the NLS and the KH domain on Sam68 function 
and localization had been extensively studied in the past; however, the function 
of the domain aa269-321 is less clear at this moment.  This domain is located in 
the proline-rich region (P3), which also overlaps the arginine-glycine (RG)-rich 
region [195].  Some of the functions that have been attributed to these proline- 
and RG-rich regions include protein-protein interaction, intracellular localization 
and non-specific RNA binding [210, 217, 245].  The RG-rich region is also a 
potential site for protein methylation [217].  Nevertheless, whether any of these 
properties contribute to Nef suppression remains to be determined. 
 
Role of SG nucleation on Nef suppression by Sam68 NLS-deleted mutants 
Heterogeneous nuclear RNAs (hnRNAs or pre-mRNAs) are synthesized, post-
transcriptionally processed and transported in the form of heterogeneous nuclear 
ribonucleoprotein (hnRNP) particles [321].  mRNAs are generally assumed to be 
translationally repressed to prevent ectopic expression while en route to the 
specific site of translation in the cytoplasm [322].  Viral mRNA including HIV-1 
should be no exception.  The movement of the viral mRNA in the cytoplasm 
requires their interaction with multiple host proteins, which give rise to RNA 
granules [323].  Multiple copies of HIV-1 mRNA have indeed been detected in 
these granules [324].  Thus, it is likely that changes in the components of this 
cellular machinery lead to aberrant targeting of HIV-1 mRNA to the translation 
machinery or to the sites of virion assembly [325, 326].  Our results showed that 
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410 and 321 mutants were capable of inducing SG formation and this 
phenomenon was associated with their ability to suppress Nef expression (Fig. 
13; Fig. 16; Fig. 31).   
 
SG are one type of RNA granules that form in response to a variety of external 
stimuli including over expression of proteins such as TIA-1 [299], G3BP [146], 
caprin-1 [147], staufen [141], FMRP [327], and pumilio [139].  SG formation has 
been recently recognized as a very effective way to spatially and temporally 
regulate gene expression by storing translationally arrested mRNA [298, 328].  
Consistent with these findings, HIV-1 nef RNA transcripts were detected in these 
SG induced by the ∆410 mutant (Fig. 25).  Although, less is known about the 
mechanism by which specific mRNAs are included or excluded from SG, different 
reports suggest that this process relies on the mRNA binding specificity of RBP 
recruited to SG [138, 298], which in turn seems to be highly dependent on mRNA 
secondary structure [124].  Our results showed that SG induction and inhibition of 
Nef expression by Sam68 NLS-deleted mutants required the RG/P3-rich region 
(aa269-aa321) (Fig. 13 & 45A).  Interestingly, RG-rich regions have been shown 
to be essential for SG assembly/recruitment of different RBP [146].  In the case 
of Sam68, the RG-rich region is involved in non-specific RNA binding [245], 
probably mediated by positively charged side chains, while the KH domain 
mandates its sequence-specific RNA binding [329].  Therefore, our results 
suggest that SG nucleation by Sam68 cytoplasmic mutants is mediated by 
heterotypic/homotypic protein-protein interactions with the P3, while the 
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sequence specific interactions between the nef mRNA and Sam68 mutants is 
likely due to the ability of the RG-rich region to confer the neighboring KH domain 
with the capacity to bind specific RNA [245], as is the case for the STAR family 
member BBP/SF1 [330].  In concordance, Sam68 RNA binding defective mutants 
(ΔKH) are incapable of suppressing Nef expression, inducing SG, or binding to 
the nef 3’UTR (Fig. 33 & 34; Table 2).  Notably, TIA-1 and G3BP expression did 
not suppress Nef expression, although their expression induced SG formation 
(Fig. 24), further supporting that Δ410 dictates the targeting specificity of nef 
mRNA to SG.  Finally, in agreement with our previous findings that no changes 
were observed on the stability of multiply spliced HIV-1 RNA (Fig. 9B), we 
determined that 410 was not localized to the P bodies (Fig. 19B), in which 
mRNA decay often occurs [294]. 
  
Differential regulation of tat, rev and nef mRNA 
In different cell types or stages of infection, the expression of tat, rev, and nef 
transcripts is reported to vary independently [331], indicating that cellular host 
factors finely tune their level of expression at the post-transcriptional stage. 
Indeed, multiple studies link the expression of host factors with specific exon 
utilization during HIV-1 splicing [332]; but little is known about differential 
translational regulation of HIV-1 gene expression.  Interestingly, tat, rev and nef 
mRNA show a significant sequence homology; however, their 5’UTRs and 
3’UTRs differ considerably in length and structure (Fig. 21B), which predispose 
them to differential regulation by host factors.  For example, nef possesses a 
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longer and more structured 5’UTR, thus a different mRNA scanning mechanism 
may be employed when compared to tat and rev.  Conversely, their 3’UTRs are 
also significantly dissimilar; hence, translational silencer proteins or miRNAs can 
have differential specificity for individual transcripts.  Using a novel minigene 
strategy, we unequivocally showed that 410 only suppressed Nef not Tat or Rev 
expression (Fig. 21), and that the 3’UTR of nef mRNA was directly involved in 
this process (Fig. 23).  The Yeast three-hybrid assay confirmed that 410 bound 
to the 3’UTR of nef mRNA while 269 or ∆KH did not (Table 2).  Since 410 fails 
to bind the nef 3’UTR in reverse orientation (Table 2), and to suppress Tat and 
Rev (Fig. 21& 22), we concluded that the nef 3’ UTR structure is critical for 410-
mediated targeting of nef mRNA to SG, and its subsequent translational 
repression. 
 
Physiological relevance of Nef suppression by Sam68-NLS deleted mutants 
Nef is a major pathogenic factor during HIV and SIV infection of primates, its 
deletion or mutation significantly reduces the pathology observed in rhesus 
macaques and humans infected with SIV or HIV-1, respectively [89]. Nef 
expression in lymphoid and monocytic cells regulates two key aspects of HIV-1 
infection and AIDS pathogenesis: evasion of the humoral and cellular immune 
response, and sustained hyperactivation of the immune system [102].  
Importantly, although clinically successful antiretroviral therapy can reduce viral 
replication to undetectable levels in plasma, Nef is continuously being expressed 
in latently infected PBMC [113], making Nef an ideal candidate for future 
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antiretroviral therapies.  In agreement with our previous results, we showed that 
410 was able to induce SG formation in a CD4+ T cell line (Fig. 26), and to 
suppress Nef expression in these cells (Fig. 27C) and in human PBMC (Fig. 
27E).  In addition, 410 expression partially restored surface expression of MHC-
I molecules (Fig. 27D).  These results show that down-regulation of Nef 
expression by 410 is observed in the natural target cells for HIV-1.  Therefore, it 
is conceivable that targeting Δ410 to infected cells could inhibit HIV replication 
through inhibition of Rev-mediated exportation, and sequestration of nef mRNA 
through SG induction, eliminating Nef expression and function and as a result, 
halting the disease progression to AIDS.  
 
Sam68, a new constituent of SG 
Sam68 has recently been shown to be in cytoplasmic RNA granules in 
hippocampal neurons and during early embryogenesis [223, 261].  To date, little 
is known about the role of Sam68 in host response to external stress; however, 
different lines of indirect evidence suggest that Sam68 could be recruited into SG 
in response to various stresses.  Sam68 translocates and accumulates in 
cytoplasmic granules under stressful conditions such as: poliovirus infection, 
ischemia, and puromycin treatment, which are also known to promote SG 
assembly [167, 261, 270-272].  Likewise, treatment with urate crystals results in 
Sam68 cytoplasmic localization in neutrophils [273].  Moreover, multiple 
previously characterized SG components are complexed with Sam68 in a direct 
or indirect manner [219, 274, 275].  During the first part of the current study, we 
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found that Sam68 cytoplasmic mutants are capable of inducing SG formation and 
inhibiting HIV-1 Nef translation through sequestration of Nef mRNA.  We report 
here that exogenous and endogenous Sam68 re-localizes with well characterized 
SG markers (TIA-1, G3BP, PABP and eIF3η) upon ARS treatment (Fig. 29 & 30).  
Sam68 also co-localized in SG with its previously characterized interacting 
protein hnRNP A1 during oxidative stress (Fig. 29).  In contrast, Sam68 was not 
found present within P bodies under any conditions tested here (Fig. 29E).  
However, similar to other proteins that serve as scaffold proteins between SG 
and P bodies [125, 128], or proteins that promote the movement of RNA from 
one structure to the other [125], some Sam68 containing granules were 
consistently in close contact with P bodies.  The relevance of this finding and its 
relation with translational regulation will warrant future experiments.   
 
The nuclear envelope as a limiting factor for Sam68 re-localization to SG 
during oxidative stress 
Despite the fact that Sam68 possesses a NLS, it is found in the cytoplasm under 
various conditions, including poliovirus infection [270], ischemia [271], urate 
crystals treatment [273], HIV infection [333], sperm cell meiosis [262], mitosis 
[308], neuronal depolarization [264], signaling transduction [224], and in 
occasional cells in mouse tissue [227].  The finding that Sam68 can be rapidly 
accumulated in the cytoplasm during acute conditions such as depolarization and 
ischemia suggests a shuttling mechanism; however, classical heterokaryon 
assays have failed to detect any apparent nuclear-cytoplasmic shuttling of 
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Sam68 [248].  On the other hand, it is possible that Sam68 localization in the 
cytoplasm results from alteration in the nuclear importation machinery (poliovirus 
infection) [334], disruption of the nuclear membrane and nuclear protein leakage 
(meiosis, mitosis) [335], or a high concentration of sam68 binding proteins that 
prevents nuclear importation just after translation (T cells, adipocytes) [336, 337].  
Furthermore, there are multiple nuclear RBP proteins that have been described 
to localize to SG upon oxidative stress.  Some of them (TIA-1, HuR, FMRP) 
constantly shuttle between the nucleus and the cytoplasm with mRNA and are 
retained in the cytoplasm during SG assembly [127, 137, 338]; others (hnRNP 
A1) undergo post-translational modifications during stress, which regulate their 
export/import rates and SG localization [160].  The current study shows that 
oxidative stress significantly enhanced Sam68 recruitment into SG although only 
in a small percentage of the cells (Fig. 30 & 31), and deletion of its NLS directly 
induces SG in a majority of the cells (Fig. 31 & 45B).  Therefore, it is conceivable 
that the nuclear envelope is a limiting factor for Sam68 recruitment to SG, while 
oxidative stress does not lead to Sam68 shuttling from the nucleus to 
cytoplasmic SG.  Instead, it seems plausible that Sam68 recruitment to SG only 
occurs in cells that have Sam68 in the cytoplasm.  One of the likely scenarios is 
possible variations on Sam68 localization in somatic cells during cell cycle 
progression, and this scenario deserves further investigation.         
 
 210
Role of the KH and RG rich domains in the process of Sam68 re-
localization to SG 
 Several proteins are recruited to SG via RNA-binding KH or RG rich domains. 
Deletion of RG-rich sequences from proteins such as FMRP [327], Caprin 1 
[147], G3BP [146], or RHAU [149] prevents their accumulation on SG;  similarly, 
KH domains target PCBP2 [145], ZBP1 [138], or hMex 3B [150] proteins to SG. 
As mention before, Sam68 binds RNA through a single KH domain (aa171-211), 
and it also contains a heavily methylated P3/RG-rich domain (aa269-321) that is 
involved in non-specific RNA binding [245], homotypic interactions [249], HIV 
replication inhibition [249, 267], and cellular localization [217].  Here, we 
demonstrated that deletion of each of these two domains abrogated Sam68 
recruitment to SG (Fig. 31; Fig. 33; Fig. 45B); however, their deletion differentially 
altered the localization of Sam68 mutant proteins.  Deletion of the P3/RG-rich 
domain resulted in a diffuse cytoplasmic (269) or nuclear (269-321) 
localization, whereas deletion of the KH domain led to formation of insoluble 
protein aggregates that are different from SG (Fig. 31; Fig. 33 & 34).  Therefore, 
our results and the fact that 410 selectively targets mRNA to free 
mRNP/monosomes fractions [267], further support our previous inference that 
cytoplasmic Sam68 binds to pre-initiation complexes through its KH domain, and 
that the P3/RG-rich region promotes nucleation of SG through homo-heterotypic 
interactions (Fig. 46).  
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Figure 46.  A working model for Sam68 recruitment to stress granules.  1. 
Large quantities of cytoplasmic Sam68-NLS mutants or endogenous Sam68 
(gray) in the presence of oxidative stress initiate stress granule (SG) nucleation 
through homotypic interactions, mediated by the RG-rich domain located 
between aa269 and aa321.  2. The small Sam68 primary aggregates are then 
cross-linked and recruited to mature SG in a secondary aggregation process, 
mediated by direct or indirect heterotypic interactions between Sam68 and SG 
core components such as TIA-1 or FAST.  3. Sam68 binds to specific mRNAs 
(red- i.e. nef mRNA) through its KH domain in a sequence specific manner, 
which are then targeted to mature SG for translational repression.  
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Role of heterotypic protein interactions in Sam68 recruitment to SG 
Recently, SG protein components have been classified into four categories: 
stalled initiation complexes (universal markers), RBP linked to translational 
regulation (reliable markers), RBP that regulate aspects of mRNA metabolism 
other than translation or decay, and proteins recruited to SG by core components 
through “piggy-back” interactions [124].  SRC3, KSRP, PMR1, and FAST are 
proteins recruited to SG through interactions with the SG core component TIA-1 
[128, 144, 156, 162].  Interestingly, Sam68 directly interacts with FAST [274], and 
forms a unique RNP complex with KSRP and intron 6 of the β-tropomyosin gene 
[275].  Here, we showed that Sam68 was not a core component of SG, since its 
knockdown does not affect SG assembly (Fig. 35).  In addition, using the 
bioinformatics and immunoprecipitation/Western blot analysis, we demonstrated 
that Sam68 bound to TIA-1 through its domain between aa269 and aa321 (Fig. 
36 & 37; Fig. 45B), and that its deletion resulted in impaired co-localization with 
TIA-1 in SG (Fig. 37B).  Therefore, it is plausible to speculate that when present 
in the cytoplasm, Sam68 is targeted to SG through its interaction with TIA (Fig. 
46).  However, whether this is a direct interaction, or mediated by RNA or FAST, 
remains to be determined.  Importantly, TIA-1 may not be the only core 
component recruiting Sam68 to SG, as results showed a possible interaction with 
G3BP (Fig. 38), and as mentioned above, Simarro et al. reported a direct 
interaction with FAST [274]. Dissecting the relevance of each of these 
interactions should be the focus of future studies.  
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The STAR family: an emerging class of proteins targeted to cytoplasmic 
RNA granules 
The extended family of STAR proteins is involved in multiple aspects of mRNA 
metabolism.  Two best characterized members, GLD-1 and Quakin 6, are bona 
fide translational repressors and involved in sexual identity [282], tumor 
suppression [283], and cell differentiation [284].  GLD-1 is targeted to 
cytoplasmic particles that resemble P bodies and SG in C. elegans [269].  The 
mouse qk gene produces three major isoforms with different cellular localization.  
QK-5 is predominantly nuclear, while QK-6 and QK-7 are localized in the 
cytoplasm.  Interestingly, over-expression of QKI-6 and QKI-7 but not QKI-5 
leads to their localization in cytoplasmic foci similar to SG [339].  All of the above, 
in addition to the results reported here that Sam68 is a novel component of SG 
(Fig. 29 & 30), indicate that STAR family proteins, when present in the 
cytoplasm, can regulate mRNA translation through targeting mRNA to 
cytoplasmic granules.  A number of RNA targets have been identified for Sam68, 
including poly (U), poly (A), A/U-rich sequences such as UAAA and UUUA, and 
several other cellular mRNA [190, 199, 200, 223, 340, 341].  Further 
characterization of Sam68 interaction with these RNAs, identification of additional 
cellular RNA targets, and elucidation of translational control of these RNA under 
oxidative stress will certainly add to our understanding of Sam68 biological 
functions, and their relation to RG localization.  
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Role of the ERK signaling pathway on eIF2α phosphorylation during 
oxidative stress 
The biological targets of ARS are still unknown.  However, it is thought that ARS 
interacts with cysteine-rich-redox-proteins such as glutathione and thioredoxin, to 
generate oxidative stress.  One of the initial characteristic cellular responses to 
ARS exposure is the inhibition of protein synthesis by eIF2α phosphorylation, in 
an HRI kinase-mediated process [169].  Increased phosphorylation of eIF2α 
during stress is the result of a balance between the activity of the stress-induced 
eIF2α kinases [168], and the rate of eIF2α dephosphorylation by PP1-GADD34 
phosphatase [342].  Importantly, the equilibrium of this reaction can be shifted by 
signaling pathways in a cell specific manner.  For example, activation of the 
MEK/ERK pathway enhances eIF2α phosphorylation by GCN2 in liver cells [319]; 
whereas it inhibits JNK activity in alveolar macrophages, which leads to PP1 
activation, eIF2α dephosphorylation, and protein synthesis [318].  During the 
present work, we showed that ARS treatment inactivates the MEK/ERK pathway 
in 293T cells (Fig. 40 & 41; Fig. 43A), and that its constitutive activation led to 
delayed phosphorylation kinetics of eIF2α (Fig. 42; Fig. 43B).  Whether the 
decreased rates of eIF2α phosphorylation are the result of increased HRI activity, 
or PP1 activity is still to be determined.  Moreover, the impact of these finding on 
cell survival or SG assembly should be further investigated in the future.   
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PERSPECTIVES 
 
Since the introduction of HAART therapy in the 1990s, the face of the pandemic 
and the course of the HIV/AIDS disease have changed drastically.  In contrast to 
the uniform fatality observed in the early eighties, HIV infection is now considered 
a chronic and manageable disease [109, 110].  Nevertheless, even though 
successful therapy can reduce viral replication to undetectable levels in plasma, 
it can not eradicate the virus from the body.  Furthermore, active viral replication 
can continue undetected in lymphoid tissue of the gut, with progressive 
deleterious effects [112].  As our understanding of the HIV/AIDS pathogenesis 
increases, HIV-1 regulatory proteins Tat, Rev and Nef have come into the light as 
key determinants for disease progression.  Tat is a critical viral factor for HIV-
associated dementia [343], whereas Nef increases immune activation and 
promotes evasion of the immune system [88].  Importantly, there are no current 
therapies directed to either of these viral proteins.  Therefore, host factors that 
regulate Tat, Rev or Nef expression or their biological functions are potential 
therapeutic targets for treatment of HIV-1 infection. 
 
The consensus binding site for Sam68  
In the current study, we have demonstrated that Sam68 NLS-deleted mutants 
are potent inhibitors of HIV-1 replication, and that Sam68 is absolutely required 
for efficient Rev-mediated nuclear exportation.  Both findings have been 
independently validated [78, 244].  Therefore, Sam68 is an ideal antiretroviral 
 216
therapeutic target.  However, its therapeutic potential will likely depend on a clear 
understanding of its biological functions.  Consequently, defining Sam68 mRNA 
targets should be the initial step in this course of action.  Previous reports have 
identified a number of mRNA targets for Sam68 [190, 199, 200, 223, 340, 341], 
however, no consensus RNA binding motif has been identified yet.  The recently 
described cross-linking immunoprecipitation (CLIP) method may allow an 
elucidation of the target specificity of Sam68 in vivo [344].  In this procedure, 
Sam68 could be immunoprecipitated from previously UV cross-linked and RNase 
treated cell lysates, generating 40-60 nt cross-linked tags, which are then cloned 
and sequenced revealing a possible consensus RNA motif.  Then, the presence 
of the consensus binding motif could be determined within the human and HIV-1 
genomes using BLAST analysis.  Subsequent experiments will address the role 
of Sam68 in the metabolism of the identified mRNA targets.  
 
Sam68 function on Rev-mediated nuclear export 
Rev exportation of intron-containing HIV-1 RNA is required for viral replication. 
Previous results in our laboratory have demonstrated that specific binding of 
Sam68 to Rev facilitates its nuclear exportation in a CRM-1-dependent manner 
[221, 243], and that its presence is absolutely required for this process to occur 
efficiently.  However, the exact role of Sam68 in the Rev nuclear export pathway 
remains undetermined.  The reasonable next step will be to determine if Sam68 
is present in the nuclear exportation megacomplex 
Rev/RRE/CRM1/RanGTP/RCC1, using sub-cellular fractionation and sucrose 
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gradient centrifugation.  In addition, our previous results suggest that Sam68 may 
promote the formation of this megacomplex; thus, similar experiments could be 
performed in cells depleted of Sam68, and the integrity of the complex can be 
evaluated in this context.  Future work regarding other aspects of this process 
such as: Sam68-mediated RanGTP hydrolysis or targeting to the nuclear pore 
complex will likely follow the initial experiments. 
 
Roles of Sam68 in HIV-1 replication in activated T cells. 
HIV-1 requires activation of T cells for efficient viral replication [5].  Therefore, 
regulatory molecules of the TCR signaling pathway can have a great impact on 
disease progression.  As previously mentioned, Sam68 interacts with and 
becomes phosphorylated by two major Src kinases that are activated upon T cell 
activation [224].  Furthermore, Sam68 has been shown to be tyrosine 
phosphorylated and recruited to signaling complexes in PBMC of HIV-1 infected 
individuals [333].  Therefore, It is reasonable to speculate that Sam68 might be 
required for proper T cell activation and consequently for HIV-1 replication.  To 
determine the role of Sam68 on HIV-1 gene expression in activated T cells, 
future experiments should take advantage of our previously tested Sam68 siRNA 
to effectively knock down Sam68 in T cells, and of NL4-3.Luc(nef) reporter virus, 
in which Luc expression is insensitive to the absence of Sam68 in 293T cells. 
Hence, HIV-1 gene expression can be examined in activated T cells with normal 
and reduced Sam68 levels.  In addition, HIV-1 LTR is potently transactivated in 
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activated T cells; thus, subsequent work can also address the relationship 
between Sam68, T cell activation and HIV-1 LTR activity. 
 
Sam68-NLS mutants as a potential anti-HIV therapy 
Nef is considered a major HIV-1 pathogenic factor; therefore, it is conceivable to 
speculate that suppression of Nef expression by Sam68-NLS mutants may be 
able to complement the current anti-HIV therapies that are mainly targeted at 
HIV-1 protease and reverse transcriptase, providing a better treatment outcome.  
To test this possibility, we could initially determine the efficacy of Sam68-NLS 
mutants to inhibit HIV-1 replication and Nef expression on an infected organism. 
Thus we could take advantage of the recently developed humanized mouse 
model, which recapitulates most of the immunological features observed in 
humans infected with HIV-1 [345].  Using a liposome based strategy; humanized 
mice infected with HIV-1 could be treated with DNA vectors expressing Sam68-
NLS mutant Δ410, thus we would be able to evaluate the effective expression of 
Δ410 in lymphoid tissues and its effect on HIV-1 replication and 
immunodeficiency progression.  Similar experiments could be performed on 
rhesus macaques infected with SIV.  However, any Δ410-based anti-HIV therapy 
should be pursued only with the certainty that Δ410 expression results in minimal 
interference with endogenous Sam68 function. 
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Identification of host factors that differentially regulate the expression of 
Tat, Rev and Nef  
Ribosomal movement to the initiation codon is abrogated in transcripts with long 
and structured 5’UTRs [289]; therefore, RNA helicases such as DHX29 or DDX3, 
are required to cooperatively unwind the cap-proximal region of those mRNAs, 
facilitating translation initiation [346, 347].  Interestingly, some of those cellular 
proteins are absolutely required for HIV-1 replication [77].  Furthermore, the nef 
mRNA 5’UTR is significantly longer and more structured than the rest of HIV-1 
RNAs (Fig. 21), suggesting that efficient translation of nef mRNA might require 
additional host factors.  Since Nef is a critical pathogenic determinant during HIV-
1 infection, cellular proteins involved in nef mRNA translational could be potential 
therapeutic targets.  Using our unique minigene system as an experimental 
model, subsequent experiments should address the role of RNA helicases 
involvement in efficient ribosomal scanning on Nef expression and HIV-1 
replication.  
 
miRNAs are small endogenous non-coding RNAs that post-transcriptionally 
repress gene expression by base-pairing with the 3’UTR of the target mRNA 
[348].  miRNAs dampen HIV-1 replication in activated T cells and contribute to 
viral latency in resting T lymphocytes [349, 350].  The extensive splicing during 
HIV-1 replication generates a myriad of mRNAs with significant sequence 
homology but with unique ORFs, 5’UTRs and 3’UTRs.  Therefore, a specific RNA 
sequence that is present in the 3’UTR of tat mRNA might also be located in the 
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5’UTR of nef mRNA, suggesting that the host miRNA machinery might finely tune 
HIV-1 gene expression, adding an additional layer of complexity to the regulation 
of HIV-1 gene expression.  This novel possibility should be addressed in future 
experiments, using the minigene system as an experimental model.  
 
Characterization of different types of SG 
The protein composition of SG varies during different stressful conditions, and 
this dictates the shape, biochemical properties, and the function of each type of 
SG.  For instance, SG which contain G3BP are significantly larger than TIA-1 + 
SG; or SG induced by overexpression of some proteins (G3BP or Δ410) are 
significantly more resistant to CHX treatment than endogenous SG; and SG 
induced by overexpression of particular proteins specifically results in 
translational repression of target mRNAs.  Consequently, understanding how 
proteins regulate SG function could shed some light into the biochemical 
mechanisms of SG-post-transcriptional gene expression regulation.  To address 
this issue, we could initially characterize the response of SG composed of 
endogenous or overexpressed proteins to chemical compounds which are known 
to affect SG stability such as translational inhibitors, microtubule destabilizng 
agents, or transcritptional inhibitors.  Importantly, using a similar approach, we 
could determine the role of specific proteins (i.e. TIA-1 or G3BP) on the assembly 
and stability of SG.  These series of characterization experiments will be very 
informative for the SG field. 
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Roles of SG in HIV-1 replication 
SG are now recognized as important cellular structures for viral reprogramming 
of the host translation machinery and cellular antiviral defense [124, 175]. 
Importantly, in a similar fashion as poliovirus, HIV-1 infection leads to a profound 
inhibition of cap dependent translation, due to proteolytic cleavage of eIF4G by 
HIV-1 PR [184], suggesting that at some stage during HIV-1 infection SG should 
be assembled.  Hence, using a previously constructed expression vector for HIV-
1 PR, an important next step will be to address in detail the effects of HIV-1 PR 
on the integrity of translational initiation factors, and its impact in SG assembly. 
Follow-up studies can then focus on SG assembly in the context of HIV-1 
replication, and on the possibility that HIV-1 viral proteins inhibit SG formation by 
specifically targeting SG core components. 
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